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Summary
Parasitic nematodes cause a wide range of diseases in humans, including river 
blindness caused by Onchocerca volvulus and elephantiasis caused by Ascaris 
lumbricoides (www.medic-planet.com). The greatest proportion of agricultural 
loss is in potato crops and is caused by potato cyst parasitic nematodes including 
Globodera pallida.
For survival, nematodes need to sequester fatty acids (usually from the host) and 
therefore must produce proteins capable of binding essential fatty acids (Kennedy 
et al, 1995). The nematode proteins studied in this project have been classified 
into two new types of fatty acid and retinoid binding proteins. Firstly, nematode 
polyprotein allergens/antigens (NPA), an example of this class of protein is the 
Ascaris body-fluid allergen (ABA-1) of the parasitic nematode Ascaris. The 
second class are known as fatty acid and retinol binding proteins (FAR), an 
example of this class is OvFARl from the parasitic nematode Onchocerca 
volvulus.
The nematode proteins are believed to be a cause of severe allergic-type reactions 
in nematode infections (Christie et al, 1990). Since the pathology of these allergic 
reactions dictate the involvement of the immune response system, it is thought 
that these classes of protein are potential candidates for vaccines containing 
recombinant protein antigens (McDermott, 1999).
ABA-1 was purified from Ascaris suum (pABA-1) and produced recombinantly 
(rABA-1). Fluorescence studies using DAUDA showed that rABA-1 is similar in 
binding to the pABA-1. Secondary structure studied using circular dichroism 
indicated rABA-1 and pABA-1 have similar secondary structures. Crystallisation 
of pABA-1 and rABA-1 using a large range of conditions failed to produce 
crystals suitable for diffraction and was investigated using dynamic light 
scattering (DLS), which suggested a dimer structure.
GpFARl, OvFARl, CeFAR2 and CeFAR3 proteins from the FAR family of 
proteins were overexpressed and purified. Ligand binding properties of rOvFARl, 
rCeFAR2 and rCeFAR3 established that the CeFARs from Caenorhabditis 
elegans were good functional homologues of rOvFARl, a major antigen of 
Onchocerca volvulus. Binding DAUDA suggested that the binding site is in an 
apolar environment and isolated from solvent. Competition between retinol and 
oleic acid indicated that the binding site was interactive or congruent. The FAR 
proteins also showed a preference for fatty acids with chain length C14-C18, 
investigated by competition of the DAUDA-FAR protein complex. This would 
indicate that the recombinant proteins are behaving as they do in vivo.
The biophysical properties of rOvFARl, rCeFAR2, rCeFAR3 and rGpFARl were 
investigated. Circular dichroism suggested that these FAR proteins have 
essentially the same secondary structure. MALDI analyses suggested that fatty 
acids are bound to the proteins and were persistently bound after a multistep 
purification, possibly sequestered from E. coli during overexpression. DLS 
measurements indicated that the proteins were heterogeneous.
The objective o f the project was to characterize a number of these NPA and FAR 
proteins with the ultimate goal of determining their 3-D structure. Initially, seven 
proteins were investigated (ABA-1, GpFARl, OvFARl, CeFARl, CeFAR2, 
CeFAR3, CeFAR5) and only the more viable and attainable were carried forward 
for further characterization and attempts at crystallisation. However, rGpFARl 
was the only FAR protein that grew protein crystals, diffraction of these needle 
crystals showed that they were twinned or hollow.
For future crystallisations to be successful, new purification methods are required 
for the FAR proteins.
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Chapter 1 Introduction
Chapter 1 - Introduction
1.1 Parasitic nematodes
Parasitic nematodes are multicellular, eukaryotic organisms with highly 
specialised mechanisms, which allow them to evade the immune system of 
their host and survive for long periods in the host. They are predominantly 
found in the tropics and subtropics. Parasitic nematodes cause a wide range of 
diseases in humans, including river blindness caused by Onchocerca volvulus 
and elephantiasis caused by Ascaris lumbricoides and other parasitic 
nematodes (www.medic-planet.com). In developed countries they cause loss 
through chronic or fatal diseases and substantial economic losses o f up to 60 
billion pounds worth of crops each year. The greatest proportion of 
agricultural loss is in potato crops and is caused by potato cyst parasitic 
nematodes including Globodera rostochiensis and Globodera pallida 
(www.inra.fr). Parasitic nematodes also cause problems in livestock.
To survive, there is a requirement for these nematodes to sequester fatty acids 
(usually from the host) and therefore the nematodes must produce proteins 
capable of binding these essential fatty acids (Kennedy et al, 1995a). For the 
nematodes studied in this project the proteins have been classified into two 
new types of fatty acid and retinoid binding proteins called nematode 
polyprotein allergens/antigens (NPA) and fatty acid and retinol binding 
proteins (FAR) (Garofalo et al, 2002).
It is currently believed (McDermott, 1999) that both types of protein play 
major roles in the metabolism of the parasites and that they are involved in the 
transport and sequestration of hydrophobic anti-nematode ligands. The ligands 
that these proteins bind and presumably protect from degradation are of great 
importance to the parasitic nematodes because they cannot synthesise these 
complex lipids themselves and must therefore acquire them from their host.
The first o f these newly classified proteins, known as nematode polyprotein 
allergens/antigens (NPAs) are synthesised as large polyproteins that are
1
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subsequently cleaved at regularly spaced sites to form multiple copies of fatty 
acid binding protein having a molecular mass between 14 and 15 kDa (Spence 
et al, 1993). An example of this class of protein is the Ascaris body-fluid 
allergen (ABA-1) of the parasitic nematode Ascaris, which sequesters fatty 
acids, including palmitic acid and stearic acid. These NPAs are extracellular 
proteins, abundant in the pseudocoelomic fluid of nematodes. This fluid is 
analogous to human blood, in that it bathes all the internal organs of the 
nematode. Therefore, it is likely that NPAs act as carriers responsible for 
organising the distribution of hydrophobic ligands within the parasite.
The second class of protein known as fatty acid and retinol binding (FAR) 
proteins are slightly larger in size, approximately 20 kDa (Bradley & Kennedy, 
1999). Like NPAs they bind fatty acids and retinol, but differ in that they 
possess a higher affinity for the latter. They also differ in that they are not 
synthesised as polyproteins. An example o f this class is OvFARl from the 
parasitic nematode Onchocerca volvulus. OvFARl is also an extracellular 
protein, which is particularly abundant in the body wall of the worm and its 
larvae, which develop within the host uteri.
The major interest in both the NPAs and FAR proteins, with respect to 
infections, is that they are secreted by the parasites and so could be involved in 
controlling the tissue environment or acting to counter immune defence 
reactions o f the host. They are believed to be a cause of severe allergic-type 
reactions, which occur in nematode infections (Christie et al, 1990). Since the 
pathology of these allergic reactions dictate the involvement of the immune 
response system, it is thought that these classes of protein are potential 
candidates for vaccines containing recombinant protein antigens (McDermott, 
1999).
2
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1.2 Nematode polyprotein allergens/antigens (NPAs)
Nematode allergens were first discovered due to the hypersensitive response of 
the immune system against them. There are a large number o f nematode 
allergens that are responsible for conditions as diverse as elephantiasis, 
filariasis and asthma. Elephantiasis is a disorder o f the lymphatic system and 
is characterised by enlargement o f body areas including limbs, torso and head 
(figure 1.1).
Figure 1.1 Elephantiasis o f legs due to filariasis (www.gsk.com/filariasis )
The swelling of body areas is caused by an accumulation of fluid as a result of 
obstruction of lymph or blood flow. This blockage can occur due to bacterial 
infection or nematodes living in ducts or glands 
(www.elephantiasis.freeyellow.com). Proteins synthesised by these parasitic 
nematodes are potent allergens that can cause many diseases and are abundant 
in both the somatic and excreted/secreted material of the parasites (Britton et 
al, 1995). Allergens have been characterised from several different species o f 
nematode (figure 1.2), including ABA-1 from Ascaris lumbricoides and
3
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Ascaris suum , gp 15/400 from Brugia pahangi, DvA-1 from Dirofilaria immitis 
and TBA-1 from Toxocara canis.
1 10 20 30 40 50 B0 70 80 90 100
RBfl-1 ffr I i  HYtDEi EGDfl KERTEHLKGG REI! KHVYGEEKflflELKNLKDSGflSkEELKflKVEEflLHflVTOrEKKQYIflDFGPflCKKIYGVHTSRRRRHIirTL 
TBft-1 HHFTL
Dvfl-1 DKTLEFYHflLPTHEKfllHDKFYTKYCWHI KEVflSOLEIGKLKEL-ESEKNKLfll LTSIYSFKDRL-i'i VDQRKVELHKET DEYVTKGL'^ KKRDS—  
Consensus . k . l . . y . . l . . . . k . . . . . . . . . . c . . . l k . v . . . e . . . . l k . l . . s . . . k e . l . . . . . . . . . . . . d e . . . . . . . . . . . . c . . . . . . . . s r . r r h h f b l
101 110 120 130 140 150 180 170 180 190 200I-------  ,-------- ,-------- ,--------    i-------- 1--------     1
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Figure 1.2 Sequence alignment of nematode polyprotein allergens. Accession numbers are 
Q06811, Q24702 and P49149 for ABA-1, DvA-1 and TBA-1 respectively. Red signifies 
100% similarity and blue signifies 50% similarity.
Nematode allergens are synthesised as large precursors (200 - 400 kDa), which 
are proteolytically cleaved giving rise to multiple polypeptide units o f 
molecular mass 1 4 - 1 5  kDa (Britton, 1995 et al\ Poole et al, 1996). For this 
reason these “ladder proteins” are called “nematode poly protein 
allergens/antigens” (NPAs). Production o f polyproteins is a highly efficient 
means o f producing proteins rapidly and economically. The large precursors 
are cleaved at proteolytic sites similar to the cleavage sites of endoproteinases 
o f the subtilisin family (Barr, 1991), as the target sites are composed o f basic 
amino acids, predominantly Arginine (figure 1.3). Repeating units within each 
NPA array also show variation in amino acid sequence. For example, 
Dictyocaulus viviparus polyprotein is composed o f 12 different units that vary 
in size and may exhibit between 17 % and 98 % amino acid identity (Britton et 
al, 1995). The amino acid sequences o f individual repeat units vary, although 
all NPAs contain conserved residues, Trpl5, Gln20, Leu42, Cys64 and Cysl20 
(figure 1.7) (McDermott, 1999). Fluorescence studies suggest Trpl5 is either 
buried internally in the structure or surrounded by several hydrophobic groups 
(McDermott, 1999). Cys64 and Cysl20 are probable candidates for a 
disulphide bond which would stabilise the structure. Since individual parasites
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can produce a different NPA, the structure-fiinction of each NPA needs to be 
investigated individually.
D. immitis ... Asn Glu Arg Arg Lys Arg Asn Asp His ...
B. malayi ... Glu Asp Arg His Lys Arg Asp Asn His Glu His ...
A. suum ... Thr Ser Arg Arg Arg Arg His His Phe ...
Figure 13  Amino acid sequence o f proposed cleavage site. Residues marked in bold indicate 
the cluster of 4 basic amino acids at which the polyprotein is cleaved.
(Kennedy, 2000).
Structural evidence
The first fatty acid binding proteins were from a family o f cytosolic proteins, 
which transport and protect hydrophobic compounds. They comprise 10 anti- 
parallel p-strands and 2 short a-helices surrounding the interior binding cavity 
in a p-barrel type structure (Banaszak et al, 1994). Multiple alignments of 
NPA sequences show no significant similarity to any protein of documented 
function on current databases and only match other NPAs (Kennedy et al, 
1995b). Throughout this project no X-ray or NMR structures were available 
for any NPA protein. However, in November 2002 an initial structure from 
NMR data became available (N. Meenan, A. Cooper, personal 
communication).
Single gel filtration peaks correspond to dimers of DvA-1 and ABA-1 
(Kennedy, 2000). Far UV circular dichroism studies analysed over 240-190 
nm by the CONTIN procedure (Provencher & Glockner, 1981) show the 
proteins to have a high a-helical signal (Kennedy, 2000). Secondary structure 
predictions of individual sequences of NPAs have been performed using GOR 
algorithms (Gamier et al, 1978), Chou and Fasman (Chou & Fasman, 1974) 
and PHD (Rost et al, 1994) and were found to agree with CD studies, as they 
predict that a single NPA unit is extensively helical, with little or no evidence 
of p-structure (Kennedy et al, 1995b).
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Functional evidence
NPAs are fatty acid and retinoid binding proteins. The fluorescence emission 
of DAUDA is taken as a measure of the polarity o f the binding site. Thus 
NPAs binding DAUDA with an increase in intensity and a blue shift in 
fluorescence indicates the ligands bind in an apolar environment (Kennedy et 
al, 1995a; McDermott, 1999). Table 1.1 shows lists of ligands found to bind 
or not bind to NPAs. There is only one binding site for each NPA molecule 
per ligand molecule. This was investigated by titrating the NPA molecule with 
DAUDA, with a dissociation constant (Kd) estimated to be (8.8 ± 0.5) x 10'8 M 
(Kennedy et al, 1995a). Ligand competition experiments indicate that the 
binding site for fatty acids is the same as that for retinol and retinoic acid 
(Kennedy et al, 1995(a), 1995(b), 2000).
Binding No binding
Oleic acid Cholesterol
Palmitic acid Tryptophan
Stearic acid Caproic acid
Retinoic acid Squalene
Retinol Tocopherol
Oleoyl-CoA Tocopherol acetate
Bilirubin Succinyl CoA
Cis parinaric acid 2-methylbutyric acid
Trans parinaric acid 2-methylvaleric acid
Arachidonic acid Bilverdin
Lysophosphatidic acid Mebendazole
Lysophosphatidyl ethanolamine Albendazole
Lysophosphatidyl choline Thiabendazole
Platelet activating factor Oxibendazole
Lysoplatelet activating factor Piperazine
Leukotrienes B4, C4, D4, E4 Tetramisole
Pyrantel
DEC
Levamisole
Table 1.1 Ligand binding by nematode polyprotein allergens/antigens.
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NPAs are abundant in the pseudocoleomic fluid o f nematodes, analogous to 
our blood as it bathes the organs of the body, and therefore it is likely that 
NPAs act as carriers o f hydrophobic ligands within the parasite. The ligands 
they bind, and presumably protect from degradation, are essential to parasitic 
nematodes. This is because nematodes cannot synthesise these complex lipids 
themselves, and hence must acquire them from their host. Since NPA function 
has not yet been determined, their allergenicity remains a focus o f attention 
(Kennedy, 2000). The NPAs could be potential drug targets, given that they 
appear to have no counterparts in vertebrates and their ligand binding sites 
have unusual properties.
1.2.1 NPAs specific to this project - Ascaris and ABA-1
The parasitic nematodes Ascaris suum and Ascaris lumbricoides are 
responsible for Ascariasis or roundworm infection, which is common in 
tropical and temperate climates (figure 1.4) where there is high humidity and 
low standards of hygiene and sanitation. About 26 % of the world population 
particularly children, are infected at any one time.
V  r *  im
Figure 1.4 Map showing in red the countries affected by elephantiasis 
( www.gsk.com/filariasis)
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Symptoms o f infection include inflammation and haemorrhage o f the liver and 
lungs due to an accumulation o f dead larvae and tissue, which contribute to 
disease manifestations, including elephantiasis (see figure 1.1). The majority 
o f infections show no symptoms, but the presence o f even a few worms can be 
fatal. Although the adult nematodes are not normally long-lived, there is an 
annual cycle (figure 1.5) o f infection coinciding with the lifecycle of Ascaris 
(Muller et al, 1975).
T h e  L i f e  C y c l e s  o f  A s c a r i s  l u m b r ic o id e s  
a n d  A s c a r i s  s u u m  
( in t e s t in a l  r o u n d w o r m s  o f  h u m a n s a n d  p ig s )
Adult m ales and fem ales 
in the small intestine.
Juveniles in eg g s  mature to 
the infective (second) stage.
M M %
E ggs ingested  by host and 
hatch in the small intestine. 
The juveniles penetrate the 
t is su e s  o f the intestine and 
enter the blood stream.
_  The Juveniles are "coughed up"
 and sw allowed. The juveniles
com plete their developm ent 
In the small Intestine.
Fem ales produce e g g s  that 
are p a ssed  In the host's feces . 
(A single fem ale can produce 
200,000 eg g s  per day!)
The third stage juveniles migrate 
from the pulmonary capillaries 
into the alveoli (air sacs).
The juveniles migrate to the 
lungs and molt into third 
stage juveniles.
(Parasites and Parasitological R esources)
Figure 1.5 Life cycle of Ascaris (www.biosci.ohio- 
state.edu/~parasite/lifecycles/ascaris_lifecycle.html).
Fertilised eggs are passed in faeces. In the soil the first-stage larva in the egg 
moult and an egg containing second-stage larva develops, which is infective 
and can survive for up to 7 years. When the eggs are swallowed the larvae 
hatch in the duodenum or small intestine which are o f ideal conditions, 37 °C 
and pH 7. The larvae then burrow into intestinal wall and are carried in lymph
8
Chapter 1 Introduction
or blood through the lungs where they moult again. Finally they travel through 
the oesophagus to the ileum. Mature female nematodes can survive for 1 -  2 
years and lay more eggs for the cycle to repeat and with it the cycle of 
infection.
Within the context of infection, Ascaris Body-fluid Allergen (ABA-1) is the 
potent allergen protein of Ascaris Lumbricoides and Ascaris suum. The 
relationship of Ascaris Lumbricoides in man compared to the parasite Ascaris 
Suum in the pig is still unresolved. Though, the latter is usually regarded as a 
separate species (Muller et al, 1975). Purified ABA-1 from Ascaris suum was 
found to be potently allergenic in experimental animals (Tomlinson et al, 
1989), and could therefore represent an important stimulus to the potentially 
lethal pulmonary and intestinal hypersensitivity reactions that arise in 
Ascariasis (Kennedy et al, 1995b). ABA-1 has been characterised as the most 
abundant protein in the pseudocoelomic fluid and in the somatic tissues of the 
adult Ascaris and it is released into the host’s tissues by the invasive stages of 
the parasite.
ABA-1 structural predictions
ABA-1 behaves like all other NPAs and shows a single peak with a molecular 
weight of 27400 Da in gel filtration, yet SDS PAGE gives a single band at 
14400 Da suggesting that ABA-1 may exist as a dimer (Kennedy et al, 1995b). 
DSC analysis revealed two major transitions, which is consistent with the 
existence of two distinct structural domains within the ABA-1 (Kennedy et al, 
1995b; Christie et al, 1993). It is not known whether biochemical activity 
depends on the formation of a dimer. The non-glycoslated protein has a mass 
of 15.1 kDa, consists of 129 amino acids and has an isoelectric point of 5.2 
(Christie et al, 1990). The polyprotein amino acid sequence consists of 395 
amino acids (figure 1.6).
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AKILHYYDEL EGDAKKEATE HLKGGCREIL KHVVGEEKAA
ELKNLKDSGA SKEELKAKVE EALHAVTDEE KKQYIADFGP
ACKKIYGVHT SRRRRHHFTL ESSLDTHLKW LSQEQKDELL
KMKKDGKAKK ELEAKILHYY DELEGDAKKE ATEHLKGGCR
EILKHVVGEE KAAELKNLKD SGASKEELKA KVEEALHAVT
DEEKKQYIAD FGPACKKIYG VHTSRRRRHH FTLESSLDTH
LKWLSQEQKD ELLKMKKDGK AKKELEAKIL HYYDELEGDA
KKEATEHLKG GCREILKHVV GEEKAAELKN LKDSGASKEE
LKAKVEEALH AVTDEEKKQY IADFGPACKK IYGVHTSRRR
RYHAEDGTDDIDGLAQSRQR RSGFFEKLID VFAFF
Figure 1.6 Amino acid sequence of polyprotein ABA, with the arginine tetrad where
cleavage occurs highlighted in bold (www.ca.expasy.org/sprot/). Accession number 
for ABA-1 is Q06811.
The polyprotein ABA is cleaved into repeat units, which are not identical; 
adjacent repeats can differ by as much as 51 % of their amino acid residues 
(Kennedy, 2000).
HHFTL ESSLDTHLKW LSQEQKDELL KMKKDGKAKK ELEAKILHYY 
DELEGDAKKE ATEHLKGGCR EILKHVVGEE KAAELKNLKD 
SGASKEELKA KVEEALHAVT DEEKKQYIAD FGPACKKIYG 
VHTSRRRR
Figure 1.7 Amino acid sequence o f ABA-1 (http://ca.expasy.org/sprot) cleaved from 
polyprotein residues 96 -  228, with conserved residues in bold.
CD analysis of the far UV spectrum analysed by the CONTIN procedure 
predicted a high degree of a-helix in the secondary structure of ABA-1. 
Secondary structure predictions of individual sequences of NPAs have been 
performed using GOR algorithms (Gamier et al, 1978), Chou and Fasman 
(Chou & Fasman, 1974) and PHD (Rost et al, 1994) and were found to agree 
with CD studies, as they predict that a single NPA unit is extensively helical, 
with no evidence of p-structure (Kennedy et al, 1995b). The amino acid
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residues fell into four regions of predicted helix, so it might therefore form a 
four-helix bundle similar to carrier proteins such as cytochromes. The 
predicted four helix structural motif (primarily amphipathic helices) shows the 
amino acids involved in the helices have well-defined hydrophobic faces and 
they orient towards a hydrophobic protein core (Kennedy et al, 1995b).
The proposed four-helix structure for ABA-1 is conserved across the whole 
family o f NPAs. The hydrophilic and hydrophobic nature of the residues are 
well conserved across all the NPAs (Kennedy et al, 1995b), strongly suggesting 
that this pattern is structurally or functionally significant.
ABA-1 provides a highly manipulative model for the investigation of the 
interaction between hydrophobic ligands and a-helical proteins. If  structural 
predictions of ABA-1 are correct then it is distinct from the family of small 
lipid binding proteins, which include intestinal fatty acid binding proteins, 
cellular retinoic acid and retinol binding proteins, all o f which are 
predominantly p-barrel with little a-helical content (Banaszak et al, 1994).
ABA-1 binding characteristics
Binding studies using the fluorescent fatty acid analogs DAUDA and DACA, 
have demonstrated that ABA-1 binds fatty acids, with a single binding site per 
monomer unit, with a dissociation constant (Kd) estimated to be (8.8 ± 0.5) x
o
10" M (Kennedy et al, 1995b; Kennedy, 2000). The fluorescence emission of 
DAUDA and DACA increases and exhibits a blue shift in emission 
wavelength when bound to ABA-1. This is distinctive from P-barrel type fatty 
acid-binding proteins (FABPs), which show less of a blue shift in emission 
wavelength. The blue shift of DAUDA in ABA-1 has also been observed with 
cyclohexane suggesting that either the environment of the protein’s binding 
site is apolar or that there are unusual specific interactions in the binding site. 
Similar blue shifts in fluorescence when bound to DACA could indicate that
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the ligand is bound in a non-polar environment and in isolation from solvent 
water (Kennedy et al, 1995b; McDermott, 1999).
ABA-1 has a single conserved tryptophan (Trp 15). Trp 15 emission at a short 
wavelength indicates that it is buried. The accessibility of the Trp 15 to the 
water environment examined using quenching of fluorescence by succinimide 
showed minimal quenching confirming that the Trp 15 is buried within the 
hydrophobic environment of the structure. Other fluorescent experiments 
show it to be unaltered when oleic acid was added to ABA-1 (Kennedy et al, 
1995b), therefore unlikely to constitute a binding site.
ABA-1 also bound retinal and retinoic acid (Kennedy et al, 1995a). The 
change in retinol and retinoic acid fluorescence in ABA-1 was reversed by 
addition of oleic acid, indicating that the binding site for retinol and oleic acid 
was competitive (Kennedy et al, 1995b).
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1.3 Fatty acid and retinol (FAR) binding proteins
Onchocerca volvulus FAR and its homologues represent another novel family 
o f fatty acid and retinoid binding protein from nematodes that are manifest by 
the severe allergic response of the immune system against them. They are 
responsible for conditions as diverse as river blindness, lymphatic filariasis 
and agricultural damage. River blindness has a variety of symptoms including, 
serious visual impairment, including blindness (figure 1.7), rashes, lesions, 
intense itching and depigmentation o f the skin. The symptoms are due to a 
parasitic worm that lives and migrates throughout the human body.
Figure 1.8 Image of Onchocerca volvulus infection of the eye (www.trachomahki.org/
imageye3).
Proteins synthesised by these parasitic nematodes are potent allergens from 
several different species of nematode and include, OvFARl a major antigen of 
the parasitic nematode Onchocerca volvulus, Bm20 from the human lymphatic 
filariasis parasite, Brugia malayi, GpFARl from the potato cyst nematode, 
Glohodera pallida and CeFAR2 and CeFAR3 from Caenorhahditis elegans 
(figure 1.9).
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Figure 1.9 Sequence alignment of the FAR proteins. Accession numbers are CAA70477, 
AAC32662, NM 073850 and NP 506251 for GpFARl, OvFARl, CeFAR2 and CeFRA3 
respectively. Red signifies 100% similarity and blue signifies 50% similarity.
Similar to the nematode polyprotein allergens (NPAs), these proteins are helix- 
rich, but are slightly larger, having a molecular mass in the range o f 20 kDa. 
They are distinct from the NPAs in that they are not produced as polyproteins 
and contain none o f the conserved residues o f NPAs (McDermott, 1999). In 
particular, OvFARl and its homologues do not contain a trytophan residue.
Structural evidence
The first fatty acid binding proteins were from a family o f cytosolic proteins, 
which comprised of 10 anti-parallel (3-strands and 2 short a-helices 
surrounding the interior-binding cavity in a (3-barrel type structure (Banaszak 
et al, 1994). Multiple alignments of FAR sequences show no significant 
similarity to any protein of documented function on current databases 
(Kennedy et al, 1995b). No X-ray or NMR structures yet available for any 
FAR protein.
Secondary structure sequence based predictions using GOR (Gamier et al, 
1978) and PredictProtein (http://ca.expasy.org/tools) indicate that the FAR 
proteins are helix-rich with no predictions for beta structures (Garofalo et al, 
2002). Circular Dichroism (CD) studies analysed over 240-190 nm by the 
CONTIN procedure were found to agree with secondary structure sequence 
based predictions, as CD shows the proteins to have a high a-helical signal
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(Kennedy et al, 1997).
Analytical ultracentrifugation shows that the dimerisation states of the FAR 
proteins differ with each protein, for example, rOvFARl forms a tight dimer 
whilst rCeFAR-5 is a monomer (Solovyova et al, 2003). These 
oligomerisation states are unaffected by ligand binding and protein 
concentration.
Functional evidence
FAR proteins have been shown to bind retinoids with a high affinity, fatty 
acids with a lesser affinity and do not bind cholesterol. The former is of 
particular importance considering that infection with Onchocerca volvulus 
causes eye pathology (figure 1.7) and disfiguring skin conditions. Similar 
symptoms are caused by a deficiency in available retinoids (Bradley, 1999).
The fluorescence emission of retinol upon mixing with a FAR protein 
undergoes a dramatic increase, indicative of entry into a protein binding site 
(Garofalo et al, 2002). There is competition for the binding site of the FAR 
proteins demonstrated with oleic acid competing effectively with DAUDA for 
binding, indicating congruence or interaction between binding sites for lipids. 
The fluorescence emission of DAUDA is taken as a measure of the polarity of 
the binding site. FAR proteins bind DAUDA with an increase in intensity and 
a blue shift in fluorescence, which indicates the ligands bind in an apolar 
environment, isolated from solvent water (Kennedy et al, 1997; Garofalo et al, 
2002).
Although the function and true in vivo binding propensities of the FAR 
proteins remains to be established (as with NPAs), their secretion into tissues 
of infected hosts could be important to the survival of the parasite. With no 
structural counterparts in mammals, OvFARl could provide a novel 
therapeutic target for onchocerciasis therapy.
The main reason for studying Caenorhabditis elegans FAR proteins is that
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they are homologues o f the OvFARl protein. Caenorhabditis elegans is 
selected as a model to investigate the function o f these proteins since 
Caenorhabditis elegans is much more amenable to experimental analysis than 
the pathogenic Onchocerca volvulus, which requires an insect vector as well as 
a human host in order to complete its life-cycle.
1.3.1 Onchocerca volvulus and OvFARl
The parasitic nematode Onchocerca volvulus is a major causative agent of 
river blindness, also known as onchocerciasis. It is most commonly found in 
West Africa and Central America (figure 1.10) where it is spread to humans 
through the black fly vector. It has been estimated that 120 million people 
worldwide are at risk o f onchocerciasis and that 96 % of these are in Africa, 
with a total o f 18 million people infected with the disease 
(www.who.int/tdr/diseases/oncho).
Figure 1.10 Geographical distribution of Onchocerca Volvulus 
(www.biosci.ohio-state.edu/~parasite/onchocerca).
Symptoms o f infection include serious visual impairment, including blindness, 
rashes, lesions, intense itching and depigmentation of the skin. The parasite 
Onchocerca volvulus is transmitted by black fly, which breeds in fast-flowing 
rivers, in contrast to the stagnant-water breeding sites o f mosquitoes. The
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infective larvae o f Onchocerca volvulus are transmitted when the fly takes a 
blood meal from an infected person, whereupon the larvae develop into adult 
parasites and gather in palpable, collagenous, subcutaneous nodules where 
they develop into sexually reproducing adult worms. Female adults release 
several hundred larvae daily (termed microfilariae), which migrate from the 
nodule to the skin where they may be taken up by the vector completing the 
lifecycle (figure 1.11). It is at the micro filarial stage o f the parasite that causes 
the pathology o f onchocerciasis (Muller et al, 1975; www.who.int).
The Life Cycle o f O n c h o c e r c a  v o l v u l u s
(ONCHOCERCIASIS OR RIVER BLINDNESS)
The adult w orm s  
o ccu r  in "nodules"  
ju st  under th e  skin  
o f th e  hum an h ost.
M icrofilariae are 
in g e ste d  b y  a black  
fly  w h en  it feed s.
\
The fem ale  w orm s  
p rod u ce m icrofilariae 
w h ich  are foun d  in the  
su b c u ta n e o u s  t is su e s .
T he in fective  
ju v e n ile s  m ature 
in to adults.
Infective ju v e n ile s  
are in jected  into a 
hum an w hen  
th e  fly  fe e d s .
t
The m icrofilariae 
m ature into  
in fective ju v e n iles .
(P a ra sites  and P arasito log ica l R eso u rces)
Figure 1.11 Lifecycle of Onchocerca volvulus (www.biosci.ohio- 
state.edu/~parasite/lifecycles/onchocerca_lifecycle.html).
The use o f vitamin A (retinol) in treatment of ocular onchocerciasis was 
introduced because it was believed that infection induced vitamin A
17
Chapter 1 Introduction
deficiency. The symptoms o f vitamin A deficiency are similar to 
onchocerciasis and include night blindness, destruction of the cornea and also 
similar skin pathology (Bradley et al, 1999). A study (Mustafa et al, 1979) on 
onchocerciasis patients found that their level of Vitamin A was reduced. 
Onchocerca volvulus infection may contribute to the host being deficient in 
vitamin A by simple sequestration of retinol. The retinol concentration in the 
nodules formed by Onchocerca volvulus has been reported to be eight times 
that of the surrounding host tissue, which is likely to be particularly harmful 
for infected patients with a poor dietary intake of vitamin A (Lai & James,
1996). It has been suggested that Onchocerca volvulus requires retinol for a 
variety of metabolic and developmental purposes, including growth, 
differentiation, embryogensis, glycoprotein synthesis and anti-oxidants (Sani 
& Vaid, 1985). A role in growth and development was suggested by 
experiments with radio labelled retinoic acid in Brugia malayi, also a filarial 
parasite, which showed that it was taken up by worms and localised to high 
concentrations in early and late embryonic forms (Bradley & Kennedy, 1999).
The treatment of river blindness includes Ivermectin and Diethylcarbamazine 
drugs which are capable o f reducing the numbers of skin microfilariae in 
infected people. Both drugs will kill the adult nematodes, however, symptoms 
such as blindness are irreversible (www.who.int).
OvFARl is the allergen protein secreted by Onchocerca volvulus and the 
causative agent of river blindness. It is hoped that by determining the 3-D 
structure by X-ray crystallography the structure/function relationship of 
OvFARl can be elucidated thereby creating a route to designing inhibitors to 
prevent river blindness.
OvFARl structural predictions
Predictions of secondary and biophysical analysis have shown that the 
molecule is predominantly a-helical, with no evidence of p structure. This 
immediately discriminates it from retinol-binding proteins of similar sizes in
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humans, in which p structures predominate (FABPs). Recent work on 
Onchocerca volvulus showed that retinol binds to OvFARl protein. OvFARl 
has a molecular weight 19.7 kDa (Bradley & Kennedy, 1999), with 178 amino 
acids (figure 1.12) (http://ca.expasy.org/sprot/).
MYHQLILMALIGVIMANWPFSMSNIPEEYKEFIPEEVKNFYKNLTQED 
RQILREL ASKHATFTNEDAALE ALKNKSDKL Y QKAVELRNF VKAKIDS 
LKPDAKAFVDEIIAKVRSLRPEDGQKLDMEKLKQAARDIIAKYEALNE 
ETKEELKATFPNTTKIITNEKFKRIANSFLQKN
Figure 1.12 Amino acid sequence o f OvFARl (www.ca.expasy.org/sprot/).
Circular dichroism shows a strong a-helix signal. Analysis of the data over 
the range 190 nm to 240 nm by CONTIN procedure estimates secondary 
structure to be 60 % a-helix, 32 % P-sheet and a remainder of 8 % (Kennedy 
et ah 1997).
Searching databases for similar structures shows no significant matches. 
Secondary structure prediction performed using PHD (Rost, 1994) algorithms 
applied to the whole sequence alignment predicted an 86 % helical 
conformation. These helices are predicted to be strongly amphipathic 
(Kennedy et ah 1997).
OvFARl binding characteristics
OvFARl molecule binds a single molecule of retinol with an affinity similar to 
that of other serum retinol-binding proteins. The dissociation constant of 
retinokrOvFARl binding has been estimated by fluorescence titrations, with 
increasing quantities of retinol added to rOvFARl, the results were consistent 
with a single retinol-binding site per molecule of rOvFARl, which provided a 
Kd of 8.5 x 10'8 M (Kennedy et ah 1997). OvFARl also binds fatty acids, but 
with a lesser affinity than ABA-1. The fluorescence emission intensity of 
DAUDA occurs at 541 nm, but moved to a shorter wavelength of 485 nm upon 
binding to OvFARl. A blue shift of this magnitude can be taken as indicative
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of entry of the fluorophore into an apolar environment and removed from 
contact with water. Changes similar to this are observed in ABA-1. The 
fluorescence enhancement of DAUDA by OvFARl was reversed upon 
addition of oleic acid, showing that the binding is competitive. The binding is 
also competitive between retinol and oleic acid with OvFARl indicating that 
the binding sites of fatty acids and retinol with the protein are interactive or the 
same (Kennedy et al, 1997).
A further important finding was that parasite retinol-binding proteins also bind 
Ivermectin, which is currently the main drug in onchocerciasis control 
programme (Bradley & Kennedy, 1999). For that reason these proteins may 
participate in the delivery of the drug to the parasite, or diminish the effect, 
and it is possible that they may be involved in the development of drug 
resistance. Ivermectin competes efficiently with retinol for retinol-binding 
sites on parasite retinol-binding protein, but not for the host-tissue retinol- 
binding protein sites. The drug has no affinity for retinoic acid-binding 
proteins from either parasite or host tissues (Lai & James, 1996).
1.3.2 Globodera Pallida and GpFARl
The potato cyst nematode or ‘eelworm’ as it is commonly known is a major 
pathogen of potato crops, including the commercial potato Solanum tuberosum 
(Duncan, 1997). There are two main species of potato cyst nematodes (figure 
1.11), Globodera pallida and Globodera rostochiensis. Plant parasitic 
nematodes destroy up to 10 % of the world’s agricultural output at a cost of up 
to 77 x 109 dollars each year in yield losses and controlling the pests (Sasser & 
Freckman, 1987). These potato nematodes are speculated to have originated 
from South America and have become established in temperate regions and a 
few other highland locations (www.inra.fr/hyppz/RAVAGEUR/bgloros.htm).
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Figure 1.13 Potato cyst nematode
Potato cyst nematodes reduce yield by about 30 %. Tiny cysts can survive in 
the soil for 15 -  20 years, each containing several hundred young nematodes 
unhatched, until a potato plant is grown in that soil. Chemicals in the roots o f 
the potato plant stimulate hatching and they then invade the roots o f the plant. 
After the adult female nematode has developed and mated, her body forms a 
cyst containing the next generation of nematodes. These cysts then become 
detached from the roots and lie dormant in the soil to continue the cycle.
GpFARl is secreted by the plant parasitic nematode Globodera pallida. 
Secreted proteins have been implicated in many aspects of the host-parasite 
interaction, including migration o f the nematode through the root before 
induction o f the feeding site and in induction and maintenance of the 
syncytium. It is the nematode secretions that lead to modification of plant 
tissue with the result that growth of the potato is slowed or stopped, leading to 
poor yield (www.inra.fr/hyppz/RAVAGEUR/bgloros.htm).
GpFARl structural predictions
GpFARl has a molecular weight o f 20.9 kDa, and consists o f 188 amino acids 
(http://ca.expasy.org/sprot/). When the leader sequence, predicted by SignalP 
program (Nielson, 1997), is removed it has a molecular weight o f 18.8 kDa. 
The predicted cleavage site for the leader sequence is between Gly-19 and Ala-
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20. The GpFARl sequence (figure 1.14) shows close similarity to other 
nematode-specific FAR proteins (figure 1.9).
MQRILLCLTGASFIVLLFGASLPPIDISSIPEQYRELIPKEVIDFYNTLTAE
DKQALKEVAERHEEFQTEEQAMEALKAKSEKLHSKAVELRNLVKEKI
DKLVPGAKTFVTETIEKLKAMRPKSGEKPNLEELRKGANDTIEKFKAL
SVEAKESLKANFPKITGVIQSEKFQALAKSLLKTEGAAPAA
Figure 1.14 Amino acid sequence of GpFARl (http://ca.expasy.org/sprot/)
Secondary structure predictions o f individual sequences of FAR proteins have 
been performed using PHD (Rost et al, 1994) algorithms and predict a-helix, 
with no evidence o f P-structure (Prior et al, 2001). COILS algorithm (Lupas et 
al, 1991) predicted several strongly amphipathic stretches, with the strongest 
predicted between 60-100 and 130-168 (Prior et al, 2001). Circular dichroism 
analysis has not been carried out on GpFARl, but other FAR proteins have 
been predicted to have a high a-helical signal (Kennedy et al, 1997; Garafalo 
et al, 2002).
There are no known similar structures and no X-ray or NMR structures yet 
available.
GpFARl binding characteristics
GpFARl binds fatty acids and retinol. It has been shown to bind the 
fluorophore tagged fatty acid DAUDA and DACA with an increase in 
intensity and with a blue shift in fluorescence indicating that it is bound in an 
apolar environment. The blue shift in fluorescence is greater than that of p- 
structure fatty acid binding proteins. Other fatty acids bind to GpFARl in 
competition with DAUDA and the fatty acids were found to displace retinol 
indicating the binding site is congruent or interactive. GpFARl also binds cis- 
parinaric acid suggesting that it is intrinsically fluorescent (Prior et al, 2001).
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GpFARl fails to bind dihydroergosterol or a range o f hydrophobic compounds 
related to plant defence responses, including glycoalkaloids (Prior et al, 2001). 
Therefore GpFARl is unlikely to be utilized in plant defences.
The preference o f GpFARl for fatty acid chain length has been investigated 
(Prior et al, 2001) and was found to prefer saturated or unsaturated fatty acids 
with a chain length in the range C12 to C l7. This correlates with the most 
abundant fatty acids found in the organism (Holz et al, 1997), which are fatty 
acids with chain length C14-C22.
1.3.3 Caenorhabditis elegans and CeFAR2 and CeFAR3
Caenorhabditis Elegans (C. elegans) is a small free-living nematode (figure 
1.15), which lives in the soil, especially in rotting vegetation. It is found in 
many parts o f the world, where they survive by feeding on microbes such as 
bacteria.
Figure 1.15 Diagram ofC. elegans.
C. elegans is conceived as a single cell, which develops, starting with 
embryonic cleavage, proceeding through morphogenesis and growth into adult 
(figure 1.15). Its average life span is 2 -  3 weeks (http://elegans.swmed.edu) 
with a lifecycle that is a simple 3 day generation time. It can be grown quickly 
and with ease on agar plates using Eschericha coli as a food source (Hodgkin 
et al, 1995).
Though C. elegans is not an important nematode in terms of infection, it is 
likely to be an excellent model for the study o f important parasitic nematodes
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in its phylum (Blaxter, 1998), including Ascaris lumbricodes, Wuchereria 
bancrofti and Brugia malayi.
Since genetic resistance to current anti-nematode drugs is increasing novel 
control strategies are needed. By studying C. elegans these could be 
developed, possibly involving nematode-specific neurotropic agents, 
disrupting sex determination or embryogenic pathways of nematodes (Blaxter, 
1998). The C. elegans genome project has identified 6 protein homologues of 
proteins from Onchocerca volvulus and other proteins from Globodera pallida. 
Therefore, there is growing interest in its potential as a vaccine component and 
as a marker of immune status in onchocerciasis (Blaxter, 1998). By studying 
the structure and function of the homologues of C. elegans, the results can be 
transferred to proteins o f other parasites (C. elegans sequencing consortium, 
1998).
CeFAR structural predictions
C. elegans contains protein homologues of NPA and FAR proteins. The 
protein sequences of CeFAR2 and CeFAR3 have been compared using the 
BLAST algorithm (Altschul et al, 1990) and show significant similarity of 
34.9 % and 36 % respectively (Tree et al, 1995). The main reason for working 
on the C. elegans fatty acid and retinol (FAR) binding proteins is that they are 
homologues of the Onchocerca volvulus FAR protein (figure 1.9). C. elegans 
has been selected as a model to investigate the function of these proteins since 
it is much more amenable to experimental analysis than the proteins from the 
pathogenic Onchocerca volvulus protein.
CeFAR2 is found in chromosome III in C elegans, expression of this protein 
was observed in the body wall muscle cells of the nematode from early 
embryogenesis to adulthood (Tree et al, 1995). It has a molecular weight of 
20035 Da and consists of 186 amino acids (figure 1.16) 
(http ://ca. expasy. org/sprot/).
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MIRAFLVVALASVAVFSAPIPEVPQNFDDIPAEYKGLIPAEVAEHLKAITAEEKAALKE 
LAQNHKE YKTEEEFKAALKEKSPSL YEKAGKLE ALLTAKFEKLD AT AQ AL VKKILAK 
GRELHQQYLAGDKPTLDSLKELAKGYIAEYKALSDDAKATITAEFPILTGFFQNEKIQA 
IVGQY VN
Figure 1.16 Amino acid sequence o f CeFAR2 (http://ca.expasy.org/sprot/)
CeFAR3 is also found in chromosome III in C elegans has 189 amino acids 
and has a molecular weight of 20905 Da (figure 1.17) 
(http://ca.expasy.org/sprot/).
MSRLFAFNVFCLVLLRFSAAAPADDSSPFSQILKQHKDLLPSEWQAYQDLSPEEKAA
LKDVFKNYKSYKNEGELIAALKEKSSSLGEKAEKLQAKLQKKVDALSPKPKDFVNELI
AGGRGLYARSVNGEKISVSEIKLLIETQVAAYKALPAEAQDELKKNFGGVAKFLEDD
KTQTLLAKLLEKNNNQ
Figure 1.17 Amino acid sequence of CeFAR3 (http://ca.expasy.org/sprot/)
They are from a new class of helix rich proteins from nematodes, which bind 
fatty acids and retinol and hence fit into the overall project. There are no 
known similar structures and no X-ray or NMR structures are yet available. 
Circular dichroism revealed that CeFAR2 and CeFAR3 have high content of 
a-helix (54 and 61% respectively) and little p-structure. They exhibit high 
probabilities of coiled coil structure by the Coils algorithm (Lupus etal, 1991).
CeFAR binding characteristics
All CeFAR proteins studied to date bind DAUDA with an increase in intensity 
and blue shift in fluorescence from 543 nm to 482 - 490 nm upon addition of 
protein, which is indicative o f an apolar binding site. Dissociation constants
7 ft * •ranged from 8 x 10' to 1 x 10' M. Binding was observed with cis-parinaric 
acid and retinol, which are intrinsically fluorescent and exhibit environment- 
sensitive fluorescence emission. Addition of oleic acid reversed retinol 
binding, suggesting binding sites for the fatty acid and retinol are either 
congruent or interactive (Garofalo et al, 2003).
This project looks at proteins from these classes to get a better understanding 
of their structure and function by biophysical techniques, including CD, DLS, 
fluorescence, MALDI-TOF and crystallography.
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Chapter 2 - Materials and methods
All materials used in this project were purchased from Sigma Aldrich unless 
otherwise stated.
2.1 Protein analysis
It is important to determine the purity, concentration and activity of the 
proteins for biophysical techniques and crystallisation studies.
2.1.1 Molecular weight determination
Inputting the amino acid sequence for each protein into the ProtParam program 
available at http://ca.expasy.org/tools/protparam.html, the molecular weight 
can be estimated. The program counts the number of amino acids and amino 
acid composition, number of charged residues, calculates molecular weight, 
gives theoretical pi, estimates the extinction coefficient and estimates the 
stability of the proteins (The results of ProtParam for each of the proteins 
studied are given in Appendix 2).
2.1.2 Concentration determination
The concentration of protein solutions was determined using a Perkin Elmer 
UV/VIS spectrometer Lambda 40 and applying Beer-Lambert law A = eel. 
Absorbance, A, was measured at 280 nm with the protein in 1 cm path length 
cuvettes. Using the protein extinction coefficient, e (M^cm'1) at 280 nm with 
path length value 1 (cm), the protein concentration was calculated. Appendix 
2 shows protein £280 values, which were estimated using ProtParam available 
at http ://ca. expasy.org/too Is/protparam. html.
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2.1.3 Sodium Dodecyl Sulphate -  Polyacrylamide Gel Electrophoresis 
(SDS-PAGE)
SDS-PAGE gels were used to estimate molecular mass and evaluate protein 
purity. 15 % SDS-PAGE gels 0.75 mm thick were prepared in the Hoefer® 
Mighty small SE245, dual gel caster (Amersham Pharmacia Biotech). Boiling 
for 5 mins denatured the proteins that had been mixed 1:1 with loading buffer. 
Electrophoreses took place under reducing conditions using a discontinuous 
buffering system at 200 V and 20 mA per gel. Low molecular weight marker 
proteins (phosphorylase (94 kDa), bovine serum albumin (67 kDa), ovalbumin 
(43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa) 
and a-lactalbumin (14.4 kDa)) from Amersham Pharmacia Biotech were 
dissolved in 2 0 0  pi loading buffer.
Gels were stained with Coomassie Brilliant Blue R250 for 30 minutes, 
followed by destaining with distilled water until a clear background was 
obtained.
2.1.4 Isoelectric focussing electrophoresis (IEF)
IEF gels are used for isoelectric point (pi) determination and confirmation of 
the presence o f charged isoforms.
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net
charge
43
Figure 2.1 Graph showing what the pi o f a protein is when the net charge is zero.
Novex® IEF gels are 5 % polyacrylamide, non-denaturing gels with a pH 3 -  
pH 10. These gels were used on the Xcell Surelock™ system from Invitrogen. 
A broad range of pi (pi 3.5 - 9.3) markers (amylglucosidase (pi 3.5), methyl 
red dye (pi 3.75), trypsin inhibitor (pi 4.55), b-lactoglobulin A (pi 5.2), bovine 
carbonic anhydrase B (pi 5.85), human carbonic anhydrase B (pi 6.55), 
myoglobin acidic band (pi 6.85), myoglobin basic band (pi 7.35), lentil lectin 
acidic (pi 8.15), lentil lectin middle (pi 8.45), lentil lectin basic (pi 8.65) and 
trypsinogen (pi 9.3)) from Amersham Pharmacia biotech were dissolved in 
100 pi loading buffer. Cathode and anode buffers were purchased from 
Invitrogen. Protein samples were mixed 1:1 with sample buffer and 
electrophoresed at 100 V for 1 hour, 200 V for 1 hour, then 500 V for 30 
minutes, at 5 mA per gel.
Gels were placed in fixing solution before staining with Coomassie Brilliant 
Blue R250 for 5 minutes. Destaining with water until the required background 
was obtained.
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2.2 Biophysical techniques
2.2.1 Circular dichroism
Sharon M. Kelly and Nicholas C. Price (Kelly & Price, 1997) have reviewed 
the application of circular dichroism. Circular dichroism (CD) reports on the 
general secondary and tertiary structures of proteins by measuring the 
differential absorption of the left and right circularly polarised components of 
plane-polarised radiation. This effect occurs when a chromophore is chiral 
either, intrinsically by reason of its structure, by being covalently linked to a 
chiral centre or by being placed in an asymmetric environment. Chiral 
molecules differentially absorb beams of left and right handed circularly 
polarised light, causing two beams to travel at different speeds through these 
molecules, rotating the polarised light. A CD spectrum is obtained when the 
dichroism is measured as a function of wavelength. Studies of the far-UV 
region (190 -  210 nm) can be used to assess quantitatively the overall 
secondary structure content of the protein. In this region the peptide bond is 
the principal absorbing group.
20
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Figure 2.2 Circular dichroism spectra o f “pure” secondary structures (Brahms & Brahms,
1980).
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Provencher and Glockner (Provencher & Glockner, 1981) introduced a 
procedure of deducing the contributions of the different structural forms. It is 
called the CONTIN procedure and involves the direct analysis o f a CD 
spectrum over the range from 240 nm to 190 nm as a linear combination of the 
CD spectra of 16 proteins whose structures have been determined to high 
resolution by X-ray crystallography. Several methods have been developed 
which analyse the experimental CD spectra using a database of reference 
protein CD spectra containing known amounts of secondary structure 
(Provencher & Glockner, 1981; Hennessey & Johnson, 1981; Sreerama & 
Woody, 1994). These methods are, in general, more accurate and reliable than 
the Provencher and Glockner approach.
In the near UV (250 -290 nm), the aromatic amino acid side chains 
(phenylalanine, tyrosine and trypothan) absorb. The tertiary folding of the 
polypeptide chain can place these side chains in chiral environments, thus 
giving rise to CD spectra that can serve as characteristic “fingerprints” of the 
native structure. These “fingerprints” can be useful for comparisons o f tertiary 
structures between related proteins.
CD experimental method
All proteins were dialysed into 20 mM phosphate, pH 7.0 and concentrated to 
1 mg/ml as estimated by absorbance at 280 nm (see chapter 2.1). Mean 
residue weights for each recombinant protein were calculated from their amino 
acid sequence, then their molar elliptically values were obtained. CD spectra 
were recorded at room temperature in a JASCO J-600 spectropolarimeter 
under PC control. The proteins were placed in quartz cells o f path length 0.02 
or 0.05 cm. Analysis of secondary structure of proteins was performed using 
the CONTIN procedure (Provencher, 1981) and SELCON procedure 
(Sreerama, 1994) in the far UV region (1 9 0 -2 1 0  nm) and also the near UV 
region (250 -  290 nm).
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2.2.2 Fluorescence
Fluorescence spectroscopy is one o f the most widely used spectroscopic 
techniques in biochemical and biophysical fields due to its sensitivity to 
changes in structural and dynamic properties o f biomolecules and 
biomolecular complexes. With macromolecules, fluorescence measurements 
can give information about conformation, binding sites, solvent interactions, 
degree o f structural flexibility, intermolecular distances and the rotational 
diffusion coefficient.
When a molecule absorbs a photon o f light the electrons in the molecule gain 
energy and are excited from their ground state energy level to a higher energy 
level. If  the molecule contains no fluorescent chromophore the excess energy 
is lost as heat by collision with solvent molecules, as the electron returns to 
ground state. If the molecule contains fluorescent chromophores, reradiation 
o f the absorbed energy as fluorescence occurs on return to ground state. The 
emitted light will have less energy than the absorbed light, therefore 
fluorescent light has a longer wavelength than the exciting light.
The Jablonski diagram (figure 2.3) is a schematic portrayal o f molecular 
electronic and vibrational energy levels, which shows the sequence o f steps 
involved in fluorescence.
Lowest excited
singlet state Lowest excited 
trip let state
a Ground 
electronic state
LU
1. Absorption
2. Fluorescence
3. Phosphorescence
4. Vibrational relaxation
5. Intersystem crossing
6. Internal conversion
 ► Processes involving photons
\ / N>- Radiationless transit ions
Figure 2.3 Jablonski diagram
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Substances that normally exhibit fluorescence are those structures that contain 
delocalised electrons present in conjugated double bonds. Two types of 
fluorophores are used in fluorescence analysis of macromolecules: intrinsic 
fluorophores contained in proteins themselves and extrinsic fluorophores 
added to proteins and usually binding to them.
For proteins there are three intrinsic fluorophores -  tryptophan, tyrosine and 
phenylalanine. The fluorescence of tryptophan is most commonly studied, as 
it is extremely sensitive to the hydrophobicity o f its surroundings and so can 
be used as a probe to assess its environment.
Extrinsic fluorophores used for protein investigation include, dansyl chloride, 
fluorescein, dansyl amide and ANS.
Measurement of a fluorescence lifetime, the average time the fluorophore 
spends in the excited state, is a useful probe of the dynamics in a system. 
Fluorescence anisotropy or polarisation is the degree to which fluorescence 
emission is depolarised relative to the polarising exciting light. These 
experiments yield information on the degree of rotational freedom of the 
fluorophore on the lifetime time scale. Fluorescence quenching is the ability 
that compounds have to decrease the fluorescence o f some fluorophores. 
Quenching of tryptophan fluorescence can reveal the extent of tryptophan 
exposure within proteins. Energy transfer is the effect observed when an 
electronically excited fluorophore (donor) can transfer its energy to another 
fluorophore (acceptor), which then emits the energy as fluorescence. Energy 
transfer experiments provide information on the distance between the donor 
and the acceptor.
Fluorescence experimental method
Fluorescence experiments were performed with a SPEX FluorMax 
Spectrofluorimeter (SPEX industries, Edison, NJ) at 25 °C using 2 ml samples 
in a silica cuvette, and the emitted light was detected at 90° relative to the 
incident beam.
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Proteins were concentrated to 1 mg/ml in PBS buffer. PBS blanks were used 
to correct for Raman and background scattering where necessary.
The fluorescent fatty acid analogue 1 l-((5-dimethylaminonaphthalene- 1- 
sulfonyl)amino)undecanoic acid (DAUDA) (Wilkinson & Wilton, 1986) 
(figure 2.4) was obtained from Molecular Probes. A 10 mM stock solution 
was made in ethanol and stored at -20 °C, this was diluted 1:1000 in PBS for 
use in assays. A 1:10 DAUDA stock solution was diluted in methanol and the 
concentration was checked by absorbance at 335 nm, using an extinction 
coefficient 6335 o f 4400 M“1cm'1. The excitation wavelength o f DAUDA is 
345 nm.
Figure 2.4 Structure of 11 -((5-dimethylaminonaphthalene- l-sulfonyl)amino)undecanoic acid
(DAUDA)
A 10 mM stock solution of the fluorescent fatty acid retinol (figure 2.5) was 
made in ethanol and was stored in the dark at -20 °C. Free retinol is poorly 
soluble in aqueous solution, so was dissolved and diluted in ethanol 
immediately before use. The concentration of retinol was estimated by 
absorbance of a solution of retinol in ethanol at 325 nm, using an extinction 
coefficient of 8325 of 52480 M '1cm'1. The excitation wavelength of retinol is 
350 nm.
Figure 2.5 Structure of Retinol 
Stock solutions of all non-fluorescent competitors (figure 2.6) were made to 
approximately 10 mM in ethanol, then diluted 1:10, 1:100 and 1:1000 in PBS 
for use in assays.
N(c h 3>2
OII
S 0 2 NH(CH2 )1 0 - c - O H
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OH
Capric acid (CIO)
OH
Undecanoic acid (Cl 1)
OH
Myristic acid (C l4)
OH
Pentadecanoic acid (C l3)
OH
Palmitic acid (C16)
OH
Heptadecanoic acid (C l7)
OH
Stearic acid (C l8)
OH
Nonadecanoic acid (C l9)
OH
Heneicosanoic acid (C21)
OH
Behenic acid (C22)
Figure 2.6 Structures o f fatty acids with different carbon chain length
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As the proteins studied are fatty acid and retinol binding proteins, fluorescence 
was used to determine if they had retained their activity. The ligand binding 
capacity of the proteins was investigated using DAUDA. 10 pi samples of 
protein at 1 mg/ml in PBS were added successively to 2 ml o f DAUDA and 
the maximal fluorescence intensity was noted. Fluorescence data were 
corrected for dilution where necessary and fitted by standard non-linear 
regression techniques using the standard hyperbolic/non-cooperative binding 
equation (shown below) (Microcal, ORIGIN 5.0) to a single non-competitive 
binding model to give estimates of the dissociation constants (Kennedy et al,
1997).
Fmax/F = 1+Ka/ (CL - nCpF/Fmax)
Cl = total ligand (DAUDA) concentration 
Cp = total protein concentration
Fmax = estimated extrapolated maximal fluorescence intensity 
Kd = dissociation constant
n = number of binding sites per protein monomer unit.
The dissociation constant for retinol was calculated similarly. To correct for 
the fluorescence of free retinol, successive additions of free retinol were made 
to a cuvette containing only PBS. Free retinol intensities were subtracted from 
protein-retinol intensities before data analysis.
For retinol titration experiments, 10 mM retinol in ethanol was added in five 2 
pi aliquots to 2 ml o f a 1 mg/ml solution of protein in PBS, mixed immediately 
and the change in emission intensity noted at 350 nm. Addition o f 10 pi 
samples of oleic acid (figure 2.7) of 1:1000, 1:100 and 1:10 dilutions and 10 pi 
of 10 mM oleic acid stock were made to the retino 1-protein complex to 
determine if bound retinol was competitively displaced by oleic acid.
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Figure 2.7 Structure of Oleic acid
To investigate the preference of the FAR proteins for fatty acid chain length, 
the same molarity of non-fluorescent competitor fatty acid (figure 2 .6 ) was 
added to a DAUDA-protein complex and the percentage decrease in DAUDA 
fluorescence was recorded at the peak fluorescence emission wavelength of 
DAUDA in the protein (488 nm). This value was recorded for successive 
dilutions of each fatty acid.
2.2.3 Dynamic light scattering
(http://cbr.med.harvard.edu/investigators/springer/lab/protocols/sara_light_scat
tering)
Scattered light from a protein sample contains information about the particles 
in solution. This information is a valuable asset in characterizing 
hydrodynamic size, conformation, interaction or aggregation of the 
macromolecule. The hydrodynamic radius of particles e.g. proteins in 
solution, estimates the molecular weight if the protein is perfectly globular. If 
not, then this measurement roughly corresponds to half the maximal dimension 
of the protein. Therefore this information may infer the oligomerisation state 
of the protein.
The method can only determine if a solution contains protein that is 
monomeric, dimeric or a mixture of oligomers. Therefore DLS is a good test 
for homogenous, pure, non-aggregated and monodispersed protein: pre­
requisites for successful crystallisation trials.
Experiments were carried out on a DynaPro-801 TC in which the coherent 
light source is a laser. The fluctuations in the scattered intensity of the protein 
particles are detected over short time-scales, due to varying constructive and
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destructive interference of light scattered from these particles travelling with 
different speeds and directions (Brownian motion). This fluctuation has a 
time-scale related to the translational diffusion coefficient, which is related to 
the hydrodynamic radius of the particle by the Stokes-Einstein equation 
(shown below).
R-h =  kbT /  67ir|DT
Rh = Hydrodynamic Radius (nm) 
kb = Boltzman’s Constant (JK'1)
T = Absolute Temperature (K) 
r\ = Solvent Viscosity (gm cm’1 s'1)
Dt  = Translational diffusion coefficient (mV1)
DLS experimental method
2 mg/ml of each protein (rABA-1, rGpFAR-1, rOvFAR-1, rCeFAR2, 
rCeFAR3 and lysozyme as a standard) were filtered through 0.2 pm filter and 
injected into the DynaPro-801 TC instrument. For each protein a range of 
buffers at specific pH values were used:
20 mM ACETATE pH 4 and 150 mM NaCl 
20 mM PIPES pH 6.6 and 150 mM NaCl 
50 mM HEPES pH 7.5 and 150 mM NaCl 
20 mM TRIS pH 8.5 and 150 mM NaCl
For each protein in each buffer DLS was performed over the range of 
temperature 5 - 25 °C in increments of 5°. Table 2.1 gives an explanation of 
DLS parameters that were recorded.
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Ampl ( ) Amplitude of the scattered light fluctuations
Diffh Coeff Translational diffusion coefficient
Radius (nm) Hydrodynamic radius calculated from Stokes-Einstein equation
Polyd (nm) Width of the Gaussian distribution of radii fitting data, which has its centre at radius
Estd MW Estimated molecular weight in kDa, assuming protein is spherical
Temp (°C) Instrument is temperature controlled
Count (cnts/s) Number of photons scattered per millisecond at 90°
Base line Quality o f fit o f the sample monodisperse model to the data. Above 1.004 indicates 
a bad model
SOS Error Second quality control. Needs to be less than 5
Table 2.1 Table explaining the parameters obtained from a DLS experiment
(http://cbr. med. harvard. eduJinvestigators/springer/lab/protocols/saraJightscattering)
2.2.4 Matrix Assisted Laser Desorption Ionisation -  Time Of Flight 
(MALDI-TOF)
MALDI (Hillenkamp et al, 1991) has been used successfully in determining 
molecular weights o f biomolecules, monitoring bioreactions, detecting post- 
translational modifications, performing protein and oligonucleotide sequencing 
analysis.
MALDI is based on the bombardment of sample molecules with laser light to 
bring about sample ionisation. The sample (analyte) is pre-mixed with a highly 
absorbing matrix compound. Matrices are small organic compounds that spare 
the analyte from degradation resulting in the detection of intact molecules.
• • • •  hv * • • •
. • J •  *  v (M+H)+
•  •  '*  •
•  (M+H)-
= M atrix
= Analyte
Figure 2.8 -  Matrix Assisted Laser Desorption Ionisation 
(http://www.astbury.leeds.ac.uk/Facil/MStut/mstutorial.htm)
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The matrix absorbs the laser energy, which in turn excites the sample. In this 
way energy transfer is efficient and also the analyte molecules are spared 
excessive direct energy. Once the sample molecules are vaporised and ionised 
they are transferred electrostatically into a time-of-flight mass spectrometer, 
where they are separated from the matrix ions, and individually detected and 
analysed according to their mass-to-charge ratios.
MALDI is a “soft” ionisation method and so results predominantly in the 
generation of singly charged molecular-related ions regardless of the 
molecular weight.
Positive ionisation mode is used for protein and peptide analyses. Protonated 
molecular ions (M+H*) are usually the dominant species. Although they can be 
accompanied by salt adducts, a trace of the doubly charged molecular ion, 
and/or a trace of a dimeric species.
MALDI-TOF experimental method
10 pmol/ml o f each protein in 10 mM TRIS pH 7.5 was prepared for MALDI- 
TOF. The protein was dissolved in an appropriate volatile solvent (sinapinic 
acid is common for protein analyses), with a trace of trifluoroacetic acid for 
positive ionisation. An aliquot (1-2 pL) of this was removed and mixed with 
an equal volume o f a solution containing a vast excess of the matrix. 2 pL of 
the final mixture was dried on a sample plate and inserted into the vacuum of a 
Voyager-DE™ PRO Biospectrometry™ Workstation mass spectrometer. 
Protein standards of known molecular weights greater than, and less than, the 
molecular weight of the protein being analysed were also run to calibrate the 
instrument. The proteins used were Chymotrypsinogen (25657.1 Da) and 
Apomyoglobin (16952.5 Da). MALDI-TOF is a relatively simple instrument 
to use compared to Electrospray. However, the downside is that the accuracy 
of the technique is compromised (especially if calibration is not performed 
carefully) and errors of approximately 50 Da in the mass measurement can be 
expected.
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Chapter 3 - Comparison of parasite-derived ABA-1 and recombinant 
ABA-1 proteins. 
3.1 Introduction
The nematode polyprotein allergens (NPAs) are a family of helical proteins, 
which bind fatty acids and retinoids. The human parasite roundworm, Ascaris 
lumbricoides and the pig parasitic roundworm Ascaris suum secrete ascaris 
body-fluid allergen (ABA-1). ABA-1 is the most abundant NPA in the 
pseudocoelomic fluid of the nematode Ascaris. Since Ascaris suum can be 
obtained from pigs in a local abattoir it is the easiest to acquire. Other 
parasites producing NPAs do not produce the allergens in sufficient quantity 
that would provide adequate amounts of proteins for crystallisation trials.
In this chapter the protein purification protocol and subsequent purity of AB A- 
1 obtained from the parasite Ascaris (hereafter denoted pABA-1) is compared 
to the recombinant ABA-1 (rABA-1). Crystallisation of ABA-1 from both 
sources is attempted using a large range of conditions. Failure to obtain 
crystals suitable for diffraction is investigated using dynamic light scattering 
(DLS).
3.2 Purification of parasite derived wild-type ABA-1
Ascaris body fluid (ABF) was collected from Prof. M. W. Kennedy’s 
laboratory, University o f Glasgow, were it had been removed from adult 
Ascaris suum obtained from a local abattoir. The large fat females were 
separated from the small curly tailed males. In a fumehood using a scalpel 
blade, the end of the female worm was removed and the body fluid allowed to 
drip into an Eppendorf. The body fluid was subsequently spun at 13000 rpm 
for 10 minutes then filtered through a 0.45 pm sterile filter to remove any fine 
particulate matter. The resulting fluid was stored at -70 °C.
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ABF was purified to yield parasite-derived ABA-1 protein (pABA-1). A 
Superose 12 gel-filtration column mounted on a Pharmacia FPLC system was 
equilibrated with 0.15 M NaCl and 0.05 M K2PO4, pH 7.0. ABF was 
centrifuged at 13000 rpm for 10 minutes to remove fine particulate matter then 
loaded onto the Superose 12 column at 0.3 ml/min, 1 ml at a time to achieve 
the best separation o f the different proteins present (figure 3.1). Protein was 
detected at 280 nm and by SDS-PAGE analysis (figure 3.1).
b
20.1
14.4
Figure 3.1 a) chart showing the 4 peaks eluted from ABF
b) M = markers, 1-3 = eluted in peak 1, 4-8 = eluted in peak 2 containing pABA- 
1,
9-10 = eluted in peak 3 containing pABA-1 and 11-12 = eluted in peak 4 containing 
pABA-1.
The fractions containing pABA-1, lanes 4-12 on SDS-PAGE (figure 3.1b) 
were pooled and dialysed into 50 mM HEPES pH 7.5 in preparation for 
loading onto an ion exchange column on a BioCAD Sprint system (Perfusion 
chromatography systems). A Hitrap Q anion exchange column was used, as 
homologues of ABA-1 have isoelectric points (pi) around 5.2. It was therefore 
expected that at pH 7.5 the proteins would have a negative charge and bind to 
the anion exchanger and subsequently be eluted individually with a salt 
gradient. The anion exchange column was washed with 2 M NaCl, then 50 
mM HEPES pH 7.5 before the protein sample was loaded to remove any 
previously bound proteins and then given a final wash with 3 column volumes
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of 50 mM HEPES pH 7.5. The protein was detected at 280 nm (figure 3.2). 5 
ml o f protein sample was loaded onto the column at 2 ml/min. Unbound 
protein was collected in flow through. A continuous gradient from 0 to 100 % 
in 50 mis was introduced using 2 M NaCl, to gradually elute off protein that 
had bound to the column.
peak 2
peak 1
Figure 3.2 Chart of pABA-1 run on HQ anion exchange column using the Sprint system
SDS-PAGE (figure 3.3) was run on all fractions that eluted from the HQ 
column.
97 
67 
43
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Figure 3.3 M = markers, 1 = sample loaded, 2 = eluted in peak 1 of flow through,
3-4 = eluted in peak 2 of flow through, 5-6 = eluted in peak 3 ,7  = eluted in shoulder 
of peak 3 and 8-9 = eluted in peak 4
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After anion exchange the main peak 3 (figure 3.2) has two bands present 
shown in lanes 5 and 6 o f SDS-PAGE (figure 3.3), one close to the molecular 
weight o f ABA-1 (15.1 kDa) and another o f higher molecular weight, 
approximately 17 kDa, which is likely to be an isomer of ABA-1 (chapter 1.3) 
and could not be separated from the 15.1 kDa protein, despite further 
purification attempts. A single band is present in lanes 3 and 4 o f SDS-PAGE 
at approximately 14 kDa, which is close to the calculated molecular weight of 
ABA-1. Other ion exchange columns (HS, mono S and mono Q) were also 
tried in an attempt to separate the 17 kDa protein and the charged iso forms 
(figure 3.8) o f pABA-1 without success.
It has been shown (Kennedy, 1995b) that ABA-1 exhibits binding to fatty 
acids with a blue shift in fluorescence. Therefore, pABA-1 eluted in the second 
flow through peak (lanes 3 and 4 on gel) was assayed using DAUDA, a 
fluorescent labelled fatty acid known to bind to NPA proteins giving a blue 
shift. The fluorescence spectrum shows clearly the expected blue shift 
confirming DAUDA has bound to pABA-1 eluted in the flow through and that 
the protein has retained activity.
Fluorescence of DAUDA to pABA-1
8000000 478 nm
7000000 -
6000000 -
« 5000000 -
 DAUDA alone
 DAUDA plus pABA-1
§ 4000000 -
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Figure 3.4 Binding of the fluorescent labelled fatty acid DAUDA to pABA-l
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3.3 Overexpression and purification of recombinant ABA-1
N. Meenan of Prof. Cooper’s and Prof. Kennedy’s lab, University o f Glasgow, 
supplied a pGEX-2T plasmid encoding the antigen of ABA-1.
The plasmid was extracted and transformed into BL21 host cells. The plasmid 
was inserted by heat shock. 100 jul of host strain BL21 was placed in a sterile 
Eppendorf tube on ice. 1 pi P-mercaptoethanol was added and left on ice for 2 
minutes, then 5 pi of plasmid was added to the tube and left on ice for 1 hour. A 
water bath was heated to 42 °C and the cells placed in it for 30 seconds and then 
on ice to cool back down to 4 °C. 400 pi of LB (Millipore) was then added and 
the tube was incubated at 37 °C for 1 hour. The cells were plated on agar with 
ampicillin and incubated overnight at 37 °C. After incubation 10 ml o f LB 200 
pg/ml ampicillin was inoculated with a single colony from the plate and incubated 
overnight at 37 °C with rotary shaking at 200 rpm. Glycerol stocks were made 
using 850 pi of culture and 150 pi of 80 % glycerol and stored at -80 °C.
A 1 litre flask containing 500 ml of 2-YT broth (Millipore) and 200 pg/ml 
ampicillin was inoculated with a glycerol stock and grown overnight at 37 °C with 
shaking at 200 rpm. This overnight broth was added to 2 more litre flasks 
containing 1 litre 2-YT broth and 200 pg/ml ampicillin each and grown at 37 °C at 
200 rpm for approximately 3 hours until cultures had grown to an A6oonm between 
0.6-1. 1 mM dioxane free Isopropyl p-D-thiogalactoside (IPTG) was added to 
induce gene expression. Cells were grown for a further 3 hours at 37 °C with 
shaking at 200 rpm. The culture was transferred to appropriate centrifuge bottles 
and centrifuged at 8000 rpm for 15 minutes to sediment the cells and the 
supernatant was removed.
Each pellet was then resuspended in 100 ml PBS with a Roche EDTA free 
protease inhibitor tablet. The cells were disrupted by sonication on ice using a
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Status US200 sonicator (Philip Harris Scientific) for six, 30 second blasts at half 
power. Cell disruption was evidenced by partial clearing of the suspension. The 
sonicate was centrifuged at 10000 rpm for 10 minutes and the supernatant 
transferred to a fresh container. 1 ml o f Glutathione Sepharose 4B was added to 
50 ml o f supernatant and incubated at room temperature with gentle rocking for an 
hour. After an hour the supernatant was gently spun at 500 rpm for 10 minutes 
and the resin was washed 3 times with PBS. Finally, the protein was released 
from the GST by cleavage with thrombin protease, 50 units of thrombin per 1 ml 
o f resin. After 16 hours at room temperature the resin was spun down at 200 rpm 
for 5 minutes. To remove the thrombin protease, the protein was run through a 
Benzamidine FFTrap column (Amersham Pharmacia Biotech) at 0.5 ml/min on an 
AKTA purifier 100 system (Amersham Pharmacia Biotech) followed by gel 
filtration using a Superose 12 column with elution buffer 50 mM HEPES pH 7.5 
run at 0.3 ml/min. Protein was detected in the supernatant at 280 nm (figure 3.5) 
and by SDS-PAGE (figure 3.6).
main peak
40
■<>
final peaks
0.0 10.0 .10.0 40.0 50.0 ml
Figure 3.5 Gel filtration of rABA-1 on the superose 12 column on the AKTA
SDS-PAGE (figure 3.6) was run on all fractions that eluted from the Superose 12 
gel filtration column.
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20.1
14.4
Figure 3. 6 M = markers, 1-3 = proteins eluted from initial small peaks, 4-6 = proteins eluted 
from main peak, including rABA-1 and 7-8 = protein eluted from final peaks
The resulting SDS-PAGE showed bands o f approximately 15 kDa in lanes 4-6, 
which is close to the predicted molecular weight o f rABA-1 (15.1 kDa). These 
fractions were assayed for DAUDA binding (figure 3.7) and were found to exhibit 
fatty acid binding activity confirming functional ABA-1 to be present.
Fluorescence binding of DAUDA to rABA-1 to saturation
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Figure 3.7 Binding of fluorescent labelled fatty acid DAUDA to rABA-1
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Having successfully purified rABA-1 and parasite-derived ABA-1 an isoelectric 
focusing gel (figure 3.8) was run to determine if charged iso forms, which are not 
readily seen on SDS-PAGE were present. Other proteins studied in the project are 
also shown and will be referred to in subsequent chapters.
9.30
8.65
8.45
8.15 
7.35 
6.85
6.55 
5.85 
5.20
4.55
3.75
3.50
M 1 2 3 4 5
Figure 3.8 Novex® 1EF gel. M = markers, 1 = rABA-1, 2 = rGpFARl, 3 = rCeFAR2,
4 = rOvFARl, 5 = rCeFAR3 before ion exchange, 6 = rCeFAR3 after ion exchange 
and 7 = pABA-1.
The resulting IEF gel (figure 3.8) indicates that parasite-derived ABA-1 in lane 7 
(samples after ion exchange on HQ column) consists of several, differently 
charged iso forms of ABA-1 grouped together in a broad band that have similar 
pis. Having tried ion exchange (chapter 3.2) it is difficult, if not impossible, to 
achieve separation into homogenous protein. Recombinant ABA-1 (lane 1), on 
the other hand, consists of two isoforms and appears as a single band on SDS- 
PAGE. Compared to pABA-1, rABA-1 is easier to produce and purify in large 
quantities for structural and biophysical studies. Upon interaction with DAUDA 
(figures 3.4 and 3.7) both ABA-1 proteins undergo dramatic blue shifts in the 
wavelength of maximum fluorescence emission from 542 nm for DAUDA in 
buffer to 478 nm and 476 nm for DAUDA interacting with pABA-1 and rABA-1 
respectively, showing that the rABA-1 is similar, if not identical, in binding to the 
pABA-1.
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3.4 Circular dichroism of pABA-1 and rABA-1
Circular dichroism (CD) analysis was carried out as described in chapter 2. The 
secondary structure, derived from the far UV spectrum of both pABA-1 and 
rABA-1 (figure 3.9), show high a-helical content.
CD spectra of rABA-1 and pABA-1
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Figure 3.9 CD of the far UV spectra of rABA-1 and pABA-1
The far UV spectra o f the ABA-1 proteins show that they have similar shape and 
that the secondary structures of pABA-1 and rABA-1 are very similar. The 
differences in the spectra may be due to concentration errors or the presence of the 
number o f charged iso forms in pABA-1.
The secondary structure content o f pABA-1 and rABA-1 was estimated using the 
CONTIN procedure (table 3.1) o f Provencher and Glockner (1981).
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Protein
Secondary structure predictions using CONTIN
a-helix p-sheet p-tum remainder
pABA-1 53% 29% 6% 12%
rABA-1 46% 37% 5% 12%
Table 3.1 Secondary structure contents of pABA-1 and rABA-1 estimated using the CONTIN
procedure
The CD spectra show that both pABA-1 and rABA-1 have folded secondary 
structure with a higher percentage of a-helix, 53 and 46 % than p-sheet, 29 and 37 
% for pABA-1 and rABA-1 respectively. This agrees with previous CD studies 
carried out on wild-type ABA-1, purified from the pseudocoelomic fluid of 
Ascaris suum by chromatofocussing and size-exclusion chromatography, which 
gave 59 % a-helix, 35 % P-sheet and 6 % remainder (Kennedy et al, 1995b). The 
main reason for the discrepancies between this study and that of Kennedy (1995b) 
is due to the difficulty in obtaining values for protein concentration, which in turn 
affects the secondary structure calculations. Other workers in this field (Kennedy 
and Garofalo) have also experienced this problem, which is possibly due to 
inaccurate protein molecular weight and the presence of DNA. However this data 
shows that ABA-1 is structurally different from the more ubiquitous lipid binding 
proteins from the family of cytosolic proteins, which are predominantly 10 anti­
parallel p-stranded with 2 short a-helices surrounding the interior binding cavity 
in a p-barrel type structure (Banaszak et al, 1994).
3.5 Dynamic light scattering (DLS) on rABA-1
DLS analysis was only carried out on rABA-1 since IEF studies already indicated 
that pABA-1 was a highly heterogeneous protein. The DLS experimental was 
carried out for rABA-1 as described in chapter 2. 2 mg/ml rABA-1 was
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investigated in 20 mM ACETATE pH 4.5, 20 mM PIPES pH 6.5, 20 mM HEPES 
pH 7.5 and 20 mM TRIS pH 8.5, with 150 mM NaCl present in all. Each of the 
above buffers was also studied at temperatures between 5 and 25 °C, in 5° 
increments. Lysozyme was used as standard. (Appendix 1, DLS results) 
rABA-1 aggregated in acetate, therefore no results were obtained in this buffer. 
The bimodal distribution o f rABA-1 in 20 mM HEPES pH 7.5 from DLS was 
analysed in a bimodal scatter diagram (figure 3.10). A gaussian graphical 
presentation (figure 3.11) for rABA-1 in 20 mM HEPES pH 7.5 is also shown. 
These diagrams give an indication o f the aggregation and oligomerisation state of 
the protein
(www.cbrweb.med.harvard.edu/investigators/protocols/sara_light_scattering).
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Figure 3.10 Bimodal scatter diagram of rABA-1 in 20 mM HEPES pH 7.5.
The resulting bimodal scatter diagram indicates that more than one species is 
present in the rABA-1 protein solution.
Bimodal scatter diagram for ABA-1 in 50mM HEPES pH7.5 at RT
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Gaussian graphical presentation for rABA-1 in 50mM HPES pH7.5 a t room temperature
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Figure 3.11 Gaussian graphical presentation for rABA-1 in 50 mM HEPES pH 7.5.
The gaussian graph agrees with the bimodal scatter diagram (figure 3.9), again 
indicating rABA-1 consists of two species possibly monomer or dimer.
The extent of polydispersity of a protein solution is often regarded as a good 
indicator as to the likelihood that crystallisation may occur (D’Arcy, 1994).
Polydispersity (%) = polydynamic radius (nm) / radius (nm) X 100
A polydispersity value of below 15 % indicates low or no polydispersity and a 
high likelihood of crystallisation of the protein occurring. Polydispersity of 
between 15 -  30 % indicates a moderate amount of polydispersity in which 
crystallisation is still possible and above 30 % indicates a largely heterogeneous 
solution with the likelihood that crystallisation may not take place.
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Chart showing polydispersity of rABA-1 dependant on buffer and temperature
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Figure 3.12 Polydispersity of lysozyme in HEPES and rABA-1 in PIPES, HEPES and TRIS
The polydispersity o f rABA-1 (figure 3.12) is uniformly greater than 30 % 
between 5 and 25 °C in all buffers, which indicates a significant amount of 
polydispersity, or heterogeneity in the protein making crystallization an unlikely 
event. Baseline errors (appendix 1) indicate rABA-1 has multimodal size 
distribution, SOS errors (appendix 1) show high background noise in the sample, 
again indicating the protein is not homogenous and unlikely to crystallise. The 
results for lysozyme in HEPES pH 7.5 show moderate to negligible polydispersity 
and narrow monomodal size distribution with low noise errors, indicating that the 
lysozyme standard is homogenous and likely to crystallise (which it does).
The molecular weight o f rABA-1 (figure 3.13) in each solution may be estimated 
if we assume the protein to be perfectly globular. If the protein is not globular, 
then this measurement roughly corresponds to half the maximal dimension o f the 
protein and may infer the oligomerisation state o f the protein.
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Chart show ing ch an g es in estim ated  m olecular weight of rABA-1 with buffer and tem perature
5 10 15 20 25
Temperature
Figure 3.13 Estimated molecular weight of rABA-1 in PIPES, HEPES and TRIS between 5 and
25 °C
The molecular weight estimates derived from DLS suggests the protein has not 
aggregated. The lowest estimated molecular weight o f 35 kDa may suggest one of 
two things, firstly, there may be a contribution from a dimer moiety (30 kDa) or 
secondly, rABA-1 is not a globular protein. That it is not a globular protein has 
been confirmed by the initial NMR studies, which suggest that ABA-1 is a two 
domain structure that is flat in one direction (N. Meenan, A. Cooper, private 
communication).
From these DLS experiments it was decided that probably the best elution buffer 
to be used in the final gel filtration step should be 20 mM HEPES pH 7.5.
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3.6 Crystallisation trials on pABA-1 and rABA-1
Crystallisation trials were undertaken on both pABA-1 and rABA-1 since protein 
was available for both. The standard sitting drop vapour diffusion technique was 
used by mixing 4 pi of the protein solution with an equal volume of crystallisation 
solution in the drop and equilibrating against 1 ml o f crystallising solution in the 
well. Initial trials were set up using the footprint screen 
(www.prg/stura/cryst/foot). Trials were set up at concentrations of pABA-1 and 
rABA-1 at 2, 5, 8, 10, 12, 15, 20 and 25 mg/ml. 21 mg/ml was found to be the 
optimum concentration for ABA-1 proteins as it resulted in fine precipitation in 
some of the drops. This high protein concentration suggests that the protein is 
fairly soluble and this is borne out by the fact that it is found in high 
concentrations in the pseudocoleomic fluid of the nematode. Trials were therefore 
set up with 4 pi of 21 mg/ml pABA-1 and rABA-1 using the standard sitting drop 
vapour diffusion technique and crystallising solutions from a large number of 
sparse matrix conditions (Brzozowski & Walton, 2001; Jancarik & Kim, 1991; 
Cryo I and II, Wizard I and II, www.emeraldbiostructures.com; Crystal Clear 
Strategy Screen I and II, www.moleculardimensions.com; 
www.hamptonresearch.com). Cryo screen 2, condition 9 (2 M ammonium 
sulphate and phosphate-citrate pH 4.2) gave small (20 pm) needle crystals, but 
optimisation failed to produced larger crystals. Frequently extensive precipitation 
and crystalline aggregates resulted and even though these conditions were 
followed up, no protein crystals suitable for diffraction were obtained. On several 
occasions microseeding techniques were used, but again suitable crystals were not 
obtained.
3.7 Discussion
Parasite derived ABA-1 shows multiple iso forms on SDS-PAGE and IEF gels. 
Despite attempts to separate the isoforms using ion exchange and gel filtration
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chromatography, it was not possible to obtain homogenous protein. Although 
recombinant ABA-1 showed one band on SDS-PAGE there are two charged 
iso forms present on the IEF gel. Both pABA-1 and rABA-1 show an increase 
and blue shift in fluorescence emission when bound to DAUDA. With equivalent 
amounts of pABA-1 and rABA-1 shifts from 542 nm to 478 nm and 476 nm 
respectively were observed. Blue shifting of a dansyl fluorophore emission 
wavelength is indicative of a hydrophobic binding site (MacGregor et al, 1986). 
The DAUDA shifts obtained for both suggest that the binding site for rABA-1 is 
similar, if not identical, to that of pABA-1. Since rABA-1 is easier to obtain and 
can be produced in larger quantities, with better purity, it was decided to use 
rABA-1 for biophysical studies in preference to pABA-1.
Circular dichroism shows that both pABA-1 and rABA-1 have folded secondary 
structure with a higher percentage of a-helix, 53 and 46 % than [3-sheet, 29 and 37 
% for pABA-1 and rABA-1 respectively, which agrees with previous CD studies 
carried out on pABA-1, which calculated 59 % a-helix, 35 % p-sheet and 6 % 
remainder (Kennedy et al, 1995b).
Dynamic light scattering is a good indication of protein homogeneity, purity, 
aggregation state and monodispersity - all pre-requisites for successful 
crystallisation. DLS results on lysozyme indicate the technique can show when a 
protein is in the optimum buffer for crystallisation. DLS studies on rABA-1 
suggest it is not optimized for crystallisation, as baseline errors indicate rABA-1 
has multimodal size distribution and SOS errors show high background noise in 
the sample. There is also a significant amount of polydispersity o f rABA-1 in all 
buffers indicating that the sample is not homogenous. The estimated molecular 
weight for rABA-1 (35 kDa), derived by DLS, was just over twice the actual 
molecular weight of rABA-1 (15.1 kDa) and suggests that the protein is not 
globular, confirmed by initial NMR studies suggesting that ABA-1 is a two 
domain structure (private communication, N. Meenan, A. Cooper). However, 
HEPES buffer seemed the best buffer to use at ambient temperatures. The
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bimodal analysis showed that there may be two species present in the rABA-1 
solution. This could indicate that rABA-1 may exist in a dimer conformation. 
The gaussian graph agrees with the bimodal scatter diagram information 
confirming two species present in rABA-1.
Crystallisation trials on both pABA-1 and rABA-1 showed that a high 
concentration of 21 mg/ml was needed to be close to supersaturation. This is a 
fairly high protein concentration and made it labour intensive to obtain enough 
protein, recombinant or parasite-derived for crystallisation trials. In the nematode, 
the concentration of pABA-1 in the pseudocoelomic fluid is high indicating a very 
soluble protein. This is confirmed by the 21 mg/ml required before 
supersaturation is approached. Having set up a large number of crystallisation 
trials without any great measure of success the protein solution was investigated 
using DLS, which indicated that rABA-1 was not homogenous. Two possible 
reasons for this are heterogeneity due to the iso forms of ABA-1 as seen on the IEF 
gel (figure 3.7) or heterogeneity due to a mixture of fatty acids present from E. 
coli, which may be in competition for the binding site. The current NMR studies 
(N Meenan, A Cooper, private communication) also show this ambiguity in fatty 
acid present in the binding site. The presence of these E. coli derived fatty acids is 
further investigated for the FAR proteins.
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Chapter 4 -  OvFARl, CeFAR2 and CeFAR3. Expression, purification and 
fluorescence studies. 
4.1 Introduction
The fatty acid and retinol-binding (FAR) proteins are a family o f 20 kDa helical 
proteins, which bind fatty acids and retinoids with a high affinity. The proteins 
from this family are not available in sufficient quantity to provide adequate 
amounts of protein directly from the organisms, thus necessitating the use of 
recombinant protein in order to study their functional properties. The use of 
recombinant protein is also advantageous in that it enables easier purification 
compared to purifying the proteins from the nematodes themselves.
GpFARl, the 18.8 kDa protein secreted by the potato cyst nematode Globodera 
pallida (see chapter 5), is the FAR family protein which has been characterised 
most by ligand binding studies (Prior, 2001). This chapter studies the ligand 
binding properties of other proteins in the FAR family, which have been 
overexpressed and purified. These are rCeFAR2, rCeFAR3 and rOvFARl. This 
is to establish if the proteins rCeFAR2 and rCeFAR3 from the nematode 
Caenorhabditis elegans are good functional homologues of the rOvFARl protein, 
a major antigen of the causative agent of river blindness, Onchocerca volvulus.
4.2 Overexpression and purification of recombinant OvFARl
Dr Antonio Garofalo of Prof. Bradley's lab in Nottingham University supplied a 
pET 15b plasmid encoding antigen of OvFARl. For expression the plasmid was 
cloned into c41 cells. Transformation is the process of inserting the plasmid into a 
host strain. The plasmid was inserted into host strain c41 by heat shock. 100 pi 
of host strain c41 was placed in a sterile Eppendorf tube on ice. 1 pi p- 
mercaptoethanol was added and left on ice for 2 minutes, then 5 pi of plasmid was 
added to the tube and left on ice for 1 hour. A water bath was heated to 42 °C and
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the cells were placed in it for 30 seconds and then replaced on ice to cool back 
down to 4 °C. 400 pi of LB (Millipore) was then added and the tube was 
incubated at 37 °C for 1 hour. The cells were then plated on agar plus ampicillin 
and incubated overnight at 37 °C. 12 ml of LB 200 pg/ml ampicillin was
inoculated with a single colony from the plate and incubated overnight at 37 °C 
with rotary shaking at 200 rpm. Glycerol stocks were made with this culture. The 
next day two 2-litre flasks containing 500 ml of 2-YT broth 200 pg/ml ampicillin 
were inoculated with 5 ml o f the overnight culture and incubated at 37 °C with 
rotary shaking at 200 rpm. When the cultures had grown to an Asoonm between 
0.6-1 (about 3 hours) they were induced with 1 mM dioxane free Isopropyl p-D- 
thiogalactoside (IPTG) from Roche and incubated for a further 3 hours at 37 °C 
with rotary shaking at 200 rpm. The cells were then pelleted by centrifugation at 
5000 rpm for 15 minutes at 4 °C. The supernatant was discarded and the cell 
pellets were stored at -70 °C until required. The pellets were resuspended in lysis 
buffer (5 mM imidazole, 50 mM TRIS and 300 mM NaCl) with a Roche EDTA 
free protease inhibitor tablet. The cells were lysed by sonication (Status US200, 
Philip Harris) on ice. Cells were sonicated 6 times at half power for 30 seconds. 
Cell disruption is observed by a partial clearing of the suspension. Sonicate was 
then centrifuged at 10000 rpm for 10 minutes at 4°C. The supernatant was 
transferred to a fresh beaker. This lysate was loaded onto an immobilised-metal 
affinity chromatography (IMAC) column on the Pharmacia FPLC. The column 
uses Nitrilotriacetic acid (Ni-NTA) to bind the 6 Histidine tag residue 
incorporated into the FAR protein, which was pre-equilibrated with the lysis 
buffer. The column was washed with lysis buffer until the A280 was stable (about 
5 column volumes), followed by two different wash steps with wash buffer 1 (10 
mM imidazole, 50 mM TRIS and 300 mM NaCl) and wash buffer 2 (75 mM 
imidazole, 50 mM TRIS and 300 mM NaCl), until the A280 was stable (figure 
4.1a). Finally an elution buffer (250 mM imidazole, 50 mM TRIS and 300 mM 
NaCl) was washed onto the column to remove the bound protein (figure 4.1b). 
Protein was detected at 280 nm and by SDS-PAGE analysis (figure 4.2).
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b
main peak during second 
wash buffer
Figure 4.1 a) chart of the second wash buffer (containing 75 mM imidazole) step of Ni-NTA 
column during purification of rOvFARl
b) Chart of the elution buffer (containing 250 mM imidazole) of Ni-NTA column 
during purification of rOvFARl
SDS-PAGE (figure 4.2) was run on all fractions that eluted from Ni-NTA column.
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Figure 4.2 M = markers, 1-4 = rOvFARl protein eluted during first wash step of Ni-NTA 
column, 5-10 = rOvFARl protein eluted during second wash step of Ni-NTA 
column (figure 4. la) and 11-14 = rOvFARl protein eluted during elution step of 
Ni-NTA column (figure 4.1b)
main peak during 
elution buffer
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The resulting gel showed rOvFARl was present in all fractions, but as a smear of 
bands o f approximately 20 kDa which is close to the predicted molecular weight 
for rOvFARl. As a final step, protein was loaded onto a pre-equilibrated 
Superose 12 gel filtration column (figure 4.3) attached to an AKTA purifier 100 
(Amersham Pharmacia Biotech) and loaded at 0.3 ml/min and eluted in 50 mM 
HEPES pH 7.5.
main peak 2
peak
peal
i A ' i
10.0 10 u 40.0 50.0 m l
Figure 4.3 Chart showing peaks obtained from the gel filtration of rOvFARl
The gel filtration yielded 3 peaks with the main peak 2 having a shoulder peak. 
Samples o f each peak were run on SDS-PAGE (figure 4.4).
60
Chapter 4 OvFARl, CeFAR2 and CeFAR3
14.4
Figure 4.4 M = markers, 1 = sample loaded, 2-3 = protein eluted in peak 1 of gel filtration,
4-7 = protein including rOvFARl eluted from main peak 2 of gel filtration and 
8-9 = protein including rOvFARl eluted in final peak 3 of gel filtration
rOvFARl appears purer in lanes 8 and 9 on the SDS-PAGE, with a band o f 20 
kDa, which is close to the molecular weight o f rOvFARl. A higher molecular 
weight band is present at about 43 kDa. Although this was a denaturing gel 
analysis by MALDI-TOF showed (see chapter 6) a dimer to be present and also 
the presence o f higher oligomeric states. This higher molecular weight band could 
not be removed by gel filtration.
MALDI-TOF analysis also indicates that possible lipid groups are present, bound 
to rOvFARl (chapter 6). Subsequently (chapter 6), rOvFARl has been shown by 
DLS studies to be heterogeneous.
Further purification of rOvFARl was attempted by loading onto a Hitrap Q anion 
exchange column on a Sprint (Biocad) (figure 4.5) in 50 mM HEPES pH 7.5. It 
was hoped that at pH 7.5 the protein would have a negative charge and bind to an 
anion exchanger and subsequently eluted by a salt gradient. The anion exchange 
column was washed with 2 M sodium chloride before the protein sample was 
loaded to remove any previously bound material and then equilibrated with 3
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column volumes o f 50 mM HEPES pH 7.5. The protein was detected at 280 nm. 
5 ml of protein sample, from lane 8 o f figure 4.4, was loaded onto the column at 2 
ml/min. Unbound protein was collected in the flow through. Bound protein was 
eluted using a salt gradient of 0 -  100 % 50 mM HEPES pH 7.5, 2 M NaCl.
0 5 To IS 20 25
min
Figure 4.5 Chart of rOvFARl run on FIQ anion exchange column using the Sprint system 
SDS-PAGE (figure 4.6) was run on all fractions that eluted ffom the HQ column.
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Figure 4.6 M = markers, 1-4 = flow through and 5-6 = proteins eluted in 25-40 % NaCl
The resulting gel after anion exchange o f rOvFARl shows 2 bands in lanes 3-4 of 
20 kDa which are close in molecular weight to the protein OvFARl. A higher 
molecular weight band at approximately 40 kDa is also present, possibly a non-
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denatured dimer. Ion exchange of rOvFARl did not significantly improve the 
purification of rOvFARl and subsequently was not used as a purification step.
4.3 Overexpression and purification of recombinant CeFAR2
Dr Antonio Garofalo o f Prof. Bradley's lab in Nottingham University supplied a 
pET 15b plasmid encoding antigen of CeFAR2. For expression the plasmid was 
cloned into c41 cells. The plasmid was inserted into host strain c41 by heat shock. 
100 pi of host strain c41 was placed in a sterile Eppendorf tube on ice. 1 pi p- 
mercaptoethanol was added and left on ice for 2 minutes, then 5 pi of plasmid was 
added to the tube and left on ice for 1 hour. A water bath was heated to 42 °C and 
the cells were placed in it for 30 seconds and then replaced on ice to cool back 
down to 4 °C. 400 pi of LB (Millipore) was then added and the tube was 
incubated at 37 °C for 1 hour. The cells were then plated on agar plus ampicillin 
and incubated overnight at 37 °C. 12 ml o f LB 200 pg/ml ampicillin was
inoculated with a single colony from the plate and incubated overnight at 37 °C 
with rotary shaking at 200 rpm. Glycerol stocks were made with this culture. The 
next day two 2-litre flasks containing 500 ml of 2-YT broth 200 pg/ml ampicillin 
were inoculated with 5 ml of the overnight culture and incubated at 37 °C with 
rotary shaking at 200 rpm. When the cultures had grown to an A^ oonm between 
0.6-1 (about 3 hours) they were induced with 1 mM dioxane free Isopropyl p-D- 
thiogalactoside (IPTG) from Roche and incubated for a further 3 hours at 37 °C 
with rotary shaking at 200 rpm. The cells were then pelleted by centrifugation at 
5000 g for 15 minutes at 4 °C. The supernatant was discarded and the cell pellets 
were stored at -70 °C until required. The pellets were resuspended in lysis buffer 
(5 mM imidazole, 50 mM TRIS and 300 mM NaCl) with a Roche EDTA free 
protease inhibitor tablet. The cells were lysed by sonication (Status US200, Philip 
Harris) on ice. Cells were sonicated 6 times at half power for 30 seconds. Cell 
disruption is observed by a partial clearing of the suspension. Sonicate was then
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centrifuged at 10000 rpm for 10 minutes at 4°C. The supernatant was transferred 
to a fresh beaker. This lysate was loaded onto an immobilised-metal affinity 
chromatography (IMAC) column on the Pharmacia FPLC. The column uses 
Nitrilotriacetic acid (Ni-NTA) to bind the 6 Histidine tag group incorporated onto 
the FAR protein. The column was pre-equilibrated with the lysis buffer. The 
column was washed with lysis buffer until the A280 was stable (about 5 column 
volumes), followed by two different wash steps with wash buffer 1 (10 mM 
imidazole, 50 mM TRIS and 300 mM NaCl) and wash buffer 2 (75 mM 
imidazole, 50 mM TRIS and 300 mM NaCl), until the A280 was stable. Finally an 
elution buffer (250 mM imidazole, 50 mM TRIS and 300 mM NaCl) was washed 
onto the column to remove the bound protein (figure 4.7a). Protein was detected 
at 280 nm and by SDS-PAGE analysis (figure 4.7).
a
b
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Figure 4.7 a) chart showing the main peak during elution (buffer containing 250 mM imidazole) 
from the Ni-NTA column
b) M = markers, 1-2 = eluted during wash buffer 1 (containing 10 mM imidazole) on 
the Ni-NTA column, 3-11=  eluted during wash buffer 2 (containing 75 mM 
imidazole) on Ni-NTA column and 12-14 = proteins including rCeFAR2 eluted 
during elution buffer step (containing 250 mM imidazole) on Ni-NTA column
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Lanes 9 -  14 on SDS-PAGE show smears o f bands at 20 kDa, which is close to 
the predicted molecular weight o f rCeFAR2. These fractions were run on the 
Superose 12 gel filtration column as a final purification step. Protein was loaded 
onto a pre-equilibrated Superose 12 gel filtration column (figure 4.8a) attached to 
the Pharmacia FPLC system, loaded at 0.3 ml/min and eluted in 50 mM HEPES 
pH 7.5. One main peak eluted and the fractions were run on SDS-PAGE (figure 
4.8b).
single gel
filtration
peak
20.1
14.4
Figure 4.8 a) chart of rCeFAR2 eluting from gel filtration column as a single peak,
b) M = markers, 1-9 = fractions eluted in main peak during gel filtration of 
rCeFAR2
Lanes 3-9 show bands o f 20 kDa, which are close to the predicted molecular 
weight o f rCeFAR2. MALDI-TOF indicates the protein to be close to its 
molecular weight of 20 kDa (chapter 6). Dynamic light scattering results indicate 
protein is not homogenous (chapter 6). Isoelectric focusing gel shows at least 2 
distinct bands (figure 3.8, lane 3) indicating that rCeFAR2 is probably
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heterogeneous. This could be due to degradation, loss of the end terminal amino 
acids or as is more likely, two species present in the sample, one species exists 
with lipid bound to rCeFAR2 and one without lipid bound to rCeFAR2 (chapter 
6).
Further purification was attempted by ion exchange. rCeFAR2 in 50 mM HEPES 
pH 7.5 was loaded a Hitrap Q anion exchange column on an AKTA purifier 100 
chromatography system (Amersham Pharmacia Biotech). Anion exchange 
column was washed with 2 M sodium chloride before the protein sample was 
loaded to remove any previously bound material and then equilibrated with 3 
column volumes o f 50 mM HEPES pH 7.5. Protein was detected at 280 nm. 5 ml 
o f protein sample was loaded onto the column at 2 mFmin. Unbound protein was 
collected in the flow through. Bound protein was eluted using a 0 -  100 % salt 
gradient with 50 mM HEPES pH 7.5, 2 M NaCl. SDS-PAGE (figure 4.9) was run 
on all fractions that eluted from the column.
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Figure 4.9 M= markers, 1 = sample loaded, 2-4 including CeFAR2 eluted from HQ column in 
20-25% NaCl and 5-6 eluted from HQ column in 25-30% NaCl.
The resulting SDS-PAGE from anion exchange indicates that further attempts at 
purification were less than successful. Smeared bands in lanes 3 and 4 in figure 
4.9 show that the protein has degraded. This step was subsequently not used in 
the purification o f rCeFAR2.
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4.4 Overexpression and purification of recombinant CeFAR3
Dr Antonio Garafalo of Prof. Bradley's lab in Nottingham University supplied a 
pET 15b plasmid encoding antigen of CeFar3. For expression the plasmid was 
cloned into c41 cells. The plasmid was inserted into host strain c41 by heat shock. 
100 pi of host strain c41 was placed in a sterile Eppendorf tube on ice. 1 pi p- 
mercaptoethanol was added and left on ice for 2 minutes, then 5 pi of plasmid was 
added to the tube and it was left on ice for 1 hour. A water bath was heated to 42 
°C and the cells were placed in it for 30 seconds and then replaced on ice to cool 
back down to 4 °C. 400 pi of LB (Millipore) was then added and the tube was 
incubated at 37 °C for 1 hour. The cells were then plated on agar plus ampicillin 
and incubated overnight at 37 °C. 12 ml o f LB 200 pg/ml ampicillin was
inoculated with a single colony from the plate and incubated overnight at 37 °C 
with rotary shaking at 200 rpm. Glycerol stocks were made with this culture. The 
next day two 2-litre flasks containing 500 ml of 2-YT broth 200 pg/ml ampicillin 
were inoculated with 5 ml of the overnight culture and incubated at 37 °C with 
rotary shaking at 200 rpm. When the cultures had grown to an A6oonm between 
0.6-1 (about 3 hours) they were induced with 1 mM dioxane free Isopropyl p-D- 
thiogalactoside (IPTG) from Roche and incubated for a further 3 hours at 37 °C 
with rotary shaking at 200 rpm. The cells were then pelleted by centrifugation at 
5000 rpm for 15 minutes at 4 °C. The supernatant was discarded and the cell 
pellets were stored at -70 °C until required. The pellets were resuspended in lysis 
buffer (5 mM imidazole, 50 mM TRIS and 300 mM NaCl) with a Roche EDTA 
free protease inhibitor tablet. The cells were lysed by sonication (Status US200, 
Philip Harris) on ice. Cells were sonicated 6 times at half power for 30 seconds. 
Cell disruption is observed by a partial clearing o f the suspension. Sonicate was 
then centrifuged at 10000 rpm for 10 minutes at 4°C. The supernatant was 
transferred to a fresh beaker. This lysate was loaded onto an immobilised-metal 
affinity chromatography (IMAC) column on the Pharmacia FPLC. The column 
uses Nitrilotriacetic acid (Ni-NTA) to bind the 6 Histidine tag residue on FAR
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proteins and was pre-equilibrated with the lysis buffer. The column was washed 
with lysis buffer until the A280 was stable (about 5 column volumes), followed by 
two different wash steps with wash buffer 1(10 mM imidazole, 50 mM TRIS and 
300 mM NaCl) and wash buffer 2 (75 mM imidazole, 50 mM TRIS and 300 mM 
NaCl), until the A280 was stable (figure 4.10a). Finally, an elution buffer (250 mM 
imidazole, 50 mM TRIS and 300 mM NaCl) was washed onto the column to 
remove the bound protein (figure 4.10b). Protein was detected by SDS-PAGE 
analysis (figure 4.11).
b
a
main peak 
obtained 
during elution 
wash
peak obtained 
during second 
wash buffer
Figure 4.10 a) chart from wash buffer 2 (containing 75 mM imidazole) step of rCeFAR3 eluting 
from Ni-NTA column,
b) Chart from elution buffer (containing 250 mM imidazole) step of rCeFAR3 
eluting from Ni-NTA column.
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20.1
14.4
Figure 4.11 M = markers, 1-2 = eluted from wash buffer 1 (containing 10 mM imidazole),
3-11=  proteins eluted during wash buffer 2 (containing 75 mM imidazole) of 
rCeFAR3 from Ni-NTA column and 12-14 = proteins eluted during elution buffer 
(containing 250 mM imidazole) step of rCeFAR3 from Ni-NTA column
SDS-PAGE lanes 7 - 1 4  contain smear bands of protein at 20 kDa, which is close 
to the molecular weight o f rCeFAR3.
Protein was dialysed into 50 mM HEPES pH 7.5 for loading a Hitrap Q anion 
exchange column on the AKTA purifier 100 chromatography system (figure 
4.12a). Ion exchange was tried instead of gel filtration since gel filtration on 
previous FAR proteins, rOvFARl and rCeFAR2, indicated protein degradation 
was occurring while on the column. The anion exchange column was washed 
with 2 M sodium chloride before the protein sample was loaded to remove any 
previously bound proteins and then given a final wash with 3 column volumes of 
50 mM HEPES pH 7.5. Protein was detected at 280 nm. 5 ml o f protein sample 
was loaded onto the column at 2 ml/min. Unbound protein was collected in the 
flow through. Bound protein was eluted using a salt gradient (50 mM HEPES pH 
7.5, 2 M NaCl). SDS-PAGE (figure 4.12b) was run on all fractions that eluted 
from the column.
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Figure 4.12 a) chart of HQ anion exchange run on AKTA system,
b) M= markers, 1= flow through, 2-4 = proteins eluted in peak one from HQ column 
in 0-5 % NaCl and 7-8 = proteins eluted in peak two o f HQ column in 5-15 % NaCl
The resulting gel showed bands o f 20 kDa in lanes 2-4 and 7-8 and lane 1, which 
is close to the molecular weight of rCeFAR3. Protein in lane 1 did not bind 
fluorescent tagged fatty acid DAUDA, therefore was not rCeFAR3. The two 
peaks that resulted from ion exchange, both contain rCeFAR3. These two peaks 
may well be iso forms of the protein since an isoelectric focusing gel (figure 3.8, 
lane 5) shows at least 2 bands (charged isoforms) present. MALDI-TOF analysis 
indicates other higher molecular weight oligomers may also be present (chapter 
6), although dynamic light scattering o f rCeFAR3 in HEPES and PIPES buffer 
suggest only moderate polydispersity o f rCeFAR3 (chapter 6).
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4.5 Results of ligand binding studies of rO vF A R l,  rCeFAR2 and rCeFAR3
4.5.1 DAUDA binding
Environment sensitive probes, like DAUDA can explore even subtle difference in 
the nature o f a fatty acid binding site (Kennedy et al, 1995b). These binding 
studies were undertaken to determine the strength o f ligand binding between the 
different FAR proteins. Upon interaction with DAUDA the FAR proteins 
undergo dramatic blue shifts in the wavelength o f maximum fluorescence 
emission from 542 nm for DAUDA in buffer to 492 nm, 489 nm and 486 nm for 
DAUDA interacting with rOvFARl, rCeFAR2 and rCeFAR3 respectively (figures 
4.13, 4.14 and 4.15 respectively). This indicates that the FAR proteins have 
bound the fluorescent fatty acid. Greater shift enhancement o f DAUDA 
fluorescence was observed in rCeFAR3 than the other FAR proteins, as a greater 
blue shift in fluorescence occurred.
Binding of DAUDA to rOvFARl to sa turation
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Figure 4.13 Binding of the fluorescent labelled fatty acid DAUDA to rOvFARl
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Binding of DAUDA to rCeFAR2 to  sa turation
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Figure 4.14 Binding of the fluorescent labelled fatty acid DAUDA to rCeFAR2
Binding of DAUDA to rCeFAR3 to sa turation
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Figure 4.15 Binding of the fluorescent labelled fatty acid DAUDA to rCeFAR3
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Experiments involving titrations o f the FAR proteins with DAUDA (figures 4.16, 
4.17 and 4.18) showed that the proteins have similar dissociation constants (Kd) 
(Table 4.1) and emphasises the greater fluorescence emission produced in 
DAUDA binding to rCeFAR3. This is shown by rCeFAR3 having the highest Kd 
value o f 0.09(±3)mM.
Fluorescence intensity versus OvFarl concentration
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Figure 4.16 Titration curve for the binding of DAUDA to rOvFARl. Relative intensity changes 
(recorded at the wavelength of maximum fluorescence emission of 492 nm for 
rOvFARl) of 0.000406 mg/ml DAUDA in PBS buffer, upon addition of increasing 
concentration of rOvFARl. The data is corrected for the effects o f dilution. The 
solid line is the theoretical binding curve for complex formation with dissociation 
constant, Kd = 0.063(±3)mM.
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Fluorescence intensity versus CeFar2 concentration
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Figure 4.17 Titration curve for the binding of DAUDA to rCeFAR2. Relative intensity changes 
(recorded at the wavelength of maximum fluorescence emission of 489 nm for 
rCeFAR2) of 0.000406 mg/ml DAUDA in PBS buffer, upon addition of increasing 
concentration of rCeFAR2. The data is corrected for the effects of dilution. The 
solid line is the theoretical binding curve for complex formation with dissociation 
constant, Kd = 0.053(±l)mM.
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Figure 4.18 Titration curve for the binding of DAUDA to rCeFAR3. Relative intensity changes 
(recorded at the wavelength of maximum fluorescence emission of 486 nm for 
rCeFAR3) of 0.000406 mg/ml DAUDA in PBS buffer, upon addition of increasing 
concentration of rCeFAR3. The data is corrected for the effects of dilution. The 
solid line is the theoretical binding curve for complex formation with dissociation 
constant, Kd = 0.095(±3)mM.
4.5.2 Retinol binding
Since retinol is the major ligand sequestered by OvFARl and perhaps CeFAR2 
and CeFAR3, the interaction of retinol with FAR proteins was monitored using 
fluorescence. Retinol (all-trans-retinol), figure 2.5, contains 5 conjugated double 
bonds and is therefore prone to oxidation by light and oxygen. It is highly 
unstable in aqueous solution, although the ligand appears stable to degradation 
upon binding to lipid binding proteins (Hemley et al, 1979). The fluorescence 
emission o f all-trans-retinol is minimal in buffer alone, but it is dramatically 
enhanced on addition o f retinol-binding proteins (Hemley et al, 1979; Narayan & 
Berliner, 1997; Papiz et al, 1986). To minimise retinol deterioration, the
75
Chapter 4 OvFARl, CeFAR2 and CeFAR3
dissociation constant o f retinol:protein binding was estimated by fluorescence 
titration in which increasing concentrations o f retinol were added to a protein 
solution in a cuvette. This means that any retinol not complexed with protein is 
prone to deterioration. Dissociation curves (figures 4.19) were corrected for free 
retinol. rCeFAR2 protein produces a slightly greater increase in the fluorescence 
emission intensity o f bound fluorescent ligand than the other FAR proteins, but 
not enough to be significant. Unfortunately, the Kd values for retinol bound to 
these FAR proteins are unreliable as the errors for each are greater than the Kd 
value obtained (table 4.1). The blue shift in wavelength from 542 nm to 477 nm, 
476 nm and 477 nm for rOvFARl, rCeFAR2 and rCeFAR3 respectively indicates 
that the FAR proteins have a similar affinity for retinol.
Fluorescence intensity versus retinol concentration
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Figure 4.19 Fluorescence titration curves showing the binding of all-trans-retinol to rOvFARl,
rCeFAR2 and rCeFAR3. Consecutive additions of retinol were added to a cuvette 
containing 200fil of rOvFARl, rCeFAR2 and rCeFAR3 and changes in the relative 
fluorescence intensity at 477 nm, 476 nm and 477 nm respectively. The data were 
corrected for the effects o f dilution and retinol fluorescence for the curves shown. 
Theoretical binding curves for complex formation are represented by the solid lines 
with dissociation constants, Kd = 0.3 mM for rOvFARl, Kd = 0.34 mM for 
rCeFAR2 and Kd = 0.09 mM for rCeFAR3 (not enough to give a reliable standard 
deviation for rOvFARl).
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rOvFAR 1 rCeFAR2 rCeFAR3
ligand binding 7-max Kd 7max Kd 7-max Kd
DAUDA 492nm 0.06mM 489nm 0.05mM 486nm 0.09mM
Retinol 477nm 0.3mM 476nm 0.34mM 477nm 0.09mM
ATnax : Wavelength of maximal fluorescence emission of ligand when bound to protein.
Kd : All dissociation constant estimations obtained by titration with fluorescent ligands. Retinol 
Kds have large errors and the data has to be judged accordingly.
Table 4.1 - Functional properties of FAR proteins
4.5.3 Competitive binding studies with oleic acid
Competition for the retinol binding site in the FAR proteins was investigated by 
adding oleic acid to the retinol-FAR protein complexes and observing a decrease 
in the fluorescence emission (figures 4.20, 4.21 and 4.22).
Binding of retinol to rOvFARI and com petition with oleic acid
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Figure 4.20 Competitive effects o f oleic acid on rOvFAR l-retinol complex. The enhanced
emission of retinol when bound to rOvFAR l was reversed by addition of oleic acid.
77
re
la
tiv
e 
fl
uo
re
sc
en
ce
Chapter 4 OvFAR 1, CeFAR2 and CeFAR3
Binding of retinol to rCeFAR2 and competition with oleic acid
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Figure 4.21 Competitive effects o f oleic acid on rCeFAR2-retinol complex. The enhanced
emission of retinol when bound to rCeFAR2 was reversed by addition of oleic acid.
Binding of retinol to rCeFAR3 and competition with oleic acid
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Figure 4.22 Competitive effects o f oleic acid on rCeFAR3-retinol complex. The enhanced
emission of retinol when bound to rCeFAR3 was reversed by addition of oleic acid.
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These competitive binding experiments show that the enhanced emission of 
retinol when bound to the FAR proteins was reversed by addition of oleic acid. 
This suggests that the retinol and oleic fatty acid do compete for the binding site, 
indicating that the binding sites are either the same (the more probable), or 
interactive because the oleic acid affected the retinol bound to the FAR proteins.
4.5.4 Preference of FAR proteins for fatty acid chain length
Experimental work to determine preference of fatty acid chain length has 
previously been carried out on rGpFARl (Prior et al, 2001) where the results 
indicated no preference for saturated or unsaturated fatty acids, but showed a 
preference for chain length C14-C18, with the greatest displacement of DAUDA 
occurring at C l5. In this section we investigate the preference of rOvFARI, 
rCeFAR2 and rCeFAR3 proteins for fatty acid chain length (figures 4.23, 4.24 and 
4.25). The same molarity of test fatty acid (chapter 2, figure 2.6 - lists fatty acids 
used) was added to a DAUDA-FAR protein complex. The percentage decrease in 
DAUDA fluorescence was recorded at the maximum fluorescence emission of 
492 nm, 489 nm and 486 nm for rOvFARI, rCeFAR2 and rCeFAR3 respectively.
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OvFarl preference for fatty acid chain length
C10 C11 C14 C15 C16 C17 C18 C19 C21 C22
carbon chain length
Figure 4.23 Chart showing the preference of rOvFAR l for fatty acid chain length
CeFar2 preference for fatty acid chain length
C10 C11 C14 C15 C16 C17
Carbon chain length
C18 C19 C21 C22
Figure 4.24 Chart showing the preference of rCeFAR2 for fatty acid chain length
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CeFar3 preference in fatty acid chain length
60
C10 C11 C14 C15 C16 C17 C18 C19 C21 C22
carbon chain length
Figure 4.25 Chart showing the preference of rCeFAR3 for fatty acid chain length
Significant binding occurred in the range C l4 - C l8 for all the FAR proteins 
investigated, with the maximum DAUDA displacement occurring for fatty acids, 
pentadecanoic acid and palmitic acid, which have a C l5 or C16 chain length.
4.5.5 Lipid binding
Lipids are naturally present in the E. coli expression system used (Wisely et al, 
2002). Because of this, there may be competition between these lipids and the 
fatty acids for the FAR protein binding site. During normal overexpression, there 
are no fatty acids present and therefore these lipids may occupy the binding site. 
It is unlikely that this will be either complete or in a fixed ratio. This is likely to 
give rise to a heterogeneous sample with some proteins with lipid in their binding 
site and others with empty binding sites. MALDI-TOF analysis o f rGpFARl 
before and after lipid removal columns suggests that the proteins do bind lipids or 
other molecules during their preparation (chapter 6). The competition for the
81
Chapter 4 OvFARl, CeFAR2 and CeFAR3
binding site in the FAR proteins suggests that the molecules bound during 
preparation may be removed by competition with other fatty acids. This removal 
is not a straight forward procedure (N. Meenan, private communication), since the 
protein requires to be bound to a media by reverse phase chromatography, 
denatured, washed with buffer, then refolded before the required fatty acid is 
added. There is also evidence (Wisely et al, 2002) that during normal protein 
folding in over-expression lipid may also get trapped in the protein interior.
4.6 Discussion
The aim of this chapter was to investigate and improve the purity of the 
overexpressed proteins rOvFARI, rCeFAR2 and rCeFAR3, to compare their 
ligand binding properties with previously studied rGpFARl and to establish if 
rCeFAR2 and rCeFAR3 are good functional homologues of rOvFAR 1.
The results indicate that the three recombinant FAR proteins investigated in this 
chapter are indeed functional lipid binding proteins. Fluorescence results showing 
that the proteins have similar activity despite sequence similarities of only 32 %. 
The purity of the three FAR proteins as depicted on SDS-PAGE show that in each 
case two very close bands of approximately 20 kDa at the expected molecular 
weight are present, indicating that the proteins either degrade, the lower band has 
been cleaved of a small number of amino acids or as is more likely the presence of 
loosely bound lipid. MALDI-TOF analysis confirms that the proteins are of a 
molecular weight close to that expected, also shown is that the proteins may have 
bound lipids or endotoxins derived from E. coli overexpression (chapter 6).
The FAR proteins investigated undergo dramatic shifts in wavelength of 
maximum fluorescence emission from 542 nm for DAUDA in buffer to 492 nm, 
489 nm and 486 nm for DAUDA interacting with rOvFARI, rCeFAR2 and 
rCeFAR3 respectively. This shows that the FAR proteins have bound to the
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fluorescent fatty acid. The greatest enhancement was observed in DAUDA 
binding rCeFAR3 with a blue shift in wavelength intensity from 542 nm for 
DAUDA in buffer to 486 nm. The dissociation constants (table 4.1) calculated for 
DAUDA binding the FAR proteins emphasises the greater fluorescence emission 
produced in DAUDA binding rCeFAR3 with a Kd of 0.095(±3) mM compared to 
Kd of 0.053(±) mM for rCeFAR2 and Kd 0.063(±3) mM for rOvFARl. Binding 
DAUDA with enhanced fluorescent emission and a large blue shift suggests that 
the binding site for the FAR proteins is in an apolar environment and isolated 
from solvent. This has already been shown for rOvFARl (Kennedy et al, 1997) 
and GpFARl (Prior, 2001) but shows that rCeFAR2 and rCeFAR3 of the FAR 
family interact in a similar way and are therefore in an apolar environment and 
isolated from solvent. This isolation of ligands from solvent water is useful in that 
it would protect oxidation-sensitive ligands, such as retinol and other hydrophobic 
ligands.
The FAR proteins have also been shown to bind retinol and rCeFAR2 was shown 
to produce a slightly greater increase in the fluorescence emission intensity of the 
bound fluorescent ligand than the other FAR proteins (figure 4.19). Blue shifts in 
wavelength of maximum fluorescence emission from 542 nm for retinol in buffer 
to 477 nm, 476 nm and 477 nm for retinol interacting with rOvFARl, rCeFAR2 
and rCeFAR3 respectively. Competitive effects with the retinol-FAR protein 
complex were observed when 10 mM oleic acid was added. This indicates that 
the binding site for retinol and fatty acids is interactive or congruent in the case of 
all the FAR proteins. This has also been shown for GpFARl (Prior et al, 2001) 
another member of the FAR family, which will be discussed in a later chapter. 
Binding retinol is important for OvFARl as it is thought that the nematode 
Onchocerca volvulus that secretes the protein OvFARl requires retinol for a 
variety of metabolic and developmental purposes including, growth, 
differentiation, embryogensis, glycoprotein synthesis and anti-oxidants. This 
suggests that the FAR proteins role in the nematodes is related to retinol 
acquisition or transport.
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The preference of the FAR proteins for fatty acid chain length was investigated by 
competition of the DAUDA-FAR protein complex. The maximal binding 
occurred in the range C14-C18 for all the FAR proteins, with the greatest 
displacement occurring between C15-C16. This is also the case for GpFARl 
(Prior et al, 2001). This preference for a C15-C16 fatty acid chain length 
correlates favorably with the most abundant fatty acids found in the Globodera 
organisms which are fatty acid chain C l4 -  C22 (Holz et al, 1998a; Holz et al, 
1998b), with the main fatty acids found in potato roots being of chain length Cl 6 
and Cl 8 (Holz et al, 1998a; Holz et al, 1998b). This would indicate that the 
recombinant proteins are behaving as they do in vivo, by binding similar fatty acid 
chain lengths.
The results from this chapter show that the FAR proteins investigated here have 
similar ligand binding activities, indicating that the binding sites for these proteins 
are most probably conserved. The sequence alignment of FAR proteins (figure 
1.9), OvFARl, CeFAR2, CeFAR3 and GpFARl shows areas of sequence 
similarity between amino acid residues 41-46, 129-131 and a large region of 
similarity between amino acid residues 78-90. These conserved regions between 
the FAR proteins indicate probable binding sites.
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Chapter 5 -  GpFARl overexpression and purification. 
5.1 Introduction
GpFARl protein is secreted by the potato cyst nematode Globodera pallida, one 
of the major pathogens of the commercial potato Solanum tuberosum. GpFARl is 
an 18.8 kDa protein that has been characterised by ligand binding studies as a 
fatty acid and retinol binding protein. This chapter studies GpFARl separately 
from the other FAR proteins as it has been already been characterised by ligand 
binding (Prior et al, 2001) and was the FAR protein that grew protein crystals. 
Recombinant protein is used to study the functional and structural properties as 
protein from the nematode is not available in sufficient quantity.
5.2 Overexpression and purification of rGpFARl
Dr A. Prior (Scottish Crop Research Institute, Dundee) supplied a plasmid 
encoding the antigen of GpFARl as a pGEX-2T plasmid containing the GpFARl 
gene.
The plasmid was extracted and transformed into BL21 host cells. The plasmids 
were inserted by heat shock. 100 pi of host strain BL21 was placed in a sterile 
Eppendorf tube on ice. 1 pi p-mercaptoethanol was added and left on ice for 2 
minutes, then 5 pi of plasmid was added to the tube and left on ice for 1 hour. A 
water bath was heated to 42 °C and the cells placed in it for 30 seconds and then 
replaced on ice to cool back down to 4 °C. 400 pi of LB (Millipore) was then 
added and the tube was incubated at 37 °C for 1 hour. The cells were then plated 
on agar with ampicillin and incubated overnight at 37 °C. After incubation 10 ml 
of LB 200 pg/ml ampicillin was inoculated with a single colony from the plate 
and incubated overnight at 37 °C with rotary shaking at 200 rpm. Glycerol stocks
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were made using 850 pi of culture and 150 pi of 80 % glycerol and stored at -80 
°C.
A I L  flask containing 500 ml of 2-YT broth and 200 pg/ml ampicillin was 
inoculated with a glycerol stock and grown overnight at 37 °C with shaking at 200 
rpm. This overnight broth was added to 2 more litre flasks containing 1 litre 2-YT 
broth 200 pg/ml ampicillin each and grown at 37 °C and 200 rpm for 
approximately 3 hours until cultures had grown to an Asoonm between 0.6-1. 1 
mM dioxane free Isopropyl P-D-thiogalactoside (IPTG) was added to induce gene 
expression. Cells were grown for a further 3 hours at 37 °C with shaking at 200 
rpm. The culture was transferred to appropriate centrifuge bottles and centrifuged 
at 8000 rpm for 15 minutes to sediment the cells and the supernatant was 
removed.
Each pellet was then resuspended in 100 ml PBS with a Roche EDTA free 
protease inhibitor tablet. The cells were disrupted by sonication on ice, using a 
Status US200 sonicator from Philip Harris Scientific for six, 30 second blasts at 
half power. Cell disruption is evidenced by partial clearing of the suspension. A 
small aliquot of sonicate was saved for analysis by SDS-PAGE. Sonicate was 
then centrifuged at 10000 rpm for 10 minutes and the supernatant transferred to a 
fresh container. 1 ml of Glutathione Sepharose 4B was then added to 50 ml of 
supernatant and this was incubated at room temperature with gentle rocking for an 
hour. After an hour this was spun down gently in the centrifuge at 500 rpm for 10 
minutes and the resin was washed 3 times with PBS. Finally the proteins were 
released from the GST by cleavage with thrombin protease, 50 units of thrombin 
per 1 ml o f resin. After 16 hours at room temperature the resin was spun down at 
200 rpm for 5 minutes and the supernatant saved for SDS-PAGE analysis. The 
protein was detected in the supernatant on SDS-PAGE. To remove the thrombin 
protease the protein was run through a Benzamidine FFTrap column from 
Amersham Pharmacia Biotech at 0.5 ml/min using AKTA purifier 100 
(Amersham Pharmacia Biotech).
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SDS-PAGE (figure 5.1) shows the thrombin cleavage steps o f rGpFARl 
preparation.
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Figure 5.1 M = marker, 2 = resin after rGpFARl removal, 3 = pellet before resin added,
4-5 = washes of resin and 6-7 = rGpFARl removed from resin.
A one step purification is affected by loading the supernatant (figure 5.1, lanes 6 
and 7) onto a pre-equilibrated Superose 12 gel filtration column (figure 5.2a) at 
0.3 ml/min and eluted in 50 mM HEPES pH 7.5. SDS-PAGE (figure 5.2b) was 
run on all fractions that were eluted.
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Figure 5.2 a) gel filtration of rGpFARl showing 2 peaks.
b) M = markers, 1 = first peak from gel filtration containing high molecular weight 
protein of approximately 42 kDa, 2-6 = second peak from gel filtration containing 
rGpFARl.
rGpFARl was judged to be homogenous by the single band in lanes 3-6 with an 
apparent molecular weight o f 18 kDa, which approximates to the predicted 
molecular weight o f rGpFARl (18.8 kDa).
These rGpFARl fractions were assayed for DAUDA binding and were shown to 
exhibit fatty acid binding activity confirming functional rGpFARl to be present. 
9 mg/ml o f rGpFARl was produced from an 8 L culture.
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5.3 Discussion
The overexpression and purification of rGpFARl resulted in a single band on 
SDS-PAGE analysis. From isoelectric focusing gel (chapter 3, figure 3.8, lane 2), 
rGpFARl may be judged to be homogenous as only a single band is shown. 
MALDI-TOF analysis (chapter 6) shows no dimeric species present, though it is 
likely that lipid is bound to rGpFARl. Dynamic light scattering suggests that the 
protein may be polydispersed. Since SDS-PAGE and IEF gel analysis suggest a 
monomeric protein crystallisation trials were attempted (chapter 7).
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Chapter 6 -  Matrix Assisted Laser Desorption Ionisation -  Time Of Flight, 
Circular Dichroism and Dynamic Light Scattering analysis of the FAR 
proteins.
6.1 Introduction
This chapter studies the biophysical properties of all the FAR proteins to get a 
better understanding of their secondary structure and to determine the optimum 
conditions for crystallisation studies.
6.2 Matrix Assisted Laser Desorption Ionisation -  Time Of Flight (MALDI- 
TOF) analysis of FAR proteins
MALDI (Hillenkamp et al, 1991) has been used successfully in determining 
molecular weights of proteins. In this chapter it is used not only to determine the 
molecular weight of the FAR proteins and to determine the presence of oligomers, 
but also in the case of rGpFARl it has been used to determine if lipid is present. 
Lipids and endotoxins from E. coli are thought to have bound to these fatty acid 
and retinol binding proteins during their expression. MALDI-TOF analysis was 
carried out as described in chapter 2.2. All spectra were baseline corrected (BC) 
and mass corrected (MC) using the standards described in chapter 2.2.
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6.2.1 rOvFAR-1
Voyager Spec #1=>BC=>NF0.7=>MC[BP = 10115.2, 25767]
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Figure 6.1 MALDI-TOF analysis o f rOvFARl
The expected molecular weight of rOvFARl from the amino acid sequence is 
20580 Da. The actual mass from MALDI-TOF (figure 6.1) of the parent peak was 
21805 Da, giving a difference between the calculated and observed molecular 
masses of approximately 1225 Da. The discrepancy between calculated and 
observed values is likely to be partially due to the sequestering of lipid into the 
binding site during overexpression, partially due to lipid non-covalently bound to 
the protein surface, and perhaps E. coli lipid(s) trapped within the protein interior 
during protein folding. This latter effect has already been evidenced for 
Hepatocyte nuclear factor 4 (HNF4), (Wisely et al, 2002). Since over-expression 
is in bacteria (E. coli), post-translational modification is unlikely in this instance. 
From experimental binding studies, described in chapter 4, it was found that there 
is a preference for fatty acids with a chain length between 1 4 - 1 8  carbon atoms. 
This would give an additional approximate mass value between 226 -  290 Da.
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The difference between the calculated and observed molecular weights of 
approximately 1225 Da makes it likely that 4 fatty acids are associated with each 
rOvFARl molecule. These fatty acids may be non-covalently bound to the 
surface of rOvFARl and fly with it during MALDI-TOF. There may also be at 
least one fatty acid in the binding pocket. The spectrum (figure 6.1) also shows 
doubly, 10895 Da and (approximately) triply, 7492 Da charged peaks are present.
V oyager S p ec  #1=>BC=>NF0.7=>MC[BP = 10115.2, 25767]
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Figure 6.2 MALDI-TOF ofrOvFARl expanded main peak
It is worth noting that the main peak at 21805 Da (figure 6.2) is really a mixture of 
several sub peaks o f near identical mass. The reason for this could be the 
presence of loosely bound lipid, which may indicate heterogeneity. The peak at 
43670 Da (figure 6.1) strongly suggests that rOvFARl may exist as a dimer in its 
native form. The dimer peak is twice the singly charge parent peak (21805 Da). 
Further low abundance peaks at approximately 66,000 and 88,000 show higher 
oligomeric states may have existed. SDS-PAGE analysis of rOvFARl (figure 
4.4) shows a band of 20 kDa, which is close to the molecular weight o f rOvFARl 
and a higher molecular weight band present at approximately 43 kDa, which again 
may support the native dimer conformation.
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6.2.2 rCeFAR2
Voyager Spec #1=>BC=>NF0.7=>MC[BP = 4190.6,17017]
4191.61100
90
70
50
40 20350.40
10173.5030
20 5264.47
5151.39 9269 49
18541.96 
17163 5$20560.21 
16173:68 20769.93
21973.6
10
11092.61
49417.031121.4 40269.212825.83678.0
M ass (m/z)
Figure 6 J  MALDI-TOF analysis o f rCeFAR2
The expected molecular mass calculated from the rCeFAR2 sequence is 20035 
Da, the molecular weight obtained from MALDI-TOF analysis (figure 6.3) was 
20350 Da, a difference of 315 Da. The discrepancy is likely to be due to the 
partial sequestering of lipid, possibly fatty acid of chain length C20. The doubly 
charged peak of 10173 Da can be clearly observed and is half the parent peak. In 
this instance the spectrum shows no evidence to support the formation of a dimer, 
but a peak at 20560 Da adjacent to the 20350 Da peak was observed. This may 
indicate protein heterogeneity, with two species present in the sample. The most 
likely explanation is that one species exists with two lipid molecules bound to 
rCeFAR2 (20560 Da) and one with only one lipid molecule bound rCeFAR2 
(20350 Da). The difference between the two species of 210 Da may well be the 
result of an extra fatty acid o f C12 chain length, molecular mass 212 Da, being 
incorporated during folding. SDS-PAGE (figure 4.8b) shows two bands of 
approximately 20 kDa close together and dynamic light scattering results indicate
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rCeFAR2 is not homogenous (see chapter 6.5) agreeing with the MALDI-TOF 
spectrum.
6.2.3 rCeFAR3
Voyager Spec #1=>BC=>NF0.7=>MC[BP = 20841.6,1810]
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Figure 6.4 MALDI-TOF analysis o f rCeFAR3
The rCeFAR3 spectrum is poor, indicating rCeFAR3 did not fly well. 
Additionally, several electronic noise peaks (spikes) can be seen that are due to 
traces o f salt present in the solution. rCeFAR3 was purified (chapter 4.4) by ion 
exchange and eluted using a salt gradient. rCefar3 was dialysed to remove salt 
before MALDI-TOF analysis, possibly traces still remained. The expected 
molecular mass o f rCeFAR3 from amino acid sequence is 20905 Da, the 
molecular weight obtained from MALDI-TOF analysis (figure 6.4) was 20843 Da, 
a difference of 63 Da. This discrepancy between calculated and observed values 
is too small to assign a fatty acid, but may be due to inaccuracy due to calibration 
errors in the MALDI-TOF experiment as well as the quality of the spectrum. It 
should also be noted that sub peaks are present around the main parent peak, 
which indicates heterogeneity o f the protein sample due to the acquisition of E.
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coli lipids. The spectrum also showed that the native structure consists of a dimer 
and several other oligomers (peaks at 41877, 62828 and 83904 Da). SDS-PAGE 
(figure 4.12) shows bands of 20 kDa, which is close to the molecular weight of 
rCeFAR3 (20.9 kDa), but also other higher molecular weight oligomers present, 
as demonstrated in the MALDI-TOF experiment.
6.2.4 rGpFARl and lipid analysis
FAR proteins are fatty acid and retinol binding proteins as observed in the 
fluorescence studies carried out in chapter 4. An abundance of lipids are present 
in E. coli, including palmitic acid (fatty acid chain length 16), myristic acid (fatty 
acid chain length 14) and cyclo heptadecanoic acid (fatty acid chain length 17 
with a cyclopropyl group) (Dhe-Paganon, 2002). Since E. coli is used for 
overexpressing the FAR proteins, it is more than likely that during overexpression 
these E. coli fatty acids will be sequestered by the FAR proteins. To determine if 
the FAR proteins had sequestered E. coli lipids during their overexpression 
MALDI-TOF analysis of rGpFARl was carried out before and after 
lipid/endotoxin removal (figures 6.5 and 6.6). This is important to know since 
lipid uptake may produce heterogeneous protein consisting of rGpFARl with and 
without lipids, which will in turn affect the quality (homogeneity) of protein 
available for crystallisation. Not only would there be a mix o f bound/unbound 
lipid proteins, but the size (chain length) of the lipids themselves could be varied 
in the binding site. There is also another important point in trying to determine 
which E. coli fatty acid(s) have been sequestered. It appears that there may be a 
strong affinity for these E. coli fatty acids and they may have a preference over the 
fatty acids normally sequestered by the FAR proteins in their natural environment. 
If this were the case, then a ready made inhibitor would be available to combat the 
parasite. Endotoxins and lipids were removed by passing purified rGpFARl 
down a gravity flow disposable column containing either polymyxn B resin 
(Sigma) column or a D-detergent removal column (Pierce).
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Voyager Spec #1=>BC=>BC=>NF0.7=>MC[BP = 1064.2, 27060]
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Figure 6.5 MALDI-TOF analysis of rGpFARl before lipid removal
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Figure 6.6 MALDI-TOF analysis o f rGpFARl after lipid removal
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The expected molecular mass of rGpFARl from the sequence is 18844 Da. The 
molecular mass from MALDI-TOF before lipid removal was 19286 Da, a 
difference of 442 Da indicating E. coli derived lipid may have been incorporated 
into the fatty acid binding site or non-covalently bound to the molecular surface. 
442 Da could support two C12 fatty acids present in binding site. The spectrum 
(figure 6.5) clearly shows doubly (9639 Da), triply (6425 Da) and quadruply 
(4817 Da) charged species. The analysis also shows that no dimeric or higher 
order oligomers are present. The MALDI-TOF analysis of rGpFARl after lipid 
removal (figure 6.6) shows many more sub peaks compared to the analysis before 
lipid removal, indicating that the protein is less stable when lipid is removed. 
However, after lipid removal the molecular weight obtained for rGpFARl is still 
19287 Da, almost identical to that before the protein is passed down the lipid 
removal columns. The near identical value (442Da) for before and after 
delipidating column usage perhaps more than anything, shows that the fatty acid 
(lipid) may be significantly bound and probably inserted at an early stage of 
expression. Although, after lipid removal, there are several sub peaks close to the 
parent peak 19287 Da, this may indicate that the extent of lipid binding has 
decreased.
Protein Difference between observed 
and calculated (Da)
Dimer
OvFARl 1225 Yes
CeFAR2 315 No
CeFAR3 63 Yes
GpFARl before lipid 
removal
442 No
GpFARl after lipid removal 442 No
Table 6.1 Showing the discrepancies between observed and calculated molecular weights from
MALDI.
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6.3 C ircu lar  dichroism of FAR proteins
Circular dichroism (CD) analysis was carried out as described in chapter 2. 
The secondary structure charts o f the far UV spectra o f the FAR proteins 
rOvFARl, rCeFAR2, rCeFAR3 and rGpFARl are compared in figure 6.6.
CD Spectra of Far proteins
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Figure 6.7 Comparison of the CD of the far UV spectra of the Far proteins
The far UV spectra o f the FAR proteins shows that they have a similar shape 
and that the secondary structures of rCeFAR2 and rCeFAR3 are almost 
identical.
The secondary structure content o f each protein was estimated using the 
CONTIN procedure (table 6.2) o f Provencher and Glockner (1981).
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Protein
Secondary structure predictions using CONTIN
a-helix P-sheet P-tum remainder
rGpFarl 35% 42% 15% 8%
rOvFarl 27% 32% 27% 15%
rCeFar2 44% 34% 9% 13%
rCeFar3 42% 29% 14% 15%
Table 6.2 Secondary structure content o f each protein estimated using the CONTIN
procedure.
In a number of studies on proteins it has been found (Kelly & Price, 1997) that 
the CONTIN procedure tends to overestimate the p -sheet content. The 
SELCON procedure (table 6.3) (Sreerama & Woody, 1993) has been attributed 
with a more accurate method of secondary structure assignment. This was 
used for rOvFARl, rCeFAR2 and rCeFAR3.
Protein
Secondary structure predictions using SELCON
a-helix anti-parallel p- 
sheet
parallel p-sheet turn other
rOvFarl 31% 12.6% 7.7% 17.7% 31.1%
rCeFar2 44.3% 8.9% 7.3% 14.7% 24.5%
rCeFar3 46.6% 7.7% 7.0% 14.1% 24.9%
Table 63  Secondary structure content of each protein estimated using the SELCON
procedure.
Recombinant GpFARl was a poor match to other proteins using the SELCON 
procedure and hence its secondary structure was not estimated by this method. 
The accuracy of these results is directly dependent upon the accuracy of the 
protein concentrations used to calculate the mean residue ellipticity values. 
rGpFARl did not give any solutions using the SELCON procedure, which 
may reflect the possibility that the concentration had been overestimated.
The CD spectra show that the recombinant proteins have folded into a 
secondary structure. The SELCON results show that the rCeFARs and 
rOvFARl proteins contain a higher percentage of a-helix than p-sheet.
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CONTIN results show rGpFARl contains approximately equal amounts of 
both a-helix and p-sheet. This shows that these FAR proteins are structurally 
different from the more ubiquitous lipid binding proteins, which are 
predominantly 10 anti-parallel p-stranded and 2 short a-helices surrounding 
the interior binding cavity in a p-barrel type structure (Banaszak et al, 1994). 
Previous CD studies carried out (Garofalo et al, 2003) show 54 and 61 % a- 
helical content for CeFAR2 and CeFAR3 respectively. The main reason for 
the difference in helical content is probably due to inaccurate measurement of 
protein concentration. Protein concentration may be inaccurate due to lipid 
being attached to the protein, as a result the molecular weight is incorrect as 
witnessed in the MALDI experiment. The presence of lipid can also affect the 
absorption of the protein sample and also the presence of DNA absorbing at 
260 nm lead to errors in protein concentration.
6.4 Dynamic light scattering (DLS) on FAR proteins
The DLS experimental protocol is described in chapter 2. DLS was carried out 
to investigate the effects of buffer, pH and temperature on each FAR protein to 
determine the optimum conditions for crystallisation. Each 2 mg/ml protein 
was investigated in 20 mM ACETATE pH 4.5, 20 mM PIPES pH 6.5, 20 mM 
HEPES pH 7.5 and 20 mM TRIS pH 8.5, with 150 mM NaCl present in all. 
Each protein solution was investigated at temperatures between 5 - 2 5  °C in 5° 
increments. Lysozyme was used as a standard. (Appendix 1, DLS results)
Polydispersity o f  FAR proteins
Polydispersity (%) = polydynamic radius (nm) / radius (nm) X 100
The degree of polydispersity of each protein solution may indicate the 
conditions whereby there is a greater likelihood that crystallisation may occur.
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(1) ACETATE
In 20 mM ACETATE pH 4.5 DLS results were obtained for lysozyme, rCeFAR2 
and rCeFAR3. rOvFARl and rGpFARl aggregated in this buffer therefore no 
results were obtained for these proteins.
Comparision of polydispersity of rCeFAR proteins and Lysozyme in Acetate pH 4.5
temperature [degrees Celsius]
•  Lysozyme 
-*-rC eFA R 2 
-*r-rCeFAR3
Figure 6.8 Polydispersity of lysozyme, rCeFAR2 and rCeFAR3 in ACETATE pH 4.5
The polydispersity o f rCeFAR3 is uniformly greater than 30 % between 5 -  25 °C 
in ACETATE pH 4.5, which indicates a significant amount of polydispersity 
indicating that these conditions are unlikely to be optimum for crystallisation. 
The baseline parameters (appendix 1) for rCeFAR3 indicate narrow mono modal 
size distribution between 15 -  25 °C and broad monomodal size distribution 
below 10 °C. The SOS noise (appendix 1) indicates significant background noise 
between 5 - 2 5  °C, corroborating the polydispersity values.
The polydispersity for rCeFAR2 is below 15 % at 10 °C in ACETATE pH 4.5 
suggesting negligible polydispersity. At 15 °C and 20 °C the polydispersity is
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below 30 % indicating a moderate amount o f polydispersity and above 25 °C there 
is a significant amount of polydispersity. The SOS errors (appendix 1) indicate 
low noise, however the baseline parameters show multimodal size distribution. 
The results suggest the protein is not homogenous, but that crystallisation in this 
buffer may be possible at temperatures below 10 °C.
The results for lysozyme in ACETATE pH 4.5 shows moderate to negligible 
polydispersity and narrow monomodal size distribution with low noise errors, 
indicating that lysozyme is homogenous and this buffer is suitable for 
crystallisation. Subsequent analysis on lysozyme with PIPES, HEPES and TRIS 
show, as expected, very similar results as to that found for ACETATE.
(11) PIPES
In 20 mM PIPES pH 6.5 DLS results were obtained for lysozyme, rGpFARl, 
rOvFARl and rCeFAR3. rCeFAR2 aggregated in this buffer therefore no results 
were obtained.
Com parision of polydispersity  of FAR proteins and Lysozyme in PIPES pH 6.5
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rGpFARI
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rCeFAR3
temperature [degrees Celsius]
Figure 6.9 Polydispersity of lysozyme, rGpFARI, rOvFARI and rCeFAR3 in PIPES pH 6.5
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rGpFARI and rOvFARI show polydispersity greater than 30 % with baseline 
errors indicating multimodal size distribution and SOS noise (appendix 1) 
showing high error for rGpFARI and significant background noise for rOvFARI. 
These results indicate that PIPES pH 6.5 is not an appropriate buffer for rGpFARI 
and rOvFARI.
rCeFAR3 shows a moderate amount of polydispersity below 20 °C and negligible 
polydispersity above 25 °C. The baseline errors (appendix 1) suggest narrow 
monomodal size distribution and SOS errors (appendix 1) indicate low noise, 
agreeing with the polydispersity values. rCeFAR3 is monodispersed in 20 mM 
PIPES pH 6.5 above 25 °C and hence the most favourable buffer and temperature 
for crystallisation.
(ul) HEPES
In 20 mM HEPES pH 7.5 DLS results were obtained for lysozyme, rGpFARI, 
rOvFARI and rCeFAR3. rCeFAR2 aggregated in this buffer therefore no results 
were obtained.
Comparision of polydisperity of FAR proteins and Lysozyme in HEPES pH 7.5
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Figure 6.10 Polydispersity o f lysozyme, rGpFARI, rOvFARI and rCeFAR3 in HEPES pH 7.5
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rGpFARI and rOvFARI show polydispersity greater than 30 % with baseline 
errors (appendix 1) indicating multimodal and broad monomodal size distribution 
and SOS noise (appendix 1) showing high error for rGpFARI and significant 
background noise for rOvFARI. These results indicate that HEPES pH 7.5 is not 
an optimum buffer for rGpFARI or rOvFARI.
rCeFAR3 shows a moderate amount of polydispersity above 20 °C and negligible 
polydispersity below 15 °C. The baseline errors (appendix 1) suggest multimodal 
and broad monomodal size distribution and SOS errors (appendix 1) indicate 
significant background noise. Crystallisation o f rCeFAR3 could be attempted in 
20 mM PIPES pH 6.5 below 15 °C, even though SOS errors are high.
(fv) TRIS
In 20 mM TRIS pH 8.5 DLS results were obtained for lysozyme, rOvFARI, 
rCeFAR2 and rCeFAR3. rGpFARI aggregated in this buffer therefore no results 
were obtained.
Comparision of polydispersity of FAR protein and Lysozyme in TRIS pH 8.5
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Figure 6.11 -  Polydispersity of lysozyme, rOvFARI, rCeFAR2 and rCeFAR3 in TRIS pH 8.5
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rOvFARI and rCeFAR2 show polydispersity greater than 30 % with baseline 
errors (appendix 1) indicating multimodal size distribution and SOS noise 
(appendix 1) showing significant background noise for rOvFARI and high SOS 
error for rCeFAR2. These results indicate that TRIS pH 7.5 would not be a 
suitable buffer for rOvFARI and rCeFAR2.
rCeFAR3 shows a moderate amount of polydispersity below 20 °C and negligible 
polydispersity above 25 °C. The baseline errors (appendix 1) suggest narrow 
monomodal size distribution and SOS errors (appendix 1) indicate low 
background noise. rCeFAR3 is monodispersed in 20 mM TRIS pH 8.5 at 25 °C.
6.4.1 Molecular weight estimates of FAR proteins using DLS measurements.
The molecular weight (figures 6.12, 6.13, 6.14 and 6.15) of each protein in each 
solution can be estimated assuming the protein is perfectly globular. If not, then 
this measurement roughly corresponds to half the maximal dimension of the 
protein. Therefore this information may infer the state of oligomerisation of the 
protein. The molecular weight of each protein was only investigated in buffers in 
which the protein was stable.
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Chart showing changes in estimated molecular weight of rGpFARI with buffer and temperature
“  20000
□ PIPES 
HEPESo 15000
10000
5 10 15 20 25 °C
Figure 6.12 Estimated molecular weight of rGpFARI in PIPES and HEPES between 5 and 25 °C
Chart showing changes in estimated molecular weight of rOvFARI with buffer and temperature
□ PIPES 
HEPES
□ TRIS
Figure 6.13 Estimated molecular weight of rOvFARI in PIPES, HEPES and TRIS between 5 and
25 °C
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Chart showing changes in estimated molecular weight of rCeFAR2 with buffer and temperature
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°C
Figure 6.14 Estimated molecular weight of rCeFAR2 in ACETATE and TRIS between 5 and
25 °C
Chart showing changes in estimated molecular weight of rCeFAR3 with buffer and temperature
□ACETATE 
PIPES
□ HEPES
□ TRIS
Figure 6.15 Estimated molecular weight of rCeFAR3 in ACETATE, PIPES, HEPES 
and TRIS between 5 and 25 °C
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The graphs (figures 6.12, 6.13, 6.14 and 6.15) give an indication of which buffer 
and temperature would give a good starting point for crystallisation trials o f 
individual proteins. For rGpFARl in HEPES (figure 6.12) the estimated 
molecular weight is in the range 2 1 - 2 7  kDa suggesting crystallisation could be 
carried out in HEPES buffer since this gives a result close to the actual molecular 
weight of rGpFARl, 18.8 kDa. The estimated molecular weight for rOvFARl 
(figure 6.13) is too high being in the range 400 -  700 kDa and indicates that the 
protein is forming large oligomers and is probably close to aggregation. 
rOvFARl shows a lower estimated molecular weight in HEPES at ambient 
temperatures (300 kDa) rather than PIPES (600 kDa) and TRIS (400 kDa), 
suggesting crystallisation could be attempted in HEPES buffer at around room 
temperature, though all buffers seem unsuitable for crystallisation. rCeFAR2 
(figure 6.14) in TRIS below 10 °C shows an estimated molecular weight of 40 
kDa, which is closer to the actual molecular weight of rCeFAR2 (20 kDa) than at 
other temperatures and in other buffers. Crystallisation of rCeFAR2 could 
therefore be attempted in TRIS buffer at temperatures below 10 °C. MALDI-TOF 
analysis also showed that rCeFAR3 was present as a dimer in its native state. In 
PIPES and HEPES buffers the estimated molecular weight of rCeFAR3 (figure 
6.15) from DLS is between 25 -  42 kDa, which is close to the real molecular 
weight of the monomer (20.9 kDa) and dimer (41.8 kDa). It is also encouraging 
that polydispersity is relatively low for these two buffers. In ACETATE and 
TRIS buffers the estimated molecular weight was too high. Crystallisation could 
be carried out in HEPES or PIPES buffer, as the molecular weights indicate they 
could be suitable buffers for crystallisation.
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6.5 Discussion
MALDI-TOF analysis o f rGpFARl suggested that the protein was a monomer, 
but that lipids or endotoxins sequestered from E. coli overexpression had bound 
irreversibly, possibly to the fatty acid/retinol binding site. It is probable that two 
C l2 fatty acids may be present in the binding site or, at least strongly bound to the 
protein. Removal of these lipids or endotoxins resulted in several peaks around 
19287 Da, possibly loosening the lipid bound. For hepatocyte nuclear factor 4 
(HNF4), an orphan member of the nuclear hormone receptor family with 
prominent functions in liver, gut, kidney and pancreatic P cells, it has been shown 
by X-ray crystallography (Dhe-Paganon, 2002) and gas chromatography/mass 
spectrometry (Wisely et al, 2002) that a mixture of fatty acids occupy the binding 
site. The mixture was found to be saturated and monounsaturated C l6-18 fatty 
acids also found in E. coli. These fatty acids were found to be persistently bound 
after a multistep purification indicating that they were tightly associated and failed 
to strip the lipids from the protein. Wisely et a l have clearly shown that fatty 
acids can be sequestered from E. coli and it is probable that a similar situation 
exists with the FAR proteins. They also speculate that the fatty acid goes through 
a selection process during the HNF4 translation and folding and is then trapped in 
the fully folded protein, therefore the fatty acid does not behave like an 
exchangeable ligand (Wisely et al, 2002). A similar situation appears to exist for 
rGpFARl, and probably all the other FAR proteins studied in the project.
MALDI-TOF analysis of rOvFARl clearly showed (peak at 43670 Da) that the 
native structure is likely to exist as a dimer, while DLS analysis has shown the 
protein either is a large oligomer (400 -  700 kDa) or close to aggregation in all the 
buffers tried. Heterogeneity is probably due to a monomer-dimer equilibrium or 
variation in stoichiometry, consisting of one species existing with lipid bound to 
rOvFARl and one with no lipid bound. Unlike rCeFAR3, no higher order 
oligomerisation is seen from MALTI-TOF analysis of rCeFAR2. However, it is 
shown from analysis of rCeFAR2 that there are two species of rCeFAR2 present,
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possibly one species exists with two lipid molecules bound to rCeFAR2 (20560 
Da) and one with only one lipid molecule bound rCeFAR2 (20350 Da), possibly a 
fatty acid with chain length C20. The difference between the two species of 210 
Da may well be the result of an extra fatty acid of C12 chain length, molecular 
mass 212 Da, being incorporated during folding. Finally, MALDI-TOF analysis 
of rCeFAR3 shows that oligomers are present and fatty acids may also be bound 
to the protein. The analysis of rCeFAR2 and rGpFARl suggests they are 
monomers and analysis of rOvFARl and rCeFAR3 suggest they are being 
expressed as dimers and possibly oligomers.
Circular dichroism shows that the recombinant proteins are folded and that they 
all have essentially the same secondary structure, with rCeFAR2 and rCeFAR3 
being almost identical. Analysis by the CONTIN and SELCON procedures 
indicate that they have a high a-helical content of 35 %, 27 %, 44% and 42 % for 
rGpFARl, rOvFARl, rCeFAR2 and rCeFAR3 respectively by CONTIN and 31 
%, 44.3 % and 46.6 % for rOvFARl, rCeFAR2 and rCeFAR3 respectively by 
SELCON. Previous CD studies on CeFAR2 and CeFAR3 proteins that show 54 
and 61 % a-helix respectively (Garofalo, 2003), which is a higher a-helical 
content prediction. The main reason for the difference in helical content is 
probably due to inaccurate protein concentration. Possibly due to lipid being 
attached to the protein, as a result the molecular weight is incorrect. The presence 
of lipid can also affect the absorption of the protein sample and also the presence 
of DNA absorbing at 260 nm lead to errors in protein concentration.
Dynamic light scattering analysis may give an indication of protein homogeneity, 
purity, aggregation state and monodispersity, all pre-requisites for successful 
crystallisation. DLS results on lysozyme suggest the technique can indicate the 
best temperature, buffer and pH for protein crystallisation. rGpFARl shows 
aggregation in ACETATE and TRIS buffer and was shown to be polydispersed in 
PIPES and HEPES, though the estimated molecular weight of rGpFARl in 
HEPES (20 -  27 kDa) was shown to be close to real molecular weight of
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rGpFARl (18.8 kDa). This suggests that HEPES may be a better buffer to use in 
crystallisation trials of rGpFARl, though polydispersity, baseline errors and SOS 
noise indicates these conditions are not ideal. rOvFARl aggregated in ACETATE 
buffer and was shown to be polydispersed in PIPES, HEPES and TRIS. From the 
estimated molecular weights of rOvFARl (300-600 kDa) in each condition, DLS 
suggests that rOvFARl may be unsuitable for crystallisation. rCeFAR2 
aggregated in PIPES and HEPES buffers and was polydispersed in TRIS buffer. 
DLS analysis showed rCeFAR2 to have negligible polydispersity in ACETATE 
buffer at 10 °C, SOS errors show low noise, but the baseline parameter shows 
multimodal size distribution suggesting the protein is not homogenous, but 
crystallisation may be possible. The estimated molecular weight calculated by 
DLS for rCeFAR2 in TRIS buffer below 10 °C was 40 kDa, close to the molecular 
weight of a dimer of rCeFAR2 (41 kDa), though from MALDI measurements, 
there is no evidence o f a dimer moiety. These results suggest that although 
rCeFAR2 is not optimised for crystallisation, it may be possible at temperatures 
below 10 °C. Finally rCeFAR3 was shown to be polydispersed in ACETATE, 
moderately polydispersed in PIPES and TRIS below 20 °C, but negligibly 
polydispersed at 25 °C in PIPES and TRIS. Negligible polydispersity was also 
observed in HEPES below 15 °C. The estimated molecular weight for rCeFAR3 
was between 25 -  42 kDa in PIPES and HEPES buffer. Since MALDI-TOF 
analysis showed that rCeFAR3 is present as a dimer in its native state with a 
molecular weight of approximately 42 kDa, therefore the molecular weight in 
HEPES and PIPES buffers is close to the actual molecular weight of the rCeFAR3 
monomer (20.9 kDa) and dimer (42 kDa). As a result of these measurements, 
crystallisation o f rCeFAR3 may give better results in HEPES buffer below 15 °C. 
Although DLS analysis suggests that these proteins are not in the optimum 
conditions for crystallisation trials, there are many examples of proteins that has 
been successfully crystallised, even though DLS measurements suggest that 
conditions were far from optimal (Stura et al, 2002; Bergfors, 2003).
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The objective of looking at a range of these novel fatty acid and retinol binding 
proteins was to find one that would crystallise. Since only rGpFARl gave crystals 
DLS was used to determine suitable conditions for crystallisation and possible 
reasons for the low success rate. However, from the data presented in this chapter 
it can be concluded that from DLS measurements rOvFARl, rGpFARl and 
rCeFAR2 are polydispersed and rCeFAR3 has negligible polydispersity in 
HEPES. MALDI shows that lipids may be attached to rGpFARl and rOvFARl. 
MALDI also confirmed that rCeFAR2 is a heterogeneous species and that 
rOvFARl and rCeFAR3 are present as oligomers. All o f which would make 
crystallisation a difficult task.
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C h ap te r  7 - Crystallisation studies of FAR proteins
7.1 Crystallisation theory
For crystal formation to occur, molecules have to be brought to a supersaturated, 
thermodynamically unstable state, which may develop into a crystalline or 
amorphous phase when it returns to equilibrium. Supersaturation (figure 7.1) can 
be achieved by slow evaporation o f the solvent or by varying parameters, such as 
ionic strength, pH and temperature. Crystallisation starts by a nucleation phase, 
followed by a growth phase. Nucleation requires greater supersaturation than 
growth, and the rate o f crystallisation increases when supersaturation increases. 
In general, it is desirable to avoid any amorphous precipitate and produce large, 
flawless crystals.
 1----
[Protein)
Solubility curve “ 
supers atur&tion
UNDERSATURATED
(Salt)
Figure 7.1 Schematic diagram of the states involved in crystallisation
Nucleation
The first step in crystallisation is nucleation. It is the process by which free 
molecules or non-crystalline aggregates (dimers, trimers, etc) in a supersaturated 
solution produce a stable aggregate repeating lattice. Crystals have ~3-6 
kcaFmole lower free energy than the relative solution state (Drenth & Haas,
:leauon zone
leteeteble zone
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1992). The aggregate must exceed a critical size (between 10 -  200 molecules) to 
form a macroscopic crystal, otherwise spontaneous dissolution will occur and 
non-specific aggregates and noncrystalline precipitation will form. The degree of 
supersaturation determines the degree of nucleation that occurs. Therefore, higher 
degrees of supersaturation produces more stable aggregates and increases the 
likelihood of the formation of stable nuclei. Thus supersaturation must be 
approached slowly to achieve only a few nuclei and resultant larger crystals in 
preference to many nuclei and showers of small crystals.
Growth
Crystal growth occurs at solute concentrations sufficient for nucleation to occur 
and continues at concentrations beneath the nucleation threshold. Growth rate is 
determined by the growing crystal surface and the diffusional rate of molecules in 
the crystallising solution (McPherson, 1995). Ideally, crystals suitable for 
diffraction have dimensions around 0.2-0.3 mm in all dimensions.
Cessation o f  growth
There are many reasons for crystal growth to stop. The decrease in concentration 
of the crystallising solute to a point where the solid and solution phases reach 
equilibrium or cumulative lattice strain effects (Feher, 1985). Poisoning of 
growth surfaces (Sato et al, 1992) due to impurities or damaged crystallising 
protein resulting in defects on the crystal surface preventing further packing of 
molecules. McPherson et al. have used atomic force microscopy to study the 
crystals as they grow to see how a range of impurities, including foreign particles, 
influence the properties of the crystals (McPherson, 2000). Macroseeding or 
microseeding (chapter 7.1.3) can be attempted to further crystal growth.
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7.1.1 Crystallisation parameters
There are a number of factors that affect nucleation and growth of 
macromolecules, including type of precipitant, precipitant concentration, protein 
concentration, temperature, pH and factors specific to the protein molecule, such 
as ligands and co factors.
Precipitants
The use of precipitants is the most widely used method of achieving protein 
supersaturation, thereby inducing crystallisation by competing for water of 
solvation. The range of precipitants includes salts, high molecular weight straight 
chain polymers (PEG), MPD and organic solvents. These precipitants are often 
used at a range of concentrations in sparse matrix trials (Jancarik & Kim, 1991). 
If a precipitant yields crystals, a fine linear grid screen surrounding this condition 
can be set up to optimise the initial condition. Different ratios of precipitant to 
protein concentration can influence the rate of nucleation and crystal growth.
pH
Proteins are charged species and the net charge often determines its solubility. 
Buffers included in the crystallisation solution control the pH of the solution. It is 
typical that crystallisation occurs over a narrow range of pH (<1 pH unit). Crystal 
morphology, including twinned and polynucleated growth forms are often related 
to pH (McPherson, 1995). As the proper pH is approached a decrease in crystal 
quality on either side of the optimal condition is observed.
Temperature
Crystallisation of proteins has been accomplished in a range of 0 -  60 °C. 
Temperature is an important parameter; for example, small rapidly formed
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crystals grown at room temperature can yield fewer, larger crystals at a lower 
temperature.
Molecule specific factors
Ligands and small molecules have been shown to affect crystallisation of proteins 
(Carter & Yin, 1994). Interactions of other molecules with the protein may fix the 
protein into one conformation or may alter interactions between solvent, other 
molecules and the protein. Two other chemicals that can be used to initiate or 
enhance crystallisation are viscosity altering compounds and anti-twinning, 
solubilising compounds (detergents and ethers). By including these compounds in 
the mother liquor, they may alter the rate of crystal growth.
7.1.2 Vapour diffusion experiment
Several techniques have been used to attain supersaturation for crystallisation 
(Bergfors, 1999). The vapour diffusion technique (figure 7.2) utilises evaporation 
and diffusion of water between solutions of different concentrations as a means of 
approaching and achieving supersaturation of macromolecules. It is the optimal 
technique to use when screening a large number of conditions. In a vapour 
diffusion experiment the solution containing the protein is mixed 1:1 with the 
reservoir solution. The drop containing the mixture has both solutions diluted to 
half their original concentration and is then suspended and sealed over the well 
solution, which contains the precipitant at the target concentration. Differences in 
precipitant concentration between drop and well means a non-equilibrium exists 
that causes water to evaporate from the drop until the concentration of precipitant 
in the drop equals that of well solution and equilibrium is reached.
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Biological macroaoiccule solution 
Reservoir of crystallitmg agent
Figure 7.2 -  Vapour diffusion techniques
7.1.3 Seeding to promote crystallisation
Seeding is a method used to provide nucleation sites for crystal growth. A protein 
crystal or crystalline aggregate is placed in a solution o f slightly lower precipitant 
concentration, crushed and mixed to make a seed solution. Ratios o f 1:10, 1:100 
and 1:1000 o f this seed solution are then added to the crystallisation drop, 
ensuring the presence o f nuclei for crystal growth (Bergfors, 2003). There are two 
commonly used methods o f seeding: microseeding involves the transfer o f 
submicroscopic seeds, which are too small to be distinguished individually and 
macroseeding, which involves the transfer of a single crystal.
7.1.4 Gelled surface crystallisation
Gels promote the growth of a few larger crystals by reducing excessive nucleation 
and precipitation. They can change the morphology o f the crystal or slow crystal 
nucleation. Silica gels (Hampton research) are stable over a wide range of 
temperatures and are compatible with a wide variety o f precipitants and additives 
used for crystal growth. This experiment can be carried out in a sitting drop 
plate.
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7.1.5 Crystallisation with oils
The use of oil as a sealant can play an important role in the crystallisation 
experiment (Chayen, 1999). The principal role of oil is to act as an inert sealant to 
prevent evaporation o f small-volume trials and also to provide a controlled 
environment for the nucleation and growth stages of crystallisation. The rationale 
behind the use of oils is that water can evaporate at different rates through 
different oils. Paraffin oil can act as a good sealant allowing only negligible 
amounts of water evaporate through it. In contrast, water can diffuse freely 
through silicone oils. A mixture of paraffin and silicone oil permits partial 
diffusion, depending on the ratio at which they are mixed.
The crystallisation techniques outlined above have been used in attempts to grow 
crystals of sufficient diffraction quality for the FAR proteins used in this project.
7.2 Crystallisation of FAR proteins
7.2.1 rOvFARl
MALDI and DLS analysis (chapter 6) indicated that rOvFARl was heterogeneous 
and polydispersed in PIPES, HEPES and TRIS. Though, DLS suggested that 
crystallisation could be set up in 20 mM HEPES pH 7.5 at room temperature since 
the polydispersity and aggregation state was slightly lower than in other buffers 
tried. Crystallisation was attempted using Cryschem plates (Hampton), using the 
standard sitting drop vapour diffusion technique by mixing 4 pi o f the protein 
solution with an equal volume of crystallisation solution from the footprint screen 
(www.prg/stura/cryst/foot) and equilibrated against 1 ml of the same crystallising 
solution. The trials were set up at various protein concentrations of 2, 5, 8, 10 and 
12 mg/ml to check for the best concentration. 9 mg/ml was found to be the 
optimum concentration for the rOvFARl protein as it resulted in light 
precipitation in several wells. More trials were set up with 4 pi o f 9 mg/ml
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rOvFARl using the standard sitting drop vapour diffusion technique and 
crystallising solutions from sparse matrix solutions (Brzozowski & Walton, 2001; 
Jancarik & Kim, 1991; Cryo I and II, Wizard I and II, 
www.emeraldbiostructures.com; Crystal Clear Strategy Screens, 
www.moleculardimensions.com;www.hamptonresearch.com). After 1 week 
small needle shaped crystals (>10pm) were formed in 0.1 M TRIS pH 8.5, 10 % 
PEG 8K and 0.5 M MgCL at 25 °C. Optimisation of PEG concentration from 5 -  
30 % w/v, pH from 6 -  9.5 of TRIS did not result in larger needles that would 
have been suitable for diffraction studies. Optimisation was also attempted at 4 
and 15 °C, with no improvement to crystal size. Other trials resulted in 
precipitation and crystalline aggregates, but no protein crystals suitable for 
diffraction experiments.
7.2.2 rCeFAR2
DLS analysis of rCeFAR2 (chapter 6) suggested that at 10 °C in 20 mM 
ACETATE pH 4.5 the protein has negligible polydispersity and also in 20 mM 
TRIS pH 8.5 below 10 °C the estimated molecular weight of rCeFAR2 was that of 
a dimer of rCeFAR2 (41 kDa), although no dimer was observed from MALDI. 
Crystallisation trials were set up under these conditions. The Cryschem 
(Hampton) sitting drop vapour diffusion plate was used with rCeFAR2 at various 
concentrations between 2 -  10 mg/ml with the footprint screen
(www.prg/stura/cryst/foot) as for rOvFARl. Light precipitation resulted at 7 
mg/ml whereas a higher concentration produced very heavy precipitation. 
Crystallisation trials were set up with 4 pi drops of rCeFAR2 at 7 mg/ml using the 
many available sparse matrix screens (Brzozowski & Walton, 2001; Jancarik & 
Kim, 1991; Cryo I and II, Wizard I and II, www.emeraldbiostructures.com; com; 
Crystal Clear Strategy Screens, www.moleculardimensions.com; 
www.hamptonresearch.com). rCeFAR2 in 20 mM ACETATE pH 4.5 was tried 
but at 7 mg/ml the protein precipitated out of solution and at lower concentrations 
of CeFAR2 no crystals or precipitation resulted. rCeFAR2 trials in 20 mM TRIS
119
Chapter 7 Crystallisation studies o f FAR proteins
pH 8.5 at 10 and 25 °C resulted in heavy precipitation in many drops, but no 
crystals resulted from any of the sparse matrix screens.
7.2.3 rCeFAR3
rCeFAR3 crystallisations were set up in 20 mM PIPES pH 6.5, 20 mM HEPES 
pH 7.5 and 20 mM TRIS pH 8.5 at 20 °C since DLS indicated negligible 
polydispersity (chapter 6) in these buffers. MALDI however, (chapter 6) 
suggested that rCeFAR3 had different oligomerisation states and therefore was 
heterogeneous. Crystallisation was attempted using the standard sitting drop 
vapour diffusion technique on Cryschem (Hampton) by mixing 4 pi o f the protein 
solution with an equal volume o f crystallisation solution from the footprint screen 
(www.prg/stura/cryst/foot) and equilibrated against 1 ml of the same crystallising 
solution at a variety of concentrations from 2 mg/ml to 12 mg/ml. The optimum 
concentration was 7 mg/ml, as this produced light precipitation. Trials were set up 
with 4 pi of 7 mg/ml CeFAR3 using sitting drop plates and crystallising solutions 
from sparse matrix solutions (Brzozowski & Walton, 2001; Jancarik & Kim, 
1991; Cryo I and II, Wizard I and II, www.emeraldbiostructures.com; Crystal 
Clear Strategy Screens, www.moleculardimensions.com;
www.hamptonresearch.com). These trials resulted in extensive precipitation and 
crystalline aggregates, but no protein crystals suitable for diffraction.
7.2.4 rGpFARl
MALDI analysis (chapter 6) indicated rGpFARl had slight heterogeneity, 
probably due to presence of E. coli lipids as discussed in previous chapters. DLS 
results (chapter 6) agreed with MALDI analysis suggesting rGpFARl was not 
monodispersed, though in 20 mM HEPES pH 7.5 at 25 °C the estimated molecular 
weight of rGpFARl was approximately 20 kDa, which is close to the actual 
molecular weight of GpFARl (18.8 kDa). Therefore rGpFARl crystallisations 
were set up in 20 mM HEPES pH 7.5 at room temperature. The optimum
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concentration o f rGpFARl was established using the standard sitting drop vapour 
diffusion technique with Cryschem plates (Hampton) and mixing 4 pi o f the 
protein solution with an equal volume o f crystallisation solution from the footprint 
screen (www.prg/stura/cryst/foot) equilibrated against 1 ml o f the same 
crystallising solution. The trials were set up at various concentrations between 2 - 
15 mg/ml to check for the best concentration. 9.6 mg/ml was found to be the 
optimum concentration for the rGpFARl protein as it resulted in light 
precipitation in several wells whereas greater than 10 mg/ml resulted in heavy 
precipitation. Trials were set up with 4 pi o f 9.6 mg/ml rGpFARl in 20 mM 
HEPES pH 7.5 with crystallising solutions from commercially available sparse 
matrix screens (Brzozowski & Walton, 2001; Jancarik & Kim, 1991; Cryo I and 
II, Wizard I and II, www.emeraldbiostructures.com; Crystal Clear Strategy 
Screens, w w w .m o le cu la rd im e n s io n s .c o m ;www.hamptonresearch.com). 
Condition 3 M Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and 0.1 M HEPES pH
7.5 gave small rod shaped crystals (figure 7.3).
Figure 7.3 Initial rod shaped crystals in 3 M Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and
0.1 M HEPES pH 7.5.
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This condition for rGpFARl, buffered with 20 mM HEPES pH 7.5, was optimised 
to give crystals (1 X 0.4 X 0.1 mm) large enough for diffraction (3 M Na/K 
Phosphate pH 7.5, 0.1 M Na Tartrate and 0.1 M HEPES pH 7.3 (figure 7.4)).
Figure 7.4 rGpFARl rod shaped crystals in 3 M Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and
0.1 M HEPES pH 7.3.
On close inspection, these rods were found to be many rod shaped crystals 
bundled together. Even with extreme care it proved impossible to separate these 
bundles into individual crystals. It was then decided to try and optimise each 
component o f the crystallising solution in turn. + and -  tartrate were tried as a 
replacement for the racemic mixture o f tartrate. A finer sampling of pH was tried 
varying the pH o f the 3 M Na/K Phosphate present in the optimised condition (3 
M Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and 0.1 M HEPES pH 7.3) between 
pH 6 -  8 by 0.05 pH units - no larger crystals were obtained. In 20 mM PIPES 
pH 6.5 in the same condition (3 M Na/K Phosphate, 0.1 M Na Tartrate and 0.1 M 
HEPES pH 7.3) longer rod shaped crystals (figure 7.5) were obtained.
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Figure 7.5 Optimised rGpFARl crystals in 3 M Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and
0.1 M HEPES pH 7.3.
Additive screens 1 -  3 from Hampton were added to the optimised conditions to 
try and grow single crystals; 5 -  20 % glycerol was added to try and improve the 
crystals - neither resulted in single crystals. Further techniques were attempted to 
grow single crystals o f rGpFARl: these included microseeding and streak 
seeding, growth o f rGpFARl crystals in gels, growth of rGpFARl crystals under 
oil with varying percentages of silicon and paraffin oils all as described earlier. 
Seeding o f rGpFARl into the optimised conditions resulted in smaller needle 
crystals being grown in bundles. Crystal growth in silica hydrogel (Hampton) was 
tried in an attempt to reduce excessive nucleation and grow fewer, larger crystals. 
5 pi o f gel was pipetted onto the post o f the Cryschem plate and allowed to 
polymerise, then 5pl o f precipitant was added. Once the precipitant was 
completely absorbed 10 pi rGpFARl at 9.6 mg/ml was placed onto the gel and 
once absorbed, the reservoir was filled with 1 ml o f precipitant. The precipitant 
used for rGpFARl trials was 3 M Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and 
0.1 M HEPES pH 7.3. The pH o f precipitant was also varied from pH 6 -  9, as 
was the concentration o f Na Tartrate from 0.05 -  0.25 M. Crystal trials in gels
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resulted in no crystals being grown. Growth of crystals under mixtures o f 10, 25, 
50 and 75 % silicon oil with 80, 75, 50 and 25 % paraffin oil respectively, resulted 
in smaller, needle crystals but again in bundles.
Crystals were also grown using the optimised conditions (3 M Na/K Phosphate pH 
7.5, 0.1 M Na Tartrate and 0.1 M HEPES pH 7.3) at 4 °C and 15 °C as well as 
room temperature (25 °C). It was found that larger crystals were grown at room 
temperature (25 °C). Temperature shifting was tried by moving crystals from 
room temperature (25 °C) to 15 °C after 24 hours and vise versa and shifting the 
temperature between room temperature and 4 °C. All without improvement under 
visual inspection.
The hanging drop method was used instead of sitting drop, but again needle 
crystals in bundles were grown and were not of sufficient quality to use in 
diffraction experiments.
In chapter 6 it was demonstrated that fatty acids or lipids may have bound to the 
protein during expression in E. coli. In chapter 4 it was also shown that fatty 
acids, which are bound in the active site can be competitively displaced by other 
fatty acids. This poor crystal quality we were experiencing, despite exhaustive 
attempts to improve by rational optimisation, may be a result o f heterogeneous 
binding of fatty acids. To try to minimise this heterogeneity 1 mM of fatty acids 
were added to 9.6 mg/ml rGpFARl before crystallisation. Palmitic acid was used 
as rGpFARl was shown to bind fatty acid chain length C l5 with the highest 
affinity (Prior et al, 2001). Oleic acid was also used as it has been shown (chapter 
4) to compete with other fatty acids and displace them from the binding site. 
Trials were set up using vapour diffusion experiments against the optimised 
condition, 3 M Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and 0.1 M HEPES pH
7.3 and varying the pH of Na/K Phosphate from pH 6 -  9, varying concentration 
of Na Tartrate from 0.05 -  0.25 M, varying the protein concentration from 8.5 -
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10.5 mg/ml and grown at 25 and 4 °C. These experiments resulted in small needle 
crystals forming, which were not large enough for diffraction experiments.
All the methods tried did not produce single crystals of rGpFARl. Therefore the 
needle crystals of rGpFARl (figure 7.5) were used for diffraction at Daresbury 
SRS and ESRF at Grenoble by positioning the crystals so that a single rod was in 
the beam.
7.3 Data collection
7.3.1 Crystal Mounting
Once crystallisation conditions have been optimised and a crystal of suitable size 
and quality has been produced, the crystal needs to be stabilized before being 
aligned in the X-ray beam to allow the diffraction experiment to be performed. 
Removal o f the crystal from the precipitant solution may damage it, as solvent 
makes up a large proportion of the volume of the crystal. Hence, the crystal needs 
to be kept in a stabilised state in the precipitant solution or in a saturated vapour of 
the mother liquor. Two methods commonly used to mount crystals are mounting 
in a glass capillary and frozen mounting in a loop (Garman, 1999).
Capillary mounting
The crystal is lifted from the drop and placed in a glass capillary tube of suitable 
diameter and sealed at one end. The thin walls o f the glass capillary tube reduce 
the amount of absorption of X-rays. To prevent the crystal drying out, a reservoir 
of mother liquor solution is placed either side of the crystal and the tube is sealed.
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Loop mounting
Crystals are lifted from the drop into a loop (from Hampton) of a similar size to 
the crystals. To prevent the crystal from being destroyed the crystals are dipped, 
or transferred, into a cryoprotectant. The cryoprotectant protects the crystal from 
shattering when introduced into the freezing liquid nitrogen stream. Successful 
cryoprotection should result in the formation o f a transparent glass, which will 
greatly extend the lifetime of the crystal in the intense synchrotron X-ray beam. 
Cryoprotectants can also be introduced slowly into the mother liquor to lessen 
crystal damage. Cryoprotectants include dried paraffin oil or reservoir solution 
with added glycerol, MPD or sodium formate.
7.3.2 Synchrotron Radiation
Synchrotron radiation is generated when electrons (or positrons) are accelerated to 
near light speed and then forced to change course by the use of powerful magnets. 
The radiation emitted is composed of all wavelengths (white light) within the 
electromagnetic spectrum ranging from ultra-violet to short wavelength X-rays. A 
synchrotron radiation source is very intense making the collection of data not only 
viable, but faster than would be possible from weakly diffracting crystals and very 
small crystals. The wavelength of the radiation from a synchrotron can be tuned 
(to the absorption edge of heavy metals bound to the protein) so that multiple 
wavelength anomalous dispersion (MAD) experiments can be performed.
7.4 Data collection of rGpFARl crystals
Needle crystals of rGpFARl were lifted from the drop using a cryoloop of 
suitable size. Paraffin oil was used as a cryoprotectant, which formed a glass 
around the crystal on freezing in a nitrogen gas stream at 100K. Data were
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collected at Daresbury, station 14.1 on an ADSC Quantum 4R CCD 
diffractometer at a wavelength o f 1.488 A and a distance o f 350 mm between the 
detector and the crystal. Data were collected to 4 A (figure 7.6).
Figure 7.6 Diffraction of rGpFARl crystal to 4 A on station 14.1 at Daresbury SRS.
20 % glycerol equilibrated in the crystallisation solution as well as 8 M Na 
formate were also trialed as cryoprotectants by immersing a rGpFARl crystal in 
each solution for varied lengths o f time. Unfortunately, the diffraction did not 
improve.
From the diffraction in figure 7.6 it can be seen that more than one crystal lattice 
is present, showing that each rod broken from the rGpFARl crystal contains more 
than one crystal or else the needles may be hollow. Auto indexing using DENZO 
(Otwinowski & Minor, 1997) and MOSFLM (Powell, 1999) could not be 
accomplished, as the programs could not distinguish between the different crystal 
lattices.
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Crystals were mounted in capillaries to ascertain if damage was a result o f the 
cryoprotectants. Data were also collected at SRS Daresbury station 9.5 on an 
ADSC Quantum 4R CCD diffractometer. The crystal was mounted in a capillary 
and data were collected at room temperature. At a wavelength o f 1.22 A and a 
distance o f 250 mm between the detector and the crystal data were collected to 2.8 
A (figure 7.7). Diffraction also showed that the lattice points were very close 
together indicating the presence o f more than one lattice.
Figure 7.7 -  Diffraction to 2.8 A of rGpFARl crystals mounted in a capillary tube at station 9.5 at
Daresbury SRS
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The program DENZO was used to search for the peaks by hand and different unit 
cells were tried to determine which fitted the diffraction pattern best. Individual 
diffraction patterns for 0, 90 and 120° § rotation positions were collected. 1° 
oscillation was used for each exposure.
For 0 degree rotation the crystal is probably orthorhombic with unit cell 
dimensions: 93.07, 47.88,155.19 A.
However, at 90 and 120 degrees rotation, the crystal lattice is possibly C centered 
monoclinic, with unit cell dimensions: 181.44, 47.83, 179.91 A, p = 115.15.
This suggests that there is more than one lattice present in the crystal (figure 7.7), 
with the result that a complete data set could not be collected and successfully 
processed.
Crystals were also taken to the microfocus beamline at the ESRF (Grenoble) in 
the hope that it would be possible to find part of a rod that was a single crystal. 
Although several crystals were tried and different cryoprotectants used, 
satisfactory diffraction could not be attained.
7.5 Discussion
Crystallisation trials of rOvFARl resulted in no crystals suitable for diffraction. 9 
mg/ml was found to be the optimum concentration for crystallisation trials. 
Unfortunately, the protein may not be pure enough for crystals to be grown as two 
bands were shown by SDS-PAGE (chapter 4) and possibly the protein has bound 
lipids acquired during expression in E. coli (chapter 4 and 6).
Crystallisation trials of rCeFAR2 and rCeFAR3 resulted in no crystals suitable for 
diffraction. 7 mg/ml was found to be the optimum concentration for
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crystallisation trials. Unfortunately, like other FAR proteins it is likely that the 
rCeFAR proteins have bound fatty acids during overexpression in E. coli (chapter 
6).
rGpFARl crystallisation trials resulted in needle crystals grown in condition 3 M 
Na/K Phosphate pH 7.5, 0.1 M Na Tartrate and 0.1 M HEPES pH 7.3. The 
crystals could not be improved to provide single crystals, though many methods 
were tried, including seeding, oils, growth in gels, pH variation and temperature 
shifting. Diffraction o f these needle crystals showed that they were twinned or 
hollow. Twinning of crystals occurs during crystal growth as nuclei sometimes 
come together in entirely different orientations in ways that achieve good 
molecular packing but violate crystal symmetry. The twinning or hollow crystals 
of rGpFARl resulted in unsolvable diffraction. This could be due to the protein 
not being pure enough because lipids have bound during expression in E. coli 
(chapter 6). Adding fatty acids to displace the lipids bound to rGpFARl did not 
improve the crystals.
New purification methods are required for the FAR proteins or ways to stop the 
proteins binding lipids during their overexpression. Other crystallisation 
conditions could also be attempted to give better crystals that give diffraction to a 
high resolution in a single space group allowing the data to be processed.
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Chapter 8 -  Conclusions
8.1 Nematode polyprotein allergens
ABA-1 purified from Ascaris suum and purified recombinantly was found to have 
similar, if not identical activity, as both show an increase and blue shift in 
fluorescence emission when bound to DAUDA. With equivalent amounts of 
pABA-1 and rABA-1 shifts from 542 nm to 478 nm and 476 nm respectively were 
observed (chapter 3.2 and 3.3). Circular dichroism (figure 3.9) shows that both 
pABA-1 and rABA-1 have folded secondary structure with high percentages of a- 
helix, 53 and 46 % for pABA-1 and rABA-1 respectively. The bimodal scatter 
diagram (figure 3.10) and gaussian graphical presentation (figure 3.11) from DLS 
studies suggest that rABA-1 is possible a dimer. Estimated molecular weight 
indicates rABA-1 is not globular, confirmed by initial NMR studies suggesting 
that ABA-1 is a two domain structure (N. Meenan, A. Cooper, private 
communication). However, rABA-1 was shown to be heterogeneous from DLS 
analysis and both were confirmed to be heterogeneous from IEF gel analysis 
(figure 3.8). The species present could be due to isoforms of ABA-1 or 
heterogeneity due to a mixture of fatty acids present from E. coli, which may be in 
competition for the binding site. The current NMR studies (N Meenan, A Cooper, 
private communication) also show this ambiguity in fatty acid present in the 
binding site. Crystallisation trials were unsuccessful due to the heterogeneity of 
ABA-1. This would indicate that new purification methods are required or ways 
to stop the proteins binding lipids during their overexpression before it will be 
possible to crystallise ABA-1 and possibly other NPAs.
8.2 Fatty acid and retinol binding proteins
GpFARl, OvFARl, CeFAR2 and CeFAR3 were all produced recombinantly in 
this project. The overexpression was in E. coli, which has fatty acids present, 
including palmitic acid (fatty acid chain length 16), myristic acid (fatty acid chain
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length 14) and cyclo heptadecanoic acid (fatty acid chain length 17 with a 
cyclopropyl group) (Dhe-Paganon et al, 2002). Fluorescence studies carried out 
in chapter 4 have shown that these proteins have an affinity for fatty acids with a 
chain length C14-C18. This is significant since not only are these recombinant 
proteins behaving as they do in vivo, they also bind the fatty acids which are 
similar in length to those found in E. coli. MALDI-TOF analysis of OvFARl, 
CeFAR2 and CeFAR3 suggested that lipid may have bound to the proteins, giving 
a heterogeneous mixture of, possibly, lipid bound protein and unbound protein 
(chapter 6), the heterogeneous mixture was also confirmed by DLS. MALDI-TOF 
analysis of rGpFARl suggested lipids had bound irreversibly, possibly to the fatty 
acid/retinol binding site. Hepatocyte nuclear factor 4 (HNF4), discussed in 
chapter 6.5, has a mixture of fatty acids occupying the binding site and it is also 
speculated that the fatty acid goes through a selection process during the HNF4 
translation and folding and is then trapped in the fully folded protein, therefore the 
fatty acid does not behave like an exchangeable ligand (Wisely et al, 2002). It is 
possible that this is the case for the FAR proteins and also ABA-1. Hence future 
overexpression of the FAR proteins should be carried out using a different 
expression system, possibly in Pichia (yeast), this is currently being attempted at 
Prof. Bradley’s lab, Nottingham University.
Fluorescence studies showed competitive effects with the retinol-FAR protein 
complex when 10 mM oleic acid was added. This indicates that the binding site 
for retinol and fatty acids is interactive or congruent in the case of all the FAR 
proteins. Binding retinol is important for OvFARl as it is thought that the 
nematode Onchocerca volvulus that secretes the protein OvFARl requires retinol 
for a variety of metabolic and developmental purposes including, growth, 
differentiation, embryogensis, glycoprotein synthesis and anti-oxidants. This 
suggests that the FAR proteins role in the nematodes is related to retinol 
acquisition or transport.
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Circular dichroism shows that the recombinant proteins are folded and that they 
all have essentially the same secondary structure, with rCeFAR2 and rCeFAR3 
being almost identical. Analysis by the CONTIN and SELCON procedures 
indicate that they have a high a-helical content of 35 %, 27 %, 44% and 42 % for 
rGpFARl, rOvFARl, rCeFAR2 and rCeFAR3 respectively by CONTIN and 31 
%, 44.3 % and 46.6 % for rOvFARl, rCeFAR2 and rCeFAR3 respectively by 
SELCON, though accurate protein concentration was a problem. This indicates 
that they are a structurally different from the more ubiquitous lipid binding 
proteins from the family of cytosolic proteins, which are predominantly 10 anti­
parallel p-stranded with 2 short a-helices surrounding the interior binding cavity 
in a P-barrel type structure (Banaszak et al, 1994).
Finally, rGpFARl was the only protein in this study to crystallize. However, 
diffraction of these needle crystals showed that they were twinned or hollow and 
resulted in unsolvable diffraction. A new purification method possibly involving a 
different expression system or ways to stop the protein binding lipids during 
overexpression could lead to crystals that diffract. Other crystallisation conditions 
could also be attempted to give better crystals that diffract to high resolution in a 
single space group allowing quality data to be collected and processed.
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Appendix 1
Appendix 1
Experiment: rABA-1 in PIPES at 5°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.6 401.0 3.4 1.9
2 20.0 0.6 419.0 3.3 1.8
3 39.0 0.6 412.0 3.3 1.9
4 59.0 0.6 414.0 3.3 1.9
5 80.0 0.6 403.0 3.4 1.9
6 101.0 0.6 443.0 3.1 1.7
7 123.0 0.6 454.0 3.0 1.7
Experiment: rABA-1 in PIPES at 10°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.5 441.0 3.5 2.0
2 25.0 0.5 492.0 3.2 1.8
3 51.0 0.5 499.0 3.1 1.8
4 77.0 0.5 420.0 3.8 2.1
5 102.0 0.5 473.0 3.3 1.9
6 127.0 0.5 439.0 3.6 2.0
7 150.0 0.5 508.0 3.1 1.8
Experiment: rABA-1 in PIPES at 15°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.5 575.0 3.1 1.8
2 24.0 0.5 569.0 3.2 1.8
3 49.0 0.5 550.0 3.3 1.9
4 71.0 0.5 535.0 3.4 1.9
5 95.0 0.5 545.0 3.3 1.8
Experiment: rABA-1 in PIPES at 20°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.6 590.0 3.5 2.0
2 21.0 0.6 678.0 3.1 1.7
3 42.0 0.6 595.0 3.5 2.0
4 62.0 0.6 630.0 3.3 1.9
5 82.0 0.6 681.0 3.0 1.7
6 101.0 0.6 668.0 3.1 1.8
Experiment: rABA-1 in PIPES at 25°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.6 704.0 3.3 1.9
2 18.0 0.6 769.0 3.1 1.7
3 37.0 0.6 737.0 3.2 1.8
4 54.0 0.6 742.0 3.2 1.8
5 88.0 0.6 760.0 3.1 1.8
6 105.0 0.6 683.0 3.5 1.9
7 122.0 0.6 738.0 3.2 1.8
8 139.0 0.6 770.0 3.1 1.7
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
59.0 5.1 21994.0 1.1 37.6
52.0 5.1 21662.0 1.1 23.2
54.0 4.9 21755.0 1.0 38.3
54.0 5.1 21122.0 1.0 18.3
58.0 5.2 21029.0 1.0 25.6
46.0 5.1 20407.0 1.0 28.3
43.0 5.0 20625.0 1.0 39.4
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
62.0 9.1 16701.0 1.0 27.8
50.0 9.9 16470.0 1.0 31.3
47.0 9.4 16785.0 1.0 33.7
73.0 9.8 18631.0 1.0 36.8
56.0 10.0 17580.0 1.0 28.3
67.0 10.1 19402.0 1.0 46.8
47.0 10.0 18777.0 1.0 29.4
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
47.0 14.6 18348.0 1.0 26.6
49.0 14.8 17975.0 1.0 25.8
53.0 14.7 19134.0 1.0 30.1
57.0 14.8 20262.0 1.0 50.4
55.0 14.8 20241.0 1.0 18.4
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
61.0 19.4 22269.0 1.0 47.9
45.0 19.7 21497.0 1.0 25.4
61.0 19.7 23528.0 1.0 41.4
54.0 19.9 22799.0 1.0 38.1
44.0 19.8 22805.0 1.0 23.7
47.0 19.8 23461.0 1.0 38.4
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
55.0 24.4 25729.0 1.0 41.8
45.0 24.5 24879.0 1.0 20.8
50.0 24.6 26396.0 1.0 40.5
49.0 24.7 27343.0 1.0 44.6
47.0 24.7 27050.0 1.0 29.6
60.0 24.6 28125.0 1.0 30.2
50.0 24.8 27554.0 1.0 26.9
45.0 24.6 27620.0 1.0 22.7
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Experiment: rABA-1 in HEPES at 5°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.6 458.0 3.0 1.7
2 33.0 0.6 448.0 3.0 1.7
3 65.0 0.6 448.0 3.0 1.7
4 98.0 0.6 411.0 3.3 1.9
5 130.0 0.5 416.0 3.3 1.8
6 161.0 0.6 429.0 3.2 1.8
7 191.0 0.6 392.0 3.5 1.9
8 222.0 0.6 410.0 3.3 1.9
9 254.0 0.6 426.0 3.2 1.8
10 285.0 0.6 443.0 3.1 1.7
Experiment: rABA-1 in HEPES at 10°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.6 494.0 3.2 1.8
2 14.0 0.6 535.0 2.9 1.6
3 29.0 0.6 494.0 3.1 1.8
4 43.0 0.6 496.0 3.1 1.8
5 57.0 0.6 522.0 3.0 1.7
6 72.0 0.6 481.0 3.2 1.8
7 87.0 0.6 516.0 3.0 1.7
8 102.0 0.6 491.0 3.2 1.8
9 117.0 0.6 496.0 3.1 1.8
10 131.0 0.6 526.0 3.0 1.7
Experiment: rABA-1 in HEPES at 15°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.6 514.0 3.5 1.9
2 31.0 0.6 625.0 2.9 1.6
3 46.0 0.6 579.0 3.1 1.7
4 77.0 0.6 585.0 3.0 1.7
5 91.0 0.6 586.0 3.0 1.7
6 126.0 0.6 621.0 2.9 1.6
7 159.0 0.6 636.0 2.8 1.6
8 174.0 0.6 597.0 3.0 1.7
9 187.0 0.6 598.0 3.0 1.7
10 200.0 0.6 644.0 2.8 1.6
Experiment: rABA-1 in HEPES at20°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.6 755.0 2.7 1.5
2 14.0 0.6 727.0 2.8 1.6
3 28.0 0.7 745.0 2.7 1.5
4 43.0 0.7 717.0 2.8 1.6
5 57.0 0.6 725.0 2.8 1.6
6 72.0 0.6 728.0 2.8 1.6
7 86.0 0.6 700.0 2.9 1.6
8 101.0 0.6 719.0 2.8 1.6
9 133.0 0.7 778.0 2.6 1.5
10 148.0 0.6 743.0 2.7 1.6
Experiment: rABA-1 in HEPES at 25°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.5 745.0 3.2 1.8
2 23.0 0.5 741.0 3.2 1.8
3 47.0 0.5 734.0 3.2 1.8
4 158.0 0.5 752.0 3.2 1.8
5 180.0 0.5 768.0 3.1 1.7
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
41.0 4.7 39000.0 1.0 19.9
44.0 4.8 39497.0 1.0 29.6
43.0 4.6 38726.0 1.0 22.6
53.0 4.6 40930.0 1.0 29.6
52.0 4.7 43591.0 1.0 22.3
49.0 4.9 40077.0 1.0 27.6
60.0 4.7 41947.0 1.0 30.6
54.0 4.6 40602.0 1.0 34.1
49.0 4.6 39562.0 1.0 25.3
45.0 4.7 38458.0 1.0 25.7
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
48.0 9.5 34557.0 1.0 33.0
40.0 9.5 33672.0 1.0 20.9
48.0 9.4 33366.0 1.0 29.3
47.0 9.3 34171.0 1.0 27.3
42.0 9.4 34912.0 1.0 33.4
51.0 9.4 35405.0 1.0 32.1
43.0 9.4 34225.0 1.0 25.3
49.0 9.4 35036.0 1.0 24.9
48.0 9.5 35105.0 1.0 32.8
41.0 9.4 33869.0 1.0 21.3
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
60.0 14.1 39150.0 1.0 47.9
38.0 14.3 36185.0 1.0 29.8
46.0 14.3 36349.0 1.0 30.2
44.0 14.1 36956.0 1.0 35.1
44.0 14.1 36688.0 1.0 32.3
38.0 14.1 35130.0 1.0 13.4
36.0 14.2 35116.0 1.0 23.1
42.0 14.2 36685.0 1.0 35.3
42.0 14.3 36418.0 1.0 28.7
35.0 14.1 34696.0 1.0 18.4
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
32.0 18.8 34422.0 1.0 17.2
36.0 18.9 35299.0 1.0 38.5
34.0 19.2 33865.0 1.0 22.6
38.0 19.2 35837.0 1.0 31.8
36.0 19.0 34332.0 1.0 29.1
36.0 19.0 35972.0 1.0 30.5
39.0 19.0 35343.0 1.0 33.6
37.0 18.9 35098.0 1.0 23.7
31.0 19.2 34750.0 1.0 19.8
34.0 19.2 34424.0 1.0 27.4
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
49.0 24.6 18599.0 1.0 28.9
50.0 24.9 18754.0 1.0 23.1
51.0 24.7 19006.0 1.0 32.1
48.0 24.8 19119.0 1.0 36.4
45.0 24.6 18348.0 1.0 18.7
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Experiment: rABA-1 in TRIS at 5°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.5 417.0 3.3 1.8
2 25.0 0.5 428.0 3.2 1.8
3 52.0 0.5 390.0 3.5 2.0
4 78.0 0.5 436.0 3.1 1.8
5 106.0 0.5 421.0 3.3 1.8
6 133.0 0.5 413.0 3.3 1.9
7 161.0 0.5 437.0 3.1 1.8
Experiment: rABA-1 in TRIS at 10°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.5 470.0 3.3 1.9
2 23.0 0.5 445.0 3.5 2.0
3 46.0 0.5 500.0 3.2 1.8
4 69.0 0.5 426.0 3.7 2.1
5 93.0 0.5 435.0 3.6 2.0
6 114.0 0.5 419.0 3.8 2.1
7 139.0 0.5 507.0 3.1 0.0
8 162.0 0.5 467.0 3.4 1.9
Experiment: rABA-1 in TRIS at 15°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.5 609.0 2.9 1.6
2 26.0 0.5 587.0 3.1 1.7
3 52.0 0.5 579.0 3.1 1.7
4 100.0 0.5 555.0 3.3 1.8
5 124.0 0.5 595.0 3.1 1.7
6 146.0 0.5 560.0 3.2 1.8
7 170.0 0.5 605.0 3.0 1.7
8 195.0 0.5 552.0 3.3 1.8
9 217.0 0.5 553.0 3.3 1.8
10 242.0 0.5 447.0 4.1 2.3
Experiment: rABA-1 in TRIS at 20°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 0.0 0.5 660.0 3.1 1.7
2 67.0 0.5 587.0 3.5 2.0
3 90.0 0.5 606.0 3.4 1.9
4 111.0 0.5 647.0 3.2 1.8
5 135.0 0.5 654.0 3.2 1.8
6 158.0 0.5 645.0 3.2 1.8
Experiment: rABA-1 in TRIS at 25°C
Meas. Time Ampl Diffn Coeff Radius Polyd
# (s) 0 (nm) (nm)
1 48.0 0.5 51.0 45.7 51.0
2 124.0 0.6 73.0 32.1 35.9
3 149.0 0.5 48.0 48.7 46.8
4 465.0 0.5 41.0 56.6 54.4
5 604.0 0.6 36.0 64.8 62.2
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
52.0 4.8 16140.0 1.0 32.8
50.0 5.1 15962.0 1.0 33.6
62.0 4.9 15719.0 1.0 29.1
48.0 5.1 15557.0 1.0 41.6
52.0 5.1 14894.0 1.0 19.9
55.0 5.1 14899.0 1.0 27.5
48.0 5.1 14911.0 1.0 38.5
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
55.0 9.5 18962.0 1.0 25.1
64.0 9.8 19152.0 1.0 48.9
48.0 9.9 17988.0 1.0 27.4
71.0 9.9 19399.0 1.0 30.8
68.0 9.9 18008.0 1.0 14.0
74.0 9.9 19771.0 1.0 24.1
47.0 9.9 17583.0 1.0 23.9
57.0 9.9 18073.0 1.0 48.1
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
40.0 14.0 16422.0 1.0 24.4
45.0 14.7 17017.0 1.0 24.0
46.0 14.5 18129.0 1.0 31.0
52.0 14.8 18519.0 1.0 27.1
45.0 14.9 18339.0 1.0 41.3
51.0 14.7 18197.0 1.0 17.2
43.0 14.9 17761.0 1.0 28.7
53.0 14.8 18264.0 1.0 17.6
53.0 14.9 18615.0 1.0 23.1
89.0 14.8 21655.0 1.0 58.6
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
45.0 18.8 17293.0 1.0 29.1
63.0 19.6 18831.0 1.0 32.5
58.0 19.5 18836.0 1.0 30.9
51.0 19.9 18557.0 1.0 26.4
49.0 19.8 18776.0 1.0 22.1
51.0 19.8 18884.0 1.0 31.4
Estd MW Temp Count Baseline SOS error
(°C) (cnts/s)
30653.0 24.2 50290.0 1.1 168.6
13083.0 24.3 45526.0 1.1 222.5
35798.0 24.2 53357.0 1.1 168.7
51576.0 24.2 53390.0 1.0 113.6
71442.0 24.0 71169.0 1.1 132.2
Appendix 1
Experiment: rGpFARl in PIPES at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 47.0 28.8 16.0 10071.0 4.6 129961.0 1.0 94.8
2 55.0 0.8 42.0 32.6 18.1 13587.0 4.8 134564.0 1.0 99.4
3 110.0 0.8 49.0 27.8 15.4 9198.0 4.9 104457.0 1.0 94.9
4 165.0 0.8 60.0 22.5 12.5 5530.0 4.6 93085.0 1.1 102.9
5 180.0 0.8 60.0 22.9 12.7 5783.0 5.1 91824.0 1.0 89.3
6 196.0 0.8 61.0 22.5 12.5 5542.0 4.9 89621.0 1.0 117.8
Experiment: rGpFARl in PIPES at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 64.0 24.3 13.5 6625.0 8.9 131238.0 1.0 108.5
2 97.0 0.8 54.0 29.1 16.2 10266.0 9.4 140623.0 1.1 93.9
3 120.0 0.8 63.0 24.9 13.9 7070.0 9.5 118036.0 1.1 119.3
4 148.0 0.8 72.0 21.9 12.2 5166.0 9.6 103048.0 1.0 117.0
5 181.0 0.7 64.0 24.5 13.6 6763.0 9.4 111452.0 1.1 111.5
6 214.0 0.8 56.0 28.4 15.8 9704.0 9.9 126372.0 1.1 98.2
Experiment: rGpFARl in PIPES at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 79.0 22.7 12.6 5617.0 14.1 125080.0 1.0 92.5
2 55.0 0.8 70.0 25.6 14.2 7506.0 14.3 133717.0 1.0 114.3
3 82.0 0.8 70.0 25.8 14.3 7703.0 14.2 132885.0 1.1 108.9
4 108.0 0.8 72.0 25.0 13.9 7113.0 14.4 129394.0 1.0 117.0
5 134.0 0.8 69.0 26.1 14.5 7935.0 14.2 135463.0 1.0 105.4
6 161.0 0.8 79.0 22.9 12.7 5758.0 14.5 123336.0 1.0 89.4
7 187.0 0.8 69.0 26.3 14.6 8060.0 14.4 130620.0 1.0 102.1
8 214.0 0.7 65.0 28.0 15.5 9353.0 14.5 144952.0 1.1 90.2
Experiment: rGpFARl in PIPES at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.6 84.0 24.5 13.6 6802.0 19.0 151576.0 1.0 66.0
2 27.0 0.6 83.0 24.7 13.7 6932.0 19.2 148208.0 1.0 67.2
3 51.0 0.7 88.0 23.2 12.9 5952.0 19.0 129197.0 1.0 100.0
4 75.0 0.8 99.0 20.8 11.5 4544.0 19.2 113848.0 1.0 112.3
5 106.0 0.7 92.0 22.3 12.4 5421.0 19.0 124239.0 1.0 103.5
6 134.0 0.8 82.0 25.0 13.9 7090.0 19.0 133696.0 1.0 107.7
Experiment: rGpFARl in PIPES at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 91.0 25.7 14.3 7615.0 24.0 127199.0 1.1 98.8
2 59.0 0.8 90.0 26.1 14.5 7909.0 24.2 129564.0 1.0 102.4
3 88.0 0.8 101.0 23.2 12.9 5934.0 23.8 123569.0 1.0 93.9
4 119.0 0.8 97.0 24.3 13.5 6636.0 24.1 126821.0 1.0 101.7
5 147.0 0.8 94.0 24.7 13.7 6925.0 23.8 130727.0 1.0 106.7
6 174.0 0.8 105.0 22.3 12.4 5387.0 23.8 118220.0 1.0 99.5
Appendix 1
Experiment: rGpFARl in HEPES at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 30.0 45.1 25.1 29773.0 5.1 157690.0 1.1 59.7
2 43.0 0.8 33.0 41.7 23.2 24640.0 4.9 136393.0 1.0 58.1
3 137.0 0.8 30.0 45.8 25.4 30775.0 4.9 151221.0 1.0 48.8
4 177.0 0.8 35.0 38.6 21.4 20342.0 4.9 129365.0 1.0 43.3
5 227.0 0.8 31.0 43.6 24.2 27346.0 4.8 146161.0 1.0 42.4
Experiment: rGpFARl in HEPES at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 37.0 42.7 23.7 25994.0 9.8 116505.0 1.0 40.9
2 57.0 0.8 32.0 48.2 26.7 34838.0 9.6 148886.0 1.1 37.8
3 121.0 0.8 39.0 40.2 22.3 22474.0 9.4 123285.0 1.0 47.3
4 175.0 0.8 31.0 50.6 28.1 39219.0 9.6 165762.0 1.1 40.6
5 228.0 0.8 39.0 40.4 22.4 22709.0 9.6 126283.0 1.0 48.3
6 276.0 0.8 42.0 37.5 20.8 19004.0 9.6 114117.0 1.0 49.3
Experiment rGpFARl in HEPES at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 40.0 45.6 25.3 30458.0 14.5 153949.0 1.0 46.3
2 47.0 0.8 37.0 48.9 27.1 36113.0 14.4 178799.0 1.0 45.2
3 85.0 0.8 42.0 42.4 23.5 25581.0 14.3 150566.0 1.0 46.4
4 133.0 0.8 46.0 38.9 21.6 20797.0 14.4 145224.0 1.0 50.2
5 178.0 0.8 52.0 34.8 19.3 15904.0 14.4 145482.0 1.0 42.2
Experiment: rGpFARl in HEPES at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 55.0 37.3 20.7 18787.0 19.0 170832.0 1.0 55.8
2 26.0 0.7 48.0 42.7 23.7 25976.0 19.2 226458.0 1.1 33.3
3 42.0 0.8 51.0 40.4 22.4 22793.0 19.0 210991.0 1.1 40.6
4 60.0 0.7 42.0 48.1 26.7 34723.0 19.0 276419.0 1.0 31.9
5 120.0 0.8 51.0 40.1 22.2 22322.0 19.2 187071.0 1.0 55.6
6 164.0 0.8 51.0 40.5 22.5 22844.0 19.3 207829.0 1.0 44.3
Experiment: rGpFARl in HEPES at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 61.0 38.3 21.3 20039.0 23.7 213020.0 1.0 41.8
2 20.0 0.8 65.0 35.7 19.8 16900.0 23.9 192449.0 1.0 52.4
3 39.0 0.8 68.0 34.3 19.1 15327.0 23.9 194127.0 1.0 46.1
4 57.0 0.8 58.0 40.2 22.3 22479.0 23.9 227212.0 1.0 55.2
5 74.0 0.8 56.0 41.2 22.9 23890.0 23.8 250317.0 1.0 44.4
6 89.0 0.8 55.0 42.0 23.3 25002.0 23.8 245193.0 1.0 50.9
Appendix 1
Experiment: rOvFARl in PIPES at 5°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
#  (s) ( )  (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 135.0 10.0 5.5 775.0 4.2 266759.0 1.0 13.7
2 32.0 0.8 133.0 10.2 5.7 807.0 4.4 267575.0 1.0 16.5
3 63.0 0.8 129.0 10.5 5.9 875.0 4.5 269275.0 1.0 24.1
4 95.0 0.8 139.0 9.6 5.3 696.0 3.7 259615.0 1.0 18.0
5 128.0 0.8 130.0 9.5 5.3 688.0 1.3 275128.0 1.0 19.6
6 160.0 0.8 138.0 8.6 4.8 545.0 0.1 258332.0 1.0 19.0
7 194.0 0.8 134.0 8.9 4.9 580.0 0.0 261957.0 1.0 20.3
8 226.0 0.8 133.0 8.9 5.0 589.0 0.0 263881.0 1.0 21.4
9 259.0 0.8 131.0 9.1 5.0 611.0 0.1 265243.0 1.0 20.8
10 291.0 0.8 134.0 8.9 4.9 582.0 0.1 259479.0 1.0 18.9
Experiment: rOvFARl in PIPES at 10°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
#  (s) ( )  (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 158.0 9.9 5.5 753.0 9.3 267729.0 1.0 19.5
2 32.0 0.8 161.0 9.7 5.4 714.0 9.0 263072.0 1.0 24.5
3 64.0 0.8 167.0 9.3 5.2 651.0 9.1 261390.0 1.0 16.2
4 97.0 0.8 155.0 10.0 5.6 782.0 9.1 273327.0 1.0 24.7
5 129.0 0.8 161.0 9.7 5.4 718.0 9.1 265995.0 1.0 19.7
6 160.0 0.8 166.0 9.3 5.2 656.0 8.9 261893.0 1.0 19.6
7 194.0 0.8 164.0 9.4 5.2 664.0 8.6 262332.0 1.0 19.3
8 228.0 0.7 175.0 8.8 4.7 567.0 8.7 1024058.0 1.0 9.5
9 235.0 0.8 168.0 9.1 5.1 626.0 8.6 256594.0 1.0 19.7
10 270.0 0.8 153.0 10.0 5.6 786.0 8.8 272959.0 1.0 23.8
Experiment: rOvFARl in PIPES at 15°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
#  (s) ( )  (nm) (nm) (°C) (cnts/s)
1 0.0 0.5 280.0 6.4 0.0 259.0 14.2 971660.0 1.0 0.7
2 7.0 0.3 374.0 4.8 0.0 132.0 14.5 958489.0 1.0 0.3
3 14.0 0.4 345.0 5.2 0.0 160.0 14.5 969954.0 1.0 0.4
4 23.0 0.5 281.0 6.4 0.0 258.0 14.2 990266.0 1.0 0.8
5 30.0 0.4 339.0 5.3 0.0 167.0 14.5 950930.0 1.0 0.7
6 37.0 0.5 292.0 6.2 0.0 241.0 14.5 958730.0 1.0 0.9
7 45.0 0.5 293.0 6.2 0.0 240.0 14.6 258252.0 1.0 0.5
8 79.0 0.3 364.0 5.0 0.0 140.0 14.4 975863.0 1.0 0.6
9 87.0 0.4 330.0 5.5 0.0 178.0 14.5 984080.0 1.0 1.0
10 94.0 0.5 298.0 6.1 0.0 228.0 14.5 249443.0 1.0 0.3
Experiment: rOvFARl in PIPES at20°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
#  (s) ( )  (nm) (nm) (°C) (cnts/s)
1 0.0 0.2 493.0 4.2 0.0 93.0 19.3 868014.0 1.0 0.5
2 7.0 0.5 338.0 6.1 0.0 236.0 19.5 883173.0 1.0 0.8
3 15.0 0.4 396.0 5.2 0.0 159.0 19.4 864565.0 1.0 0.8
4 23.0 0.4 413.0 5.0 0.0 144.0 19.4 870202.0 1.0 1.2
5 31.0 0.5 351.0 5.9 0.0 211.0 19.3 882022.0 1.0 0.9
6 38.0 0.5 339.0 6.1 0.0 234.0 19.5 891368.0 1.0 0.9
7 46.0 0.5 330.0 6.3 0.0 248.0 19.5 914155.0 1.0 0.4
8 53.0 0.5 361.0 5.7 0.0 199.0 19.4 889580.0 1.0 0.7
9 61.0 0.3 396.0 5.2 0.0 158.0 19.3 888614.0 1.0 0.3
10 68.0 0.5 331.0 6.3 0.0 248.0 19.5 885645.0 1.0 1.0
Experiment: rOvFARl in PIPES at25°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
#  (s) ( )  (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 67054.0 0.0 0.0 607.0 24.5 280028.0 1.0 26.4
2 34.0 0.7 67054.0 0.0 0.0 585.0 24.4 988544.0 1.0 24.9
3 42.0 0.7 67054.0 0.0 0.0 594.0 24.4 977796.0 1.0 18.3
4 49.0 0.7 67054.0 0.0 0.0 620.0 24.5 987976.0 1.0 28.3
5 57.0 0.7 67054.0 0.0 0.0 546.0 24.5 975221.0 1.0 16.6
6 63.0 0.7 67054.0 0.0 0.0 664.0 24.4 1019631.0 1.0 21.8
7 70.0 0.7 67054.0 0.0 0.0 589.0 24.2 963747.0 1.0 21.6
8 77.0 0.8 67054.0 0.0 0.0 622.0 24.2 278533.0 1.0 30.8
9 112.0 0.7 67054.0 0.0 0.0 573.0 24.5 976922.0 1.0 16.7
10 119.0 0.7 67054.0 0.0 0.0 560.0 24.4 948908.0 1.0 20.4
Appendix 1
Experiment: rOvFARl in HEPES at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 166.0 8.2 4.6 481.0 4.7 121576.0 1.0 16.8
2 29.0 0.8 177.0 7.7 4.3 416.0 4.7 111864.0 1.0 15.8
3 59.0 0.8 170.0 8.1 4.5 463.0 4.9 109843.0 1.0 17.7
4 91.0 0.8 184.0 7.5 3.7 386.0 5.1 100745.0 1.0 11.4
5 125.0 0.8 176.0 7.7 4.3 420.0 4.6 100443.0 1.0 15.1
6 139.0 0.8 182.0 7.6 3.7 396.0 4.9 97831.0 1.0 10.2
7 154.0 0.8 189.0 7.2 3.6 350.0 4.6 95174.0 1.0 12.3
8 169.0 0.8 187.0 7.3 3.6 360.0 4.6 94041.0 1.0 11.0
9 185.0 0.8 185.0 7.4 4.0 381.0 5.0 92089.0 1.0 13.8
Experiment: rOvFARl in HEPES at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
#  (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 219.0 7.1 3.7 335.0 9.0 128472.0 1.0 12.0
2 25.0 0.8 219.0 7.2 3.5 347.0 9.4 126601.0 1.0 11.2
3 54.0 0.8 222.0 7.0 3.5 334.0 9.4 123465.0 1.0 10.3
4 82.0 0.8 211.0 7.5 4.0 389.0 9.7 125488.0 1.0 13.2
5 110.0 0.8 204.0 7.7 4.1 409.0 9.4 125926.0 1.0 13.5
6 138.0 0.8 206.0 7.7 4.2 412.0 9.7 123014.0 1.0 13.6
7 167.0 0.8 202.0 7.8 4.4 428.0 9.7 121417.0 1.0 15.4
8 196.0 0.8 196.0 8.1 4.5 465.0 9.7 122939.0 1.0 15.7
9 223.0 0.8 195.0 8.1 4.5 466.0 9.7 121731.0 1.0 20.6
Experiment: rOvFARl in HEPES at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 258.0 6.9 3.4 313.0 13.7 132398.0 1.0 11.6
2 26.0 0.8 259.0 6.9 3.4 321.0 14.2 132335.0 1.0 10.0
3 53.0 0.8 259.0 7.0 3.7 323.0 14.3 131830.0 1.0 13.2
4 80.0 0.8 259.0 6.9 3.4 320.0 14.2 130301.0 1.0 10.7
5 107.0 0.8 255.0 7.1 3.8 335.0 14.3 131126.0 1.0 13.7
6 133.0 0.8 258.0 7.0 3.7 326.0 14.3 129943.0 1.0 12.8
7 161.0 0.8 255.0 7.1 3.9 338.0 14.4 130771.0 1.0 14.6
8 186.0 0.8 250.0 7.3 3.9 358.0 14.5 131046.0 1.0 13.9
9 214.0 0.8 261.0 6.9 3.7 321.0 14.4 126899.0 1.0 11.8
Experiment: rOvFARl in HEPES at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 298.0 6.9 3.8 318.0 19.1 135601.0 1.0 14.5
2 26.0 0.8 298.0 6.9 3.7 315.0 19.0 136316.0 1.0 13.5
3 52.0 0.8 288.0 7.1 3.9 343.0 19.0 138888.0 1.0 13.9
4 78.0 0.8 246.0 8.4 4.7 506.0 19.1 157366.0 1.0 23.2
5 105.0 0.8 283.0 7.3 4.0 360.0 19.1 139593.0 1.0 14.7
6 128.0 0.8 305.0 6.8 3.3 302.0 19.2 131842.0 1.0 9.3
7 155.0 0.8 309.0 6.7 3.6 293.0 19.2 130943.0 1.0 12.7
8 182.0 0.8 307.0 6.7 3.3 296.0 19.1 131620.0 1.0 10.7
9 209.0 0.8 296.0 7.0 3.7 324.0 19.2 133587.0 1.0 13.6
10 235.0 0.8 296.0 6.9 3.8 320.0 19.0 134639.0 1.0 15.6
Experiment: rOvFARl in HEPES at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 332.0 7.0 3.5 330.0 23.8 132972.0 1.0 10.7
2 26.0 0.8 347.0 6.7 2.6 296.0 23.8 130103.0 1.0 8.0
3 54.0 0.8 347.0 6.7 3.3 297.0 23.8 130117.0 1.0 10.4
4 82.0 0.8 348.0 6.7 3.3 295.0 23.8 131037.0 1.0 11.1
5 108.0 0.8 352.0 6.6 3.3 287.0 23.8 130301.0 1.0 9.9
6 136.0 0.8 355.0 6.6 3.3 285.0 24.0 130634.0 1.0 10.1
7 163.0 0.8 327.0 7.2 3.8 346.0 23.9 138659.0 1.0 13.2
8 190.0 0.8 349.0 6.7 3.3 293.0 23.8 132148.0 1.0 11.4
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Experiment: rOvFARl in TRIS at5°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) CO (cnts/s)
1 0.0 0.8 171.0 8.0 4.2 448.0 4.6 96855.0 1.0 12.1
2 31.0 0.8 173.0 7.9 3.9 446.0 4.9 91528.0 1.0 10.8
3 46.0 0.8 161.0 8.5 4.7 530.0 4.9 97610.0 1.0 15.0
4 61.0 0.8 160.0 8.6 4.8 547.0 5.1 97679.0 1.0 14.4
5 76.0 0.8 164.0 8.4 4.5 509.0 4.9 92883.0 1.0 14.6
6 91.0 0.8 160.0 8.6 4.7 544.0 5.0 93965.0 1.0 13.2
7 106.0 0.8 158.0 8.7 4.6 563.0 5.1 91578.0 1.0 12.9
8 122.0 0.8 161.0 8.6 4.8 539.0 5.1 90880.0 1.0 16.7
9 136.0 0.8 162.0 8.5 4.7 525.0 5.0 89624.0 1.0 15.8
Experiment: rOvFARl in TRIS at 10°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) CO (cnts/s)
1 0.0 0.8 194.0 8.2 4.6 477.0 9.7 69587.0 1.0 18.1
2 17.0 0.8 182.0 8.6 4.8 544.0 9.4 74072.0 1.0 22.0
3 37.0 0.8 198.0 8.0 4.5 459.0 9.9 71800.0 1.0 15.0
4 55.0 0.8 197.0 8.0 4.3 458.0 9.7 73023.0 1.0 12.1
5 73.0 0.8 145.0 10.9 6.1 961.0 9.8 98561.0 1.0 50.3
6 89.0 0.8 168.0 9.4 5.3 677.0 9.9 86672.0 1.0 28.1
7 105.0 0.8 205.0 7.7 3.0 412.0 9.6 73447.0 1.0 8.4
8 123.0 0.8 196.0 8.0 4.0 453.0 9.4 78308.0 1.0 11.2
9 142.0 0.8 192.0 8.2 4.6 477.0 9.4 78794.0 1.0 17.6
10 161.0 0.8 187.0 8.4 4.7 507.0 9.4 81409.0 1.0 19.6
Experiment: rOvFARl in TRIS at 15°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 226.0 8.0 4.4 448.0 14.2 75886.0 1.0 16.2
2 18.0 0.8 228.0 7.9 4.4 439.0 14.3 77226.0 1.0 16.9
3 36.0 0.8 222.0 8.2 4.6 478.0 14.5 82484.0 1.0 17.1
4 54.0 0.8 197.0 9.2 5.2 643.0 14.7 93953.0 1.0 30.1
5 70.0 0.8 225.0 8.0 4.5 451.0 14.2 86527.0 1.0 18.1
6 86.0 0.8 240.0 7.5 4.2 394.0 14.5 83428.0 1.0 15.8
7 104.0 0.8 239.0 7.6 3.7 402.0 14.7 85555.0 1.0 9.5
8 120.0 0.8 222.0 8.1 4.5 468.0 14.2 92444.0 1.0 18.0
9 137.0 0.8 210.0 8.7 4.8 554.0 14.7 98190.0 1.0 23.5
10 153.0 0.8 216.0 8.4 4.7 512.0 14.6 97067.0 1.0 20.4
Experiment: rOvFARl in TRIS at 20°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) <°C) (cnts/s)
1 0.0 0.8 265.0 7.8 4.3 422.0 19.1 91111.0 1.0 15.2
2 16.0 0.8 239.0 8.6 4.8 547.0 19.2 105968.0 1.0 24.6
3 31.0 0.8 242.0 8.5 4.7 525.0 19.1 107918.0 1.0 29.2
4 62.0 0.8 253.0 8.2 4.6 476.0 19.2 107297.0 1.0 21.2
5 94.0 0.8 278.0 7.4 4.1 381.0 19.3 103790.0 1.0 14.3
6 125.0 0.8 266.0 7.8 4.4 430.0 19.5 112365.0 1.0 20.7
7 158.0 0.8 265.0 7.8 4.3 422.0 19.1 115483.0 1.0 18.7
8 188.0 0.8 272.0 7.5 4.0 393.0 19.0 116402.0 1.0 12.5
9 218.0 0.8 258.0 7.9 4.4 445.0 19.0 124521.0 1.0 22.1
Experiment: rOvFARl in TRIS at 25°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) CO (cnts/s)
1 0.0 0.8 322.0 7.2 4.0 355.0 23.7 115801.0 1.0 16.6
2 29.0 0.8 328.0 7.1 3.5 343.0 23.9 119291.0 1.0 12.1
3 60.0 0.8 315.0 7.4 4.1 378.0 23.9 125486.0 1.0 15.8
4 88.0 0.8 321.0 7.3 3.6 360.0 23.8 128777.0 1.0 12.4
5 115.0 0.8 319.0 7.4 3.9 370.0 24.0 130916.0 1.0 13.2
6 141.0 0.8 294.0 7.9 4.4 444.0 23.8 139959.0 1.0 20.7
7 166.0 0.8 323.0 7.2 3.9 352.0 23.8 135957.0 1.0 14.9
Appendix 1
Experiment: rCeFAR2 in ACETATE at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.7 10.0 146.2 0.0 513698.0 8.7 392813.0 1.0 2.2
2 717.0 0.7 10.0 140.8 39.3 468848.0 8.6 407432.0 1.0 2.1
3 1173.0 0.7 10.0 147.1 0.0 521162.0 8.6 416243.0 1.0 1.1
4 1281.0 0.7 10.0 144.6 0.0 500321.0 8.6 323910.0 1.0 0.2
5 1495.0 0.7 11.0 139.8 0.0 461265.0 8.8 360552.0 1.0 0.5
6 1958.0 0.7 10.0 146.7 33.0 517750.0 8.8 366577.0 1.0 0.7
Experiment: rCeFAR2 in ACETATE at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (crrts/s)
1 0.0 0.7 12.0 138.1 53.9 447471.0 13.0 355915.0 1.0 5.1
2 76.0 0.7 11.0 146.8 57.3 519310.0 13.1 458864.0 1.0 4.3
3 141.0 0.7 12.0 136.5 39.4 434744.0 13.2 315694.0 1.0 2.1
4 199.0 0.7 12.0 146.1 56.2 513099.0 13.4 378154.0 1.0 4.1
5 282.0 0.7 12.0 141.4 0.0 473791.0 13.2 382815.0 1.0 1.8
6 334.0 0.7 13.0 129.7 50.6 384479.0 13.0 424050.0 1.0 3.4
7 393.0 0.7 12.0 143.0 50.3 487029.0 13.2 349545.0 1.0 3.4
8 452.0 0.6 12.0 139.9 40.4 461416.0 13.4 531168.0 1.0 1.2
9 522.0 0.7 12.0 139.8 52.5 461224.0 13.2 381484.0 1.0 4.2
10 578.0 0.8 12.0 144.6 0.0 500504.0 13.1 304759.0 1.0 2.8
Experiment: rCeFAR2 in ACETATE at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.7 14.0 133.5 52.1 412063.0 17.4 273552.0 1.0 6.5
2 86.0 0.8 15.0 129.8 37.5 385194.0 17.6 354135.0 1.0 1.9
3 168.0 0.7 13.0 142.1 55.5 479782.0 17.4 433407.0 1.0 6.2
4 233.0 0.8 14.0 133.2 35.3 409801.0 17.6 300959.0 1.0 1.3
5 315.0 0.8 16.0 117.9 0.0 305020.0 17.6 226174.0 1.0 0.6
6 459.0 0.7 15.0 130.5 0.0 390237.0 17.6 317400.0 1.0 0.8
7 598.0 0.7 13.0 143.2 50.3 488248.0 17.8 468315.0 1.0 3.4
8 668.0 0.7 15.0 129.8 0.0 384746.0 17.6 370391.0 1.0 1.1
9 715.0 0.7 15.0 129.0 0.0 379229.0 17.7 357397.0 1.0 1.6
10 773.0 0.7 15.0 127.0 36.7 364916.0 17.6 360239.0 1.0 1.9
Experiment: rCeFAR2 in ACETATE at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 14.0 156.2 61.0 602780.0 22.6 312927.0 1.1 7.2
2 174.0 0.8 16.0 134.7 38.9 421190.0 22.5 266294.0 1.0 2.9
3 214.0 0.7 16.0 134.3 47.2 418101.0 22.4 354517.0 1.1 3.5
4 285.0 0.7 17.0 132.6 64.7 405259.0 22.6 352036.0 1.1 8.2
5 358.0 0.8 17.0 129.2 50.4 380718.0 22.4 321701.0 1.1 3.6
6 429.0 0.8 18.0 125.3 48.9 353815.0 22.4 340338.0 1.0 4.3
7 482.0 0.8 18.0 122.8 35.5 336783.0 22.4 286454.0 1.0 2.4
8 556.0 0.7 17.0 127.7 28.9 369998.0 22.4 336840.0 1.0 0.6
9 633.0 0.8 19.0 116.0 0.0 293359.0 22.6 230189.0 1.0 4.5
10 686.0 0.8 17.0 127.3 49.7 367142.0 22.4 286778.0 1.0 6.0
Experiment: rCeFAR2 in TRIS at 5°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.7 28.0 48.5 26.9 35396.0 4.7 431152.0 1.1 33.2
2 19.0 0.7 28.0 48.5 26.9 35414.0 4.5 426273.0 1.0 26.1
3 36.0 0.7 29.0 46.7 25.9 32303.0 4.5 443075.0 1.0 24.2
4 53.0 0.7 29.0 45.9 25.5 31032.0 4.5 371623.0 1.1 34.5
5 75.0 0.8 32.0 42.3 23.5 25487.0 4.5 328932.0 1.1 16.3
6 113.0 0.8 34.0 39.9 21.2 22025.0 4.4 336366.0 1.0 11.3
7 180.0 0.7 28.0 48.0 26.6 34557.0 4.1 360705.0 1.1 28.8
8 203.0 0.7 21.0 62.9 34.9 66651.0 3.8 507523.0 1.0 45.7
9 227.0 0.8 21.0 63.2 35.1 67304.0 3.7 409049.0 1.0 67.6
10 279.0 0.7 25.0 52.5 29.2 43027.0 3.4 425943.0 1.0 26.8
Experiment: rCeFAR2 in TRIS at10°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 35.0 40.3 22.4 22657.0 9.6 322809.0 1.0 28.2
2 21.0 0.7 28.0 48.6 27.0 35570.0 9.4 421090.0 1.1 37.5
3 43.0 0.7 24.0 56.8 31.5 51907.0 9.5 453161.0 1.0 69.1
4 70.0 0.7 29.0 48.2 26.8 34927.0 9.7 418917.0 1.0 36.1
5 90.0 0.8 28.0 49.6 27.5 37394.0 9.5 372990.0 1.0 67.1
6 114.0 0.8 33.0 42.2 23.4 25250.0 9.4 347648.0 1.1 43.3
7 137.0 0.7 29.0 48.5 26.9 35422.0 9.7 433284.0 1.1 23.8
8 158.0 0.7 30.0 45.6 25.3 30551.0 9.6 399571.0 1.0 30.2
9 180.0 0.7 27.0 50.9 28.3 39848.0 9.5 523237.0 1.1 24.7
10 229.0 0.7 21.0 66.1 36.7 75053.0 9.4 558569.0 1.1 68.6
Experiment: rCeFAR2 in TRIS at15°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 37.0 0.7 34.0 52.0 28.9 41943.0 13.7 428108.0 1.1 39.6
2 53.0 0.7 34.0 52.5 29.1 42939.0 13.7 426228.0 1.1 44.5
3 71.0 0.7 45.0 39.5 22.0 21614.0 13.8 333458.0 1.0 27.4
4 130.0 0.7 43.0 41.1 22.8 23704.0 13.7 340432.0 1.0 29.9
5 149.0 0.7 38.0 46.8 26.0 32456.0 13.8 389682.0 1.0 35.8
6 171.0 0.7 41.0 42.7 23.7 26031.0 13.8 371111.0 1.0 25.1
7 191.0 0.8 41.0 43.4 24.1 27049.0 13.6 344235.0 1.0 64.5
8 212.0 0.7 35.0 50.3 27.9 38798.0 13.4 423782.0 1.0 37.8
9 236.0 0.7 35.0 50.3 27.9 38678.0 13.7 447223.0 1.1 36.9
10 256.0 0.7 35.0 50.6 28.1 39258.0 13.6 437413.0 1.0 43.7
Experiment: rCeFAR2 in TRIS at 20°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 16.0 0.8 40.0 50.4 28.0 38923.0 18.3 410766.0 1.0 52.9
2 33.0 0.7 41.0 48.8 27.1 35960.0 18.5 386823.0 1.0 50.5
3 53.0 0.8 39.0 51.3 28.5 40559.0 18.6 384510.0 1.0 49.2
4 72.0 0.7 48.0 41.8 23.2 24752.0 18.4 348355.0 1.0 19.9
5 156.0 0.7 35.0 57.3 31.8 52971.0 18.3 530927.0 1.1 31.4
6 184.0 0.7 36.0 55.4 30.8 49000.0 18.4 459827.0 1.0 32.1
7 201.0 0.7 39.0 51.7 28.7 41400.0 18.5 393378.0 1.1 56.4
8 218.0 0.7 43.0 46.7 25.9 32417.0 18.2 382310.0 1.1 46.3
9 258.0 0.8 41.0 48.9 27.1 36126.0 18.5 376225.0 1.0 30.6
10 277.0 0.8 44.0 45.3 25.1 30036.0 18.4 359345.0 1.0 33.9
Experiment: rCeFAR2 in TRIS at 25°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 61.0 36.9 20.5 18257.0 22.4 278043.0 1.0 42.1
2 62.0 0.7 65.0 34.3 19.0 15297.0 22.3 272567.0 1.0 27.9
3 75.0 0.7 57.0 39.5 21.9 21529.0 22.5 311947.0 1.1 28.3
4 88.0 0.8 58.0 38.6 21.5 20440.0 22.2 296181.0 1.0 25.2
5 115.0 0.7 35.0 63.9 35.5 69208.0 22.2 536684.0 1.0 39.1
6 163.0 0.7 32.0 68.6 38.1 82162.0 22.4 442392.0 1.1 105.3
7 181.0 0.7 37.0 60.8 33.7 61277.0 22.2 440840.0 1.1 59.2
8 203.0 0.8 52.0 43.3 24.0 26903.0 22.4 303888.0 1.0 41.4
9 224.0 0.8 50.0 44.5 24.7 28700.0 22.4 299850.0 1.0 52.8
10 246.0 0.8 59.0 37.8 21.0 19319.0 22.4 268240.0 1.1 29.5
Appendix 1
Experiment rCeFAR3 in ACETATE at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (crrts/s)
1 0.0 0.8 306.0 4.4 1.7 109.0 4.6 84984.0 1.0 9.6
2 16.0 0.8 304.0 4.5 1.8 114.0 4.9 83126.0 1.0 6.6
3 32.0 0.8 297.0 4.6 1.8 120.0 4.9 82855.0 1.0 6.0
4 49.0 0.8 293.0 4.7 1.8 123.0 4.8 82256.0 1.0 5.2
5 67.0 0.8 295.0 4.6 1.6 120.0 4.7 82686.0 1.0 4.1
6 83.0 0.8 287.0 4.7 1.9 128.0 4.6 84230.0 1.0 8.1
7 100.0 0.8 300.0 4.5 1.8 114.0 4.6 81927.0 1.0 7.1
8 116.0 0.8 292.0 4.7 1.8 124.0 4.7 83117.0 1.0 9.1
9 133.0 0.8 297.0 4.6 1.8 118.0 4.6 82189.0 1.0 9.1
10 149.0 0.8 289.0 4.7 1.9 126.0 4.6 84053.0 1.0 4.5
Experiment rCeFAR3 in ACETATE at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 329.0 4.7 1.9 126.0 9.1 83046.0 1.0 8.2
2 17.0 0.8 344.0 4.5 1.8 115.0 9.3 80388.0 1.0 7.2
3 34.0 0.8 345.0 4.5 1.8 115.0 9.4 80426.0 1.0 8.2
4 51.0 0.8 332.0 4.7 1.9 127.0 9.5 81958.0 1.0 7.6
5 69.0 0.8 350.0 4.5 1.8 111.0 9.4 79064.0 1.0 5.9
6 87.0 0.8 346.0 4.5 1.8 113.0 9.3 80164.0 1.0 4.4
7 105.0 0.8 347.0 4.5 1.8 113.0 9.3 80191.0 1.0 6.8
8 123.0 0.8 345.0 4.5 1.8 115.0 9.4 81402.0 1.0 8.1
9 139.0 0.8 342.0 4.6 1.8 117.0 9.4 80474.0 1.0 7.6
10 157.0 0.8 355.0 4.4 1.7 106.0 9.3 79792.0 1.0 5.7
Experiment rCeFAR3 in ACETATE a t 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 400.0 4.5 1.8 112.0 14.2 81853.0 1.0 8.1
2 17.0 0.8 411.0 4.4 1.7 105.0 14.3 81074.0 1.0 4.8
3 35.0 0.8 415.0 4.3 1.7 103.0 14.3 80158.0 1.0 7.5
4 52.0 0.8 414.0 4.3 1.7 103.0 14.3 79749.0 1.0 5.0
5 70.0 0.8 406.0 4.4 1.7 108.0 14.3 81101.0 1.0 7.1
6 87.0 0.8 403.0 4.5 1.8 111.0 14.3 81627.0 1.0 7.1
7 105.0 0.8 409.0 4.4 1.7 106.0 14.2 81574.0 1.0 7.9
8 122.0 0.8 422.0 4.2 1.6 97.0 14.1 79772.0 1.0 4.6
9 139.0 0.8 400.0 4.5 1.8 112.0 14.2 81791.0 1.0 8.5
10 157.0 0.8 403.0 4.4 1.8 110.0 14.2 81271.0 1.0 7.6
Experiment: rCeFAR3 in ACETATE at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) () (nm) (nm) <°C) (cnts/s)
1 0.0 0.8 484.0 4.2 1.7 97.0 19.1 81538.0 1.0 8.2
2 16.0 0.8 490.0 4.2 1.6 94.0 19.0 81495.0 1.0 7.8
3 33.0 0.8 486.0 4.2 1.7 96.0 19.0 80554.0 1.0 5.2
4 50.0 0.8 491.0 4.2 1.5 94.0 19.0 80687.0 1.0 3.7
5 67.0 0.8 476.0 4.3 1.7 102.0 19.1 82161.0 1.0 5.5
6 85.0 0.8 507.0 4.0 1.6 87.0 19.1 79567.0 1.0 7.3
7 102.0 0.8 494.0 4.1 1.6 92.0 19.0 79769.0 1.0 5.2
8 120.0 0.8 475.0 4.3 1.7 102.0 19.0 81426.0 1.0 9.1
9 137.0 0.8 481.0 4.2 1.7 99.0 19.0 79169.0 1.0 5.4
10 155.0 0.8 483.0 4.2 1.7 98.0 19.0 80074.0 1.0 5.4
Experiment rCeFAR3 in ACETATE at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 572.0 4.0 1.6 88.0 23.7 76130.0 1.0 5.5
2 18.0 0.8 561.0 4.1 1.6 91.0 23.6 75749.0 1.0 9.0
3 53.0 0.8 559.0 4.1 1.6 93.0 23.8 75233.0 1.0 5.8
4 71.0 0.8 565.0 4.1 1.6 91.0 23.7 75018.0 1.0 6.4
5 90.0 0.8 568.0 4.1 1.6 89.0 23.7 73927.0 1.0 4.3
6 108.0 0.8 555.0 4.2 1.6 94.0 23.7 74737.0 1.0 6.7
7 127.0 0.8 560.0 4.1 1.6 92.0 23.7 73868.0 1.0 6.9
8 146.0 0.8 547.0 4.2 1.7 98.0 23.7 74269.0 1.0 5.1
9 164.0 0.8 554.0 4.2 1.6 95.0 23.7 73407.0 1.0 5.0
10 184.0 0.8 561.0 4.1 1.6 92.0 23.7 72358.0 1.0 4.3
Appendix 1
Experiment: rCeFAR3 in PIPES at 5°C
Meas. Time Ampl Diffn Coefl Radius
# (s) 0 (nm)
1 0.0 0.8 443.0 3.0
2 29.0 0.8 442.0 3.0
3 59.0 0.9 439.0 3.1
4 89.0 0.9 432.0 3.1
5 118.0 0.9 435.0 3.1
6 149.0 0.8 437.0 3.1
7 178.0 0.9 433.0 3.1
8 208.0 0.8 431.0 3.0
9 237.0 0.9 435.0 2.7
10 267.0 0.9 436.0 2.7
Experiment: rCeFAR3 in PIPES at 10°C
Meas. Time Ampl Diffn Coefl Radius
# (s) 0 (nm)
1 0.0 0.9 517.0 3.0
2 31.0 0.9 528.0 2.9
3 63.0 0.8 516.0 3.0
4 94.0 0.9 520.0 3.0
5 124.0 0.9 527.0 2.9
6 155.0 0.9 529.0 2.9
7 185.0 0.8 528.0 2.9
8 247.0 0.8 520.0 3.0
9 277.0 0.9 526.0 2.9
10 308.0 0.9 522.0 3.0
Experiment: rCeFAR3 in PIPES at 15*C
Meas. Time Ampl Diffn Coefl Radius
# (s) 0 (nm)
1 0.0 0.9 622.0 2.8
2 29.0 0.9 629.0 2.8
3 59.0 0.9 631.0 2.8
4 89.0 0.8 628.0 2.8
5 119.0 0.8 626.0 2.8
6 149.0 0.8 618.0 2.8
7 178.0 0.8 624.0 2.8
8 208.0 0.9 626.0 2.8
9 237.0 0.8 629.0 2.8
10 267.0 0.9 625.0 2.8
Experiment: rCeFAR3 in PIPES at 20°C
Meas. Time Ampl Diffn Coefl Radius
# (s) 0 (nm)
1 0.0 0.9 730.0 2.7
2 30.0 0.9 728.0 2.7
3 59.0 0.9 736.0 2.7
4 89.0 0.8 732.0 2.7
5 118.0 0.9 732.0 2.7
6 148.0 0.8 729.0 2.7
7 178.0 0.9 737.0 2.7
8 209.0 0.9 728.0 2.7
9 239.0 0.8 734.0 2.7
10 270.0 0.9 731.0 2.7
Experiment: rCeFAR3 in PIPES at 25°C
Meas. Time Ampl Diffn Coefl Radius
# (s) 0 (nm)
1 0.0 0.9 850.0 2.6
2 32.0 0.8 854.0 2.6
3 47.0 0.8 842.0 2.6
4 80.0 0.8 822.0 2.6
5 95.0 0.8 855.0 2.6
6 109.0 0.9 820.0 2.7
7 124.0 0.9 832.0 2.6
8 139.0 0.8 855.0 2.5
9 154.0 0.8 852.0 2.6
10 170.0 0.8 847.0 2.6
Polyd Estd MW Temp
(nm) (°C)
0.7 44.0 4.4
0.7 44.0 4.5
0.7 45.0 4.5
0.8 46.0 4.3
0.7 45.0 4.3
0.7 44.0 4.2
0.7 45.0 4.1
0.9 43.0 3.2
0.6 33.0 0.1
0.6 33.0 0.0
Polyd Estd MW Temp
(nm) (°C)
0.9 42.0 9.2
0.6 40.0 9.2
0.6 42.0 9.2
0.7 41.0 9.0
0.5 40.0 9.1
0.8 39.0 9.0
0.8 40.0 9.2
0.6 41.0 9.1
0.6 40.0 9.1
0.8 41.0 9.2
Polyd Estd MW Temp
(nm) cc)
0.6 36.0 13.4
0.6 36.0 13.7
0.6 36.0 13.7
0.6 36.0 13.7
0.5 36.0 13.7
0.7 37.0 13.6
0.5 36.0 13.6
0.0 36.0 13.7
0.5 35.0 13.5
0.5 36.0 13.5
Polyd Estd MW Temp
(nm) (°C)
0.6 33.0 18.1
0.6 34.0 18.1
0.5 33.0 18.1
0.6 33.0 18.2
0.0 33.0 18.2
0.5 34.0 18.2
0.6 33.0 18.1
0.6 34.0 18.1
0.7 33.0 18.3
0.6 34.0 18.2
Polyd Estd MW Temp
(nm) CC)
0.5 29.0 21.7
0.0 29.0 21.9
0.6 30.0 21.8
0.8 31.0 21.6
0.0 29.0 21.9
0.6 32.0 21.7
0.6 31.0 21.7
0.0 29.0 21.7
0.6 29.0 21.8
0.0 29.0 21.7
Count Baseline SOS error
(cnts/s)
117738.0 1.0 1.1
115400.0 1.0 0.7
115377.0 1.0 1.0
114842.0 1.0 1.5
115165.0 1.0 1.0
114683.0 1.0 0.9
114945.0 1.0 0.9
115977.0 1.0 1.7
115004.0 1.0 0.7
115089.0 1.0 0.7
Count Baseline SOS error
(cnts/s)
110190.0 1.0 1.2
109764.0 1.0 0.4
111587.0 1.0 0.5
111245.0 1.0 1.1
111066.0 1.0 0.5
111672.0 1.0 1.4
111737.0 1.0 1.2
112604.0 1.0 0.4
112955.0 1.0 0.4
112655.0 1.0 1.0
Count Baseline SOS error
(cnts/s)
114584.0 1.0 0.9
114438.0 1.0 0.6
115435.0 1.0 0.6
115964.0 1.0 0.8
116295.0 1.0 0.5
116782.0 1.0 0.8
116063.0 1.0 0.5
116547.0 1.0 0.7
116851.0 1.0 0.4
117003.0 1.0 0.4
Count Baseline SOS error
(cnts/s)
116497.0 1.0 0.9
116997.0 1.0 0.7
116295.0 1.0 0.4
115623.0 1.0 0.8
115303.0 1.0 0.6
115029.0 1.0 0.5
114485.0 1.0 0.6
114454.0 1.0 0.6
114010.0 1.0 1.0
113116.0 1.0 0.5
Count Baseline SOS error
(cnts/s)
101726.0 1.0 0.6
100027.0 1.0 1.1
99744.0 1.0 0.9
98638.0 1.0 2.5
98131.0 1.0 0.7
98693.0 1.0 1.5
97366.0 1.0 1.6
96615.0 1.0 0.9
96371.0 1.0 1.6
95997.0 1.0 1.3
Appendix 1
Experiment: rCeFAR3 in HEPES at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.6 593.0 2.3 0.0 21.0 4.7 29927.0 1.0 3.1
2 15.0 0.5 595.0 2.3 0.0 21.0 4.8 29843.0 1.0 2.0
3 31.0 184.3 67054.0 0.0 0.0 0.0 4.8 29878.0 1.0 5.2
4 47.0 0.2 848.0 1.6 0.0 9.0 4.7 30396.0 1.0 6.1
5 63.0 0.2 15901.0 0.1 0.0 0.0 4.7 29956.0 1.0 7.0
6 78.0 269.9 67054.0 0.0 0.0 0.0 5.1 30236.0 1.0 2.7
7 94.0 0.0 4905.0 0.3 0.0 0.0 4.8 29654.0 1.0 5.3
8 109.0 0.6 595.0 2.3 0.0 21.0 4.6 30159.0 1.0 3.2
9 125.0 0.0 5245.0 0.3 0.0 0.0 4.6 29738.0 1.0 9.9
10 140.0 0.6 509.0 2.7 0.0 31.0 4.7 31688.0 1.1 3.5
Experiment: rCeFAR3 in HEPES at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 30.0 0.7 548.0 2.9 0.0 39.0 10.0 29963.0 1.0 6.9
2 46.0 0.7 488.0 3.2 0.0 49.0 9.4 32248.0 1.1 18.8
3 79.0 0.7 531.0 3.0 0.0 41.0 9.7 30106.0 1.0 6.7
4 95.0 0.7 566.0 2.8 1.1 35.0 9.7 29296.0 1.0 10.2
5 172.0 0.7 543.0 2.9 0.0 39.0 9.7 29084.0 1.0 5.7
6 188.0 0.7 544.0 2.9 0.0 39.0 9.7 29113.0 1.0 5.8
7 205.0 0.7 452.0 3.5 1.7 61.0 9.7 34884.0 1.0 10.5
8 221.0 0.7 517.0 3.0 0.0 43.0 9.5 29812.0 1.0 17.7
9 271.0 0.7 568.0 2.7 0.0 34.0 9.4 28844.0 1.0 9.5
10 287.0 0.7 527.0 3.0 1.2 42.0 9.7 29816.0 1.0 4.7
Experiment: rCeFAR3 in HEPES at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 47.0 0.7 649.0 2.8 0.0 35.0 14.5 30523.0 1.0 4.8
2 62.0 0.7 647.0 2.8 0.0 36.0 14.7 30492.0 1.0 4.0
3 92.0 0.7 665.0 2.7 1.1 33.0 14.7 30086.0 1.0 10.4
4 108.0 0.7 644.0 2.8 0.0 36.0 14.6 30326.0 1.0 9.5
5 123.0 0.7 665.0 2.7 0.0 33.0 14.7 30499.0 1.0 9.2
6 139.0 0.7 667.0 2.7 1.1 33.0 14.5 30542.0 1.0 4.4
7 167.0 0.7 659.0 2.7 1.1 34.0 14.7 30160.0 1.0 8.0
8 183.0 0.7 657.0 2.7 0.0 34.0 14.6 30700.0 1.0 5.9
9 244.0 0.7 644.0 2.8 0.0 36.0 14.6 30740.0 1.0 3.3
10 259.0 0.7 630.0 2.9 0.0 38.0 14.6 30493.0 1.0 8.0
Experiment: rCeFAR3 in HEPES at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 33.0 0.7 810.0 2.5 1.0 28.0 19.4 30567.0 1.0 8.2
2 49.0 0.7 818.0 2.5 1.0 28.0 19.5 30606.0 1.0 7.1
3 64.0 0.7 775.0 2.7 0.0 32.0 19.6 30557.0 1.0 7.5
4 80.0 0.7 757.0 2.7 1.1 34.0 19.5 30358.0 1.0 6.4
5 95.0 0.7 745.0 2.8 0.0 35.0 19.4 31310.0 1.0 5.5
6 139.0 0.7 784.0 2.6 0.0 31.0 19.7 30378.0 1.0 3.9
7 153.0 0.7 734.0 2.8 1.1 37.0 19.7 30586.0 1.0 7.3
8 183.0 0.7 784.0 2.6 1.0 31.0 19.7 29961.0 1.0 5.3
9 198.0 0.7 728.0 2.8 0.0 37.0 19.4 30792.0 1.0 5.7
10 215.0 0.7 746.0 2.8 1.1 35.0 19.5 30286.0 1.0 6.1
Experiment: rCeFAR3 in HEPES at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.7 916.0 2.5 0.0 29.0 24.3 30150.0 1.0 5.5
2 15.0 0.7 879.0 2.7 1.1 32.0 24.5 29820.0 1.0 6.6
3 31.0 0.7 819.0 2.9 0.0 38.0 24.5 30352.0 1.0 5.9
4 48.0 0.7 892.0 2.6 0.0 32.0 24.7 29256.0 1.0 4.9
5 80.0 0.7 899.0 2.6 0.0 30.0 24.4 29026.0 1.0 8.6
6 98.0 0.7 859.0 2.7 1.1 34.0 24.4 29495.0 1.0 12.8
7 114.0 0.7 891.0 2.6 0.0 31.0 24.5 28777.0 1.0 6.9
8 131.0 0.7 861.0 2.7 1.1 34.0 24.3 28592.0 1.0 8.5
9 164.0 0.7 912.0 2.6 1.0 29.0 24.5 28171.0 1.0 5.2
10 209.0 0.7 851.0 2.8 1.4 35.0 24.7 28129.0 1.0 14.6
Appendix 1
Experiment: rCeFAR3 in TRIS at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 380.0 3.6 1.0 65.0 4.7 110435.0 1.0 1.4
2 28.0 0.8 378.0 3.6 1.0 65.0 4.6 110132.0 1.0 1.5
3 59.0 0.8 376.0 3.6 1.1 68.0 4.9 109735.0 1.0 1.6
4 90.0 0.8 372.0 3.6 1.1 68.0 4.6 110151.0 1.0 1.4
5 121.0 0.8 367.0 3.7 0.8 70.0 4.6 109894.0 1.0 1.3
6 153.0 0.8 377.0 3.6 1.0 66.0 4.7 108958.0 1.0 1.5
7 185.0 0.8 371.0 3.7 0.8 70.0 4.9 109433.0 1.0 1.0
8 216.0 0.8 379.0 3.6 1.0 65.0 4.6 108410.0 1.0 1.5
9 248.0 0.8 372.0 3.6 0.8 68.0 4.6 108801.0 1.0 1.1
10 Z78.0 0.8 369.0 3.7 1.1 69.0 4.6 109333.0 1.0 2.3
Experiment: rCeFAR3 in TRIS a t 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
#
1
(s)
0.0
0
0.8 453.0
(nm)
3.5
(nm)
0.8 60.0
(°C)
9.6
(cnts/s)
101091.0 1.0 1.0
2 33.0 0.8 452.0 3.4 1.0 60.0 9.4 101555.0 1.0 2.0
3 66.0 0.8 452.0 3.5 0.8 62.0 9.9 102177.0 1.0 1.3
4 100.0 0.8 448.0 3.5 1.0 62.0 9.7 102432.0 1.0 1.6
5 133.0 0.8 449.0 3.5 1.0 63.0 9.9 102512.0 1.0 1.4
6 167.0 0.8 449.0 3.5 1.0 62.0 9.7 102186.0 1.0 1.6
7 199.0 0.8 445.0 3.5 1.0 63.0 9.7 102740.0 1.0 2.0
8 233.0 0.8 449.0 3.5 0.7 63.0 9.9 103252.0 1.0 0.7
9 265.0 0.8 452.0 3.5 0.8 61.0 9.7 102668.0 1.0 1.0
10 298.0 0.8 453.0 3.5 0.7 60.0 9.7 102452.0 1.0 0.9
Experiment rCeFARS in TRIS at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
#
1
(s)
0.0
0
0.8 532.0
(nm)
3.4
(nm)
0.6 57.0
(°C)
14.5
(cnts/s)
101060.0 1.0 0.7
2 33.0 0.8 532.0 3.4 1.0 58.0 14.7 101495.0 1.0 1.6
3 65.0 0.8 536.0 3.4 1.0 57.0 14.7 102210.0 1.0 2.1
4 98.0 0.8 534.0 3.4 0.9 57.0 14.7 102735.0 1.0 1.1
5 130.0 0.8 537.0 3.4 1.0 56.0 14.6 103118.0 1.0 1.7
6 163.0 0.8 538.0 3.4 0.9 56.0 14.7 103366.0 1.0 1.4
7 195.0 0.8 535.0 3.4 1.0 57.0 14.7 104256.0 1.0 1.4
8 228.0 0.8 533.0 3.4 0.9 58.0 14.7 104012.0 1.0 1.5
9 262.0 0.8 533.0 3.4 0.9 57.0 14.7 104355.0 1.0 1.2
10 294.0 0.8 534.0 3.4 1.0 57.0 14.7 104474.0 1.0 1.3
Experiment: rCeFAR3 in TRIS at20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
#
1
(s)
0.0
()
0.8 621.0
(nm)
3.3
(nm)
0.9 54.0
(°C)
19.4
(cnts/s)
105448.0 1.0 1.1
2 31.0 0.8 627.0 3.3 0.8 54.0 19.6 104995.0 1.0 1.1
3 64.0 0.8 631.0 3.3 0.7 52.0 19.4 104771.0 1.0 0.8
4 96.0 0.8 626.0 3.3 0.8 54.0 19.6 104736.0 1.0 1.4
5 129.0 0.8 629.0 3.3 0.8 53.0 19.6 104795.0 1.0 1.1
6 162.0 0.8 626.0 3.3 0.8 54.0 19.7 104090.0 1.0 1.1
7 195.0 0.8 632.0 3.3 0.7 53.0 19.7 103594.0 1.0 1.1
8 227.0 0.8 630.0 3.3 0.8 53.0 19.5 103608.0 1.0 0.9
9 260.0 0.8 633.0 3.3 0.7 52.0 19.5 103169.0 1.0 0.9
10 292.0 0.8 632.0 3.3 0.6 53.0 19.6 102791.0 1.0 0.5
Experiment rCeFAR3 in TRIS at25®C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
#
1
(s)
0.0
0
0.8 728.0
(nm)
3.2
(nm)
0.9 51.0
(°C)
24.3
(cnts/s)
98478.0 1.0 1.2
2 34.0 0.8 741.0 3.2 0.0 49.0 24.6 97623.0 1.0 2.3
3 48.0 0.8 727.0 3.2 0.0 51.0 24.5 95873.0 1.0 0.6
4 64.0 0.8 731.0 3.2 0.0 50.0 24.4 95249.0 1.0 1.3
5 79.0 0.8 732.0 3.2 0.9 51.0 24.5 95265.0 1.0 2.4
6 95.0 0.8 712.0 3.3 0.9 54.0 24.5 95404.0 1.0 1.8
7 110.0 0.8 724.0 3.2 0.0 52.0 24.4 94080.0 1.0 1.8
8 125.0 0.8 737.0 3.2 0.0 50.0 24.5 93039.0 1.0 1.8
9 141.0 0.8 726.0 3.2 0.0 52.0 24.5 93057.0 1.0 1.3
10 156.0 0.8 734.0 3.2 0.0 50.0 24.4 92494.0 1.0 1.8
Appendix 1
Experiment: Lysozyme in ACETATE at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) CO (cnts/s)
1 0.0 0.9 584.0 2.3 0.0 22.0 4.6 196132.0 1.0 0.2
2 19.0 0.9 575.0 2.3 0.4 23.0 4.6 197349.0 1.0 0.4
3 37.0 0.9 561.0 2.4 0.6 25.0 5.0 197285.0 1.0 0.6
4 58.0 0.9 558.0 2.4 0.0 26.0 5.1 197594.0 1.0 0.4
5 77.0 0.9 559.0 2.4 0.0 25.0 4.8 198630.0 1.0 0.5
6 97.0 0.9 555.0 2.4 0.5 26.0 4.8 197994.0 1.0 0.6
7 117.0 0.9 549.0 2.5 0.6 27.0 4.9 198900.0 1.0 1.0
8 135.0 0.9 547.0 2.5 0.5 27.0 4.7 200009.0 1.0 0.6
9 155.0 0.9 547.0 2.5 0.6 26.0 4.6 199603.0 1.0 1.1
10 174.0 0.9 539.0 2.5 0.6 28.0 4.7 200227.0 1.0 1.1
Experiment: Lysozyme in ACETATE at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) CC) (cnts/s)
1 0.0 0.9 673.0 2.3 0.0 22.0 9.3 168137.0 1.0 0.4
2 19.0 0.9 684.0 2.3 0.0 21.0 9.4 169210.0 1.0 0.6
3 41.0 0.9 685.0 2.3 0.3 22.0 9.6 171759.0 1.0 0.3
4 63.0 0.9 680.0 2.3 0.0 22.0 9.6 172482.0 1.0 0.3
5 84.0 0.9 681.0 2.3 0.0 22.0 9.5 174029.0 1.0 0.2
6 106.0 0.9 674.0 2.3 0.4 22.0 9.4 175619.0 1.0 0.4
7 128.0 0.9 687.0 2.3 0.4 22.0 9.7 176716.0 1.0 0.2
8 149.0 0.9 672.0 2.3 0.5 22.0 9.4 178008.0 1.0 1.1
9 170.0 0.9 683.0 2.3 0.4 22.0 9.4 178659.0 1.0 0.4
10 191.0 0.9 687.0 2.3 0.0 21.0 9.4 178474.0 1.0 0.3
Experiment: Lysozyme in ACETATE at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 958.0 1.8 0.3 13.0 14.1 148840.0 1.0 0.2
2 24.0 0.9 947.0 1.9 0.4 13.0 14.2 150209.0 1.0 0.4
3 48.0 0.9 963.0 1.8 0.0 13.0 14.2 150712.0 1.0 0.5
4 72.0 0.9 962.0 1.8 0.0 13.0 14.2 150684.0 1.0 0.3
5 95.0 0.9 952.0 1.9 0.3 13.0 14.3 151567.0 1.0 0.4
6 120.0 0.9 963.0 1.8 0.0 13.0 14.2 152341.0 1.0 0.2
7 144.0 0.9 960.0 1.8 0.0 13.0 14.2 152603.0 1.0 0.3
8 167.0 0.9 953.0 1.9 0.0 13.0 14.3 152644.0 1.0 0.8
Experiment: Lysozyme in ACETATE at 2Q“C
Meas. Time Ampl Difin Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) () (nm) (nm) <°C) (cnts/s)
1 0.0 0.9 1132.0 1.8 0.0 12.0 18.9 130442.0 1.0 0.2
2 26.0 0.9 1118.0 1.8 0.3 12.0 19.1 131046.0 1.0 0.4
3 53.0 0.9 1131.0 1.8 0.3 12.0 18.9 131665.0 1.0 0.3
4 79.0 0.9 1123.0 1.8 0.4 12.0 19.1 132500.0 1.0 0.7
5 106.0 0.9 1120.0 1.8 0.3 12.0 19.0 132806.0 1.0 0.3
6 132.0 0.9 1127.0 1.8 0.3 12.0 19.1 133151.0 1.0 0.5
7 159.0 0.9 1116.0 1.8 0.3 12.0 18.9 133837.0 1.0 0.3
8 185.0 0.9 1129.0 1.8 0.4 12.0 18.9 133962.0 1.0 0.4
9 211.0 0.9 1118.0 1.8 0.3 12.0 19.1 134877.0 1.0 0.4
10 237.0 0.9 1124.0 1.8 0.3 12.0 19.1 134872.0 1.0 0.4
Experiment: Lysozyme in ACETATE at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) CC) (cnts/s)
1 0.0 0.9 1298.0 1.7 0.0 11.0 23.4 136213.0 1.0 0.6
2 26.0 0.9 1279.0 1.8 0.4 12.0 23.8 136975.0 1.0 0.5
3 51.0 0.9 1294.0 1.8 0.4 12.0 23.8 135653.0 1.0 0.6
4 77.0 0.9 1299.0 1.8 0.0 12.0 23.8 134984.0 1.0 0.3
5 102.0 0.9 1309.0 1.7 0.0 11.0 23.8 134839.0 1.0 0.4
6 129.0 0.9 1299.0 1.8 0.0 12.0 23.7 133939.0 1.0 0.5
7 155.0 0.9 1309.0 1.7 0.4 11.0 23.8 133647.0 1.0 0.8
8 182.0 0.9 1295.0 1.8 0.0 12.0 23.7 132748.0 1.0 0.4
9 208.0 0.9 1283.0 1.8 0.4 12.0 23.8 132678.0 1.0 0.7
10 235.0 0.9 1293.0 1.8 0.4 12.0 23.8 131593.0 1.0 0.6
Appendix 1
Experiment Lysozyme in PIPES at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 662.0 2.0 0.0 16.0 4.3 191883.0 1.0 0.6
2 19.0 0.9 648.0 21 0.0 17.0 4.4 191260.0 1.0 0.3
3 39.0 0.9 637.0 2.1 0.0 18.0 4.4 191179.0 1.0 0.3
4 59.0 0.9 641.0 2.1 0.4 18.0 4.4 191208.0 1.0 0.5
5 79.0 0.9 635.0 2.1 0.4 18.0 4.4 191113.0 1.0 0.5
6 98.0 0.9 635.0 2.1 0.0 18.0 4.5 190503.0 1.0 0.5
7 118.0 0.9 634.0 2.1 0.5 18.0 4.2 189782.0 1.0 0.8
8 139.0 0.9 631.0 2.1 0.5 18.0 4.5 189464.0 1.0 0.7
9 159.0 0.9 624.0 21 0.0 19.0 4.4 189096.0 1.0 0.4
10 178.0 0.9 632.0 2.1 0.3 18.0 4.4 189736.0 1.0 0.3
Experiment Lysozyme in PIPES at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 773.0 2.0 0.0 15.0 8.8 176165.0 1.0 0.3
2 18.0 0.9 771.0 2 0 0.4 15.0 8.9 176369.0 1.0 0.5
3 40.0 0.9 776.0 2.0 0.3 15.0 9.1 176145.0 1.0 0.3
4 60.0 0.9 774.0 2.0 0.4 15.0 8.9 176466.0 1.0 0.5
5 81.0 0.9 770.0 2.0 0.4 15.0 8.8 177118.0 1.0 0.7
6 101.0 0.9 775.0 2.0 0.3 15.0 8.9 177372.0 1.0 0.3
7 122.0 0.9 770.0 2.0 0.4 15.0 8.8 177753.0 1.0 0.4
8 142.0 0.9 766.0 2.0 0.4 15.0 8.7 177768.0 1.0 0.5
9 163.0 0.9 774.0 1.9 0.4 15.0 8.6 178475.0 1.0 0.6
10 184.0 0.9 771.0 2.0 0.0 15.0 8.9 178808.0 1.0 0.3
Experiment: Lysozyme in PIPES at 15*C
Meas. Time Ampl Diffn Coed Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) CC) (cnts/s)
1 0.0 0.9 923.0 1.8 0.3 13.0 12.9 177061.0 1.0 0.2
2 20.0 0.9 917.0 1.9 0.4 14.0 13.4 177313.0 1.0 0.4
3 41.0 0.9 924.0 1.9 0.0 13.0 13.4 178016.0 1.0 0.4
4 62.0 0.9 922.0 1.9 0.0 14.0 13.5 178822.0 1.0 0.2
5 83.0 0.9 923.0 1.9 0.0 14.0 13.4 179853.0 1.0 0.6
6 104.0 0.9 916.0 1.9 0.3 14.0 13.5 182465.0 1.0 0.4
7 124.0 0.9 921.0 1.9 0.0 14.0 13.4 179441.0 1.0 0.7
8 145.0 0.9 924.0 1.9 0.3 13.0 13.4 179915.0 1.0 0.4
9 166.0 0.9 927.0 1.9 0.4 13.0 13.4 181253.0 1.0 0.6
10 186.0 0.9 928.0 1.9 0.4 13.0 13.5 180152.0 1.0 0.6
Experiment Lysozyme in PIPES at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) cc) (cnts/s)
1 0.0 0.8 1053.0 1.9 0.4 13.0 18.1 186027.0 1.0 0.9
2 20.0 0.9 1093.0 1.8 0.4 12.0 18.2 178580.0 1.0 0.6
3 41.0 0.9 1095.0 1.8 0.3 12.0 18.3 178721.0 1.0 0.4
4 61.0 0.9 1088.0 1.8 0.3 12.0 18.2 179065.0 1.0 0.5
5 83.0 0.9 1100.0 1.8 0.3 12.0 18.3 178833.0 1.0 0.4
6 103.0 0.9 1090.0 1.8 0.3 13.0 18.3 179112.0 1.0 0.3
7 124.0 0.9 1100.0 1.8 0.3 12.0 18.3 178286.0 1.0 0.5
8 145.0 0.9 1092.0 1.8 0.3 12.0 18.1 179067.0 1.0 0.6
9 165.0 0.9 1094.0 1.8 0.3 12.0 18.3 178866.0 1.0 0.4
Experiment: Lysozyme in PIPES at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) <°c) (cnts/s)
1 0.0 0.9 1258.0 1.8 0.0 12.0 221 176885.0 1.0 0.6
2 20.0 0.9 1270.0 1.7 0.3 11.0 221 175990.0 1.0 0.6
3 41.0 0.9 1279.0 1.8 0.0 12.0 23.1 174630.0 1.0 0.4
4 62.0 0.9 1277.0 1.7 0.3 11.0 22.7 173985.0 1.0 0.3
5 84.0 0.9 1275.0 1.8 0.3 12.0 23.1 172715.0 1.0 0.3
6 105.0 0.9 1276.0 1.7 0.0 11.0 22.9 172054.0 1.0 0.3
7 127.0 0.9 1280.0 1.7 0.3 11.0 22.9 170403.0 1.0 0.5
8 148.0 0.9 1290.0 1.7 0.0 11.0 23.1 168799.0 1.0 0.4
9 170.0 0.9 1285.0 1.7 0.3 11.0 23.0 167388.0 1.0 0.4
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Experiment: Lysozyme in HEPES at 5°C
Meas. Time Ampl Diffn Coeff Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.1 670.0 1.6 0.0 14.0 4.8 201558.0 1.0 0.3
2 18.0 0.0 671.0 1.0 0.0 14.0 4.6 201934.0 1.0 0.4
3 37.0 0.0 691.0 0.4 0.0 13.0 4.9 202068.0 1.0 0.3
4 56.0 0.0 648.0 0.9 0.0 14.0 4.8 200176.0 1.0 0.6
5 74.0 0.7 651.0 3.0 0.0 14.0 4.6 198592.0 1.0 0.3
6 94.0 0.0 651.0 0.6 0.0 13.0 4.9 199474.0 1.0 0.6
7 114.0 0.0 681.0 0.3 0.0 14.0 4.9 201363.0 1.0 0.3
8 132.0 0.1 699.0 1.4 0.0 14.0 5.1 199131.0 1.0 0.3
9 152.0 0.8 659.0 3.2 0.0 14.0 4.8 202273.0 1.0 0.6
10 172.0 0.2 693.0 2.0 0.0 14.0 4.8 203439.0 1.0 0.3
Experiment: Lysozyme in HEPES at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.2 753.0 2.1 0.0 15.0 10.1 201151.0 1.0 0.2
2 21.0 0.1 773.0 1.4 0.0 15.0 9.7 200219.0 1.0 0.5
3 43.0 0.0 798.0 0.6 0.0 15.0 9.8 198387.0 1.0 0.2
4 64.0 0.2 789.0 2.3 0.0 15.0 10.1 201009.0 1.0 0.3
5 82.0 0.1 775.0 1.6 0.0 16.0 9.6 195824.0 1.0 0.4
6 100.1 0.2 748.0 2.1 0.0 15.0 10.1 196978.0 1.0 0.3
7 115.0 0.1 764.0 1.6 0.0 16.0 9.8 199383.0 1.0 0.1
8 126.0 0.0 777.0 0.2 0.0 16.0 9.7 194310.0 1.0 0.2
9 48.0 0.1 748.0 2.1 0.0 15.0 9.8 196166.0 1.0 0.5
10 162.0 0.1 746.0 2.0 0.0 15.0 9.9 195018.0 1.0 0.2
Experiment: Lysozyme in HEPES at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.8 978.0 2.6 0.0 13.0 13.7 180870.0 1.0 0.2
2 20.0 0.1 920.0 0.1 0.0 13.0 13.9 180471.0 1.0 0.3
3 41.0 0.0 938.0 0.2 0.0 13.0 13.0 180241.0 1.0 0.3
4 62.0 0.0 965.0 0.3 0.0 14.0 11.8 179618.0 1.0 0.4
5 82.0 0.0 971.0 0.7 0.0 14.0 11.2 180360.0 1.0 0.2
6 103.0 0.0 990.0 0.1 0.0 13.0 10.8 179534.0 1.0 0.2
7 124.0 76.1 954.0 0.0 0.0 14.0 10.2 179379.0 1.0 0.4
8 144.0 0.7 968.0 2.5 0.0 14.0 11.0 197467.0 1.0 0.3
9 165.0 0.6 961.0 2.3 0.0 13.0 11.0 194740.0 1.0 0.3
10 184.0 0.0 952.0 0.7 0.0 14.0 11.2 182333.0 1.0 0.1
Experiment: Lysozyme in HEPES at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.2 1100.0 1.7 0.0 12.0 19.2 175063.0 1.0 0.3
2 20.0 0.0 1037.0 0.8 0.0 13.0 19.3 172204.0 1.0 0.1
3 41.0 0.0 1011.0 0.4 0.0 12.0 19.3 170978.0 1.0 0.2
4 63.0 0.0 1020.0 0.6 0.0 13.0 19.3 172042.0 1.0 0.4
5 84.0 125.2 1054.0 0.0 0.0 13.0 19.4 170024.0 1.0 0.3
6 106.0 0.0 1080.0 0.9 0.0 13.0 19.3 171740.0 1.0 0.3
7 128.0 0.1 1020.0 0.1 0.0 12.0 19.5 170706.0 1.0 0.6
8 149.0 0.0 1064.0 0.6 0.0 12.0 19.3 171324.0 1.0 0.4
9 171.0 0.0 1069.0 0.2 0.0 13.0 19.3 171126.0 1.0 0.3
10 192.0 109.4 1054.0 0.0 0.0 13.0 19.5 171311.0 1.0 0.2
Experiment: Lysozyme in HEPES at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd Estd MW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 41.0 0.0 1245.0 0.2 0.0 12.0 23.0 180241.0 1.0 0.3
2 62.0 0.0 1254.0 0.3 0.0 12.0 23.8 179618.0 1.0 0.4
3 82.0 0.0 1271.0 0.7 0.0 13.0 24.0 180360.0 1.0 0.2
4 103.0 0.0 1020.0 0.1 0.0 13.0 24.3 179534.0 1.0 0.2
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Experiment: Lysozyme in TRIS at 5°C
Meas. Time Ampl Diffn Coefl Radius Polyd EstdMW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 684.0 2.3 0.0 21.0 4.8 169210.0 1.0 0.6
2 20.0 0.9 685.0 2.3 0.3 22.0 4.6 171759.0 1.0 0.3
3 41.0 0.9 680.0 2.3 0.0 22.0 4.8 172482.0 1.0 0.3
4 62.0 0.9 672.0 2.3 0.5 22.0 4.8 178008.0 1.0 1.1
5 82.0 0.9 683.0 2.3 0.4 22.0 4.6 178659.0 1.0 0.4
6 103.0 0.9 555.0 2.4 0.5 26.0 4.7 197994.0 1.0 0.6
7 124.0 0.9 567.0 1.8 0.0 23.0 4.9 150712.0 1.0 0.5
8 144.0 0.9 562.0 1.8 0.0 22.0 4.9 150684.0 1.0 0.3
9 165.0 0.9 652.0 1.9 0.3 23.0 4.8 151567.0 1.0 0.4
10 184.0 0.9 639.0 2.5 0.6 28.0 4.8 200227.0 1.0 1.1
Experiment: Lysozyme in TRIS at 10°C
Meas. Time Ampl Diffn Coefl Radius Polyd EstdMW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 555.0 2.4 0.5 26.0 9.3 172482.0 1.0 0.4
2 19.0 0.9 663.0 1.8 0.0 23.0 9.2 178008.0 1.0 0.6
3 41.0 0.9 662.0 1.8 0.0 22.0 9.6 150209.0 1.0 0.3
4 63.0 0.9 680.0 2.3 0.0 22.0 9.6 150712.0 1.0 0.4
5 84.0 0.9 648.0 2.1 0.0 22.0 9.5 174029.0 1.0 0.5
6 106.0 0.9 676.0 2.0 0.0 21.0 9.4 175619.0 1.0 0.4
7 128.0 0.9 684.0 2.3 0.0 21.0 9.7 176716.0 1.0 0.2
8 149.0 0.9 685.0 2.3 0.3 22.0 9.6 152603.0 1.0 0.6
9 170.0 0.9 680.0 2.3 0.0 22.0 9.4 178659.0 1.0 0.3
10 191.0 0.9 681.0 2.3 0.0 22.0 9.4 178474.0 1.0 0.6
Experiment: Lysozyme in TRIS at 15°C
Meas. Time Ampl Diffn Coefl Radius Polyd EstdMW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 958.0 1.8 0.3 13.0 14.1 148840.0 1.0 0.2
2 24.0 0.9 947.0 1.9 0.4 13.0 14.2 150209.0 1.0 0.4
3 48.0 0.9 963.0 1.8 0.0 13.0 14.2 150712.0 1.0 0.5
4 72.0 0.9 962.0 1.8 0.0 13.0 14.2 150684.0 1.0 0.3
5 95.0 0.9 952.0 1.9 0.3 13.0 14.3 151567.0 1.0 0.4
6 120.0 0.9 963.0 1.8 0.0 13.0 14.2 152341.0 1.0 0.2
7 144.0 0.9 960.0 1.8 0.0 13.0 14.2 152603.0 1.0 0.3
8 167.0 0.9 953.0 1.9 0.0 13.0 14.3 152644.0 1.0 0.8
Experiment: Lysozyme in TRIS at 20°C
Meas. Time Ampl Diffn Coefl Radius Polyd EstdMW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 1132.0 1.8 0.0 12.0 18.9 160442.0 1.0 0.2
2 26.0 0.9 1100.0 1.8 0.3 12.0 18.3 178833.0 1.0 0.4
3 53.0 0.9 1090.0 1.8 0.3 13.0 18.3 179112.0 1.0 0.3
4 79.0 0.9 1100.0 1.8 0.3 12.0 18.3 178286.0 1.0 0.5
5 106.0 0.9 1120.0 1.8 0.3 12.0 19.0 152806.0 1.0 0.3
6 132.0 0.9 1127.0 1.8 0.3 12.0 19.1 163151.0 1.0 0.5
7 159.0 0.8 1053.0 1.9 0.4 13.0 18.1 186027.0 1.0 0.9
8 185.0 0.9 1093.0 1.8 0.4 12.0 18.2 178580.0 1.0 0.6
9 211.0 0.9 1118.0 1.8 0.3 12.0 19.1 154877.0 1.0 0.4
10 237.0 0.9 1124.0 1.8 0.3 12.0 19.1 154872.0 1.0 0.4
Experiment: Lysozyme in TRIS at 25°C
Meas. Time Ampl Diffn Coefl Radius Polyd EstdMW Temp Count Baseline SOS error
# (s) 0 (nm) (nm) (°C) (cnts/s)
1 0.0 0.9 1298.0 1.7 0.0 11.0 23.4 136213.0 1.0 0.6
2 26.0 0.9 1297.0 1.8 0.3 12.0 23.8 131279.0 1.0 0.3
3 38.0 0.9 1296.0 1.8 0.3 12.0 23.7 130884.0 1.0 0.5
4 53.0 0.9 1299.0 1.8 0.3 12.0 23.8 130466.0 1.0 0.5
5 72.0 0.9 1309.0 1.7 0.0 11.0 23.8 134839.0 1.0 0.4
6 96.0 0.9 1299.0 1.8 0.0 12.0 23.7 133939.0 1.0 0.5
7 106.0 0.9 1297.0 1.8 0.3 12.0 23.8 131279.0 1.0 0.3
8 118.0 0.9 1296.0 1.8 0.3 12.0 23.7 130884.0 1.0 0.5
9 125.0 0.9 1299.0 1.8 0.3 12.0 23.8 130466.0 1.0 0.5
10 169.0 0.9 1293.0 1.8 0.4 12.0 23.8 131593.0 1.0 0.6
A ppendix  2
2.1 ABA-1 Protein parameters
rABA-1 sequence:
1 11 21 31 41 51
1 HHFTLESSLD THLKW LSQEQ KDELLKMKKD GKAKKELEAK 
ILHYYDELEG DAKKEATEHL 60 
61 KGGCREILKH VVGEEKAAEL KNLKDSGASK EELKAKVEEA 
LHAVTDEEKK QYIADFGPAC 120 
121 KKIYGVHTSR RRR
N um ber o f am ino acids: 133 
M olecu lar w eight: 15267.3 
T heoretical p i: 7.92
A m ino acid com position:
Ala (A) 1 2 9.0%
Arg (R) 5 3.8%
Asn (N) 1 0 .8 %
Asp (D) 8 6 .0 %
C ys(C ) 2 1.5%
Gin (Q) 3 2.3%
Glu (E) 19 14.3%
Gly (G) 8 6 .0 %
His (H) 8 6 .0 %
lie (I) 4 3.0%
Leu (L) 15 11.3%
L ys(K ) 23 17.3%
M et (M) 1 0 .8 %
Phe(F ) 2 1.5%
Pro (P) 1 0 .8 %
Ser (S) 6 4.5%
Thr (T) 5 3.8%
T rp(W ) 1 0 .8 %
T yr(Y ) 4 3.0%
Val (V) 5 3.8%
Asx (B) 0 0 .0 %
Glx (Z) 0 0 .0 %
X aa (X) 0 0 .0 %
Total number of negatively charged residues (Asp + Glu): 27
Total number of positively charged residues (Arg + Lys): 28
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Atomic composition:
Carbon C 672
Hydrogen H 1090
Nitrogen N 192
Oxygen O 207
Sulfur s 3
F orm ula : C672H 1090N 192O207S3 
T otal n u m b er o f atom s: 2164 
Extinction coefficients:
Conditions: 6.0 M  guanidium hydrochloride, 0.02 M  phosphate buffer, pH  6.5
Extinction coefficients are in units o f  M "1 cm ' 1 .
The first table lists values computed assuming ALL Cys 
residues appear as half cystines, whereas the second table 
assumes that NONE do.
276 278 279 280 282
nm nm nm nm nm
Ext. coefficient 11345 11327 11160 10930 10520
Abs 0.1% (=1 g/1) 0.743 0.742 0.731 0.716 0.689
276 278 279 280 282
nm nm nm nm nm
Ext. coefficient 1 1 2 0 0 1 1 2 0 0 11040 10810 10400
Abs 0.1% (=1 g/1) 0.734 0.734 0.723 0.708 0.681
E stim ated  half-life:
The N-terminal o f  the sequence considered is H  (His).
The estimated half-life is: 3.5 hours (mammalian reticulocytes, in vitro). 
1 0  min (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Instab ility  index:
The instability index (II) is computed to be 49.83 
This classifies the protein as unstable.
Aliphatic index: 75.64
Grand average of hydropathicity (GRAVY): -1.018
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2.2 OvFARl Protein parameters
rO vFA Rl sequence:
1 11 21 31 41 51
1 M YHQLILM ALIGVIM ANVVP FSMSNIPEEY KEFIPEEVKN 
FYKNLTQEDR QILRELASKH 60 
61 ATFTNEDAAL EALKNKSDKL YQKAVELRNF VKAKIDSLKP 
DAKAFVDEII AKVRSLRPED 120 
121 GQKLDMEKLK QAARDIIAKY EALNEETKEE LKATFPNTTK 
IITNEKFKRI ANSFLQKN
N um ber o f am ino acids: 178 
M olecu lar w eight: 20580.8 
T heoretical p i: 8.58 
A m ino acid com position:
Ala (A) 18 1 0 .1 %
Arg (R) 7 3.9%
Asn (N) 1 2 6.7%
Asp (D) 9 5.1%
C ys(C ) 0 0 .0 %
Gin (Q) 7 3.9%
Glu (E) 19 10.7%
Gly (G) 2 1 . 1 %
His (H) 2 1 . 1 %
lie (I) 14 7.9%
Leu (L) 17 9.6%
L ys(K ) 23 12.9%
M et (M) 5 2 .8 %
Phe (F) 9 5.1%
Pro (P) 6 3.4%
Ser (S) 7 3.9%
Thr (T) 8 4.5%
Trp (W) 0 0 .0 %
T yr(Y ) 5 2 .8 %
Val (V) 8 4.5%
Asx (B) 0 0 .0 %
Glx (Z) 0 0 .0 %
Xaa (X) 0 0 .0 %
Total n u m b er o f negatively charged  residues (Asp + Glu): 28 
Total n u m b er o f positively charged  residues (A rg + Lys): 30 
Atom ic com position:
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Carbon C 924
Hydrogen H  1495
Nitrogen N  245
Oxygen O 274
Sulfur S 5
F orm ula : C924H 1495N 245O274S5 
T otal n u m b e r o f atom s: 2943
E xtinction coefficients:
Conditions: 6.0 M guanidium hydrochloride, 0.02 M phosphate buffer, pH  6.5 
Extinction coefficients are in units o f  M -1 cm ' 1 .
Ext. coefficient 
Abs 0.1% (=1 g/1)
276 278 279 280 282
nm nm nm nm nm
7250 7000 6725 6400 6000
0.352 0.340 0.327 0.311 0.292
E stim ated  half-life:
The N-terminal o f  the sequence considered is M (Met).
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
> 2 0  hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Instab ility  index:
The instability index (II) is computed to be 45.01 
This classifies the protein as unstable.
A liphatic index: 91.07
G ran d  average o f hydropath ic ity  (GRAVY): -0.516
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2.3 CeFAR2 protein parameters
rCeFAR2 sequence:
1 11 21 31 41 51
1 M IRAFLVVAL ASVAVFSAPI PEVPQNFDDI PAEYKGLIPA 
EVAEHLKAIT AEEKAALKEL 60 
61 AQNHKEYKTE EEFKAALKEK SPSLYEKAGK LEALLTAKFE 
KLDATAQALV KKIIAKGREL 120 
121 HQQYLAGDKP TLDSLKELAK GYIAEYKALS DDAKATITAE 
FPILTGFFQN EKIQAIVGQY 180 
181 VN
N um ber o f am ino acids: 182
M olecu lar w eight: 20035.1
T heore tical p i: 5.73
A m ino acid com position:
Ala (A) 30 16.5%
A rg(R ) 2 1 . 1 %
A sn (N) 4 2 .2 %
Asp (D) 7 3.8%
C ys(C ) 0 0 .0 %
Gin (Q) 8 4.4%
Glu (E) 2 0 1 1 .0 %
G ly(G ) 7 3.8%
His (El) 3 1 .6 %
lie (I) 1 2 6 .6 %
Leu (L) 2 0 1 1 .0 %
Lys (K) 2 2 1 2 . 1 %
M et (M) 1 0.5%
Phe (F) 8 4.4%
Pro (P) 8 4.4%
Ser (S) 6 3.3%
T hr(T ) 8 4.4%
Trp (W) 0 0 .0 %
T yr(Y ) 7 3.8%
Val (V) 9 4.9%
A sx (B) 0 0 .0 %
Glx (Z) 0 0 .0 %
Xaa (X) 0 0 .0 %
Total number of negatively charged residues (Asp + Glu): 27
Total number of positively charged residues (Arg + Lys): 24
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Atomic composition:
Carbon C 917
Hydrogen H  1464
N itrogen N  228
Oxygen O 270
Sulfur S 1
F orm ula : C917H 1464N 228O270S 1 
Total n u m b e r o f  atom s: 2880
Extinction coefficients:
Conditions: 6.0 M  guanidium hydrochloride, 0.02 M  phosphate buffer, pH  6.5 
Extinction coefficients are in units o f  M ' 1 cm ' 1 .
Ext. coefficient 
Abs 0.1% (=1 g/1)
276 278 279 280 282
nm nm nm nm nm
10150 9800 9415 8960 8400
0.507 0.489 0.470 0.447 0.419
E stim ated  half-life:
The N-terminal o f  the sequence considered is M  (Met).
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
> 2 0  hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Instab ility  index:
The instability index (II) is computed to be 20.02 
This classifies the protein as stable.
A liphatic index: 99.40
G ran d  average o f hydropath ic ity  (GRAVY): -0.164
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2.4 CeFAR3 protein parameters
rCeFAR3 sequence:
1 11 21 31 41 51
1 M SRLFAFNVF CLVLLRFSAA APADDSSPFS QILKQHKDLL 
PSEVVQAYQD LSPEEKAALK 60 
61 DVFKNYKSYK NEGELIAALK EKSSSLGEKA EKLQAKLQKK 
VDALSPKPKD FVNELIAGGR 120 
121 GLYARSVNGE KISVSEIKLLIETQVAAYKA LPAEAQDELK 
KNFGGVAKFL EDDKTQTLIA 180 
181 KLLEKNNNQ
N um ber o f am ino acids: 189
M olecular w eight: 20905.0 
T heoretical p i: 8.76 
A m ino acid com position:
Ala (A) 2 2 1 1 .6 %
Arg (R) 4 2 . 1 %
Asn (N) 9 4.8%
Asp (D) 1 0 5.3%
C ys(C ) 1 0.5%
G ln(Q ) 1 0 5.3%
Glu (E) 16 8.5%
Gly (G) 8 4.2%
His (H) 1 0.5%
lie (I) 1r 3.7%
Leu (L) 25 13.2%
Lys (K) 25 13.2%
M et (M) 1 0.5%
P he(F ) 9 4.8%
Pro (P) 7 3.7%
S er(S ) 15 7.9%
Thr (T) 3 1 .6 %
Trp (W) 0 0 .0 %
T yr(Y ) 5 2 .6 %
Val (V) 1 1 5.8%
A sx (B) 0 0 .0 %
Glx (Z) 0 0 .0 %
X aa(X ) 0 0 .0 %
Total number of negatively charged residues (Asp + Glu): 26
Total number of positively charged residues (Arg + Lys): 29
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Atomic composition:
Carbon C 941
Hydrogen H 1523
Nitrogen N 247
Oxygen O 284
Sulfur s 2
F orm ula : C9 4 1H 1523N 247O284S2
T otal n u m b e r o f  atom s: 2997 
Extinction coefficients:
Conditions: 6.0 M  guanidium hydrochloride, 0.02 M  phosphate buffer, pH  6.5
Extinction coefficients are in units o f  M ' 1 cm*1 .
The first table lists values computed assuming ALL Cys 
residues appear as ha lf cystines, whereas the second table 
assumes that NONE do.
276 278 279 280 282
nm nm nm nm nm
Ext. coefficient 7250 7000 6725 6400 6000
Abs 0.1% (=1 g/1) 0.347 0.335 0.322 0.306 0.287
276 278 279 280 282
nm nm nm nm nm
Ext. coefficient 7250 7000 6725 6400 6000
Abs 0.1% (=1 g/1) 0.347 0.335 0.322 0.306 0.287
E stim ated  half-life:
The N-terminal o f  the sequence considered is M  (Met).
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
> 2 0  hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Instab ility  index:
The instability index (II) is computed to be 44.41 
This classifies the protein as unstable.
Aliphatic index: 94.55
Grand average of hydropathicity (GRAVY): -0.367
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2.5 GpFARl protein parameters
rG pFA Rl (with leader sequence) sequence:
1 11 21 31 41 51
1 M QRILLCLTG ASFIVLLFGA SLPPIDISSIPEQY RELIPK  
EVIDFYNTLT AEDKQALKEV 60 
61 AERHEEFQTE EQAM EALKAK SEKLHSKAVE LRNLVKEKID 
KLVPGAKTFV TETIEKLKAM 120 
121 RPKSGEKPNL EELRKGANDTIEKFKALSVE AKESLKANFP 
KITGVIQSEK FQALAKSLLK 180 
181 TEGAAPAA
N um ber o f am ino acids: 188
M olecu lar w eight: 20922.3
Theoretical p i: 7.75
A m ino acid com position:
Ala (A) 21 1 1 .2 %
Arg (R) 6 3.2%
Asn (N) 5 2.7%
Asp (D) 5 2.7%
C ys(C ) 1 0.5%
Gin (Q) 7 3.7%
Glu (E) 24 1 2 .8 %
G ly(G ) 7 3.7%
His (H) 2 1 . 1 %
lie (I) 12 6.4%
Leu (L) 22 11.7%
L ys(K ) 24 1 2 .8 %
M et (M) 3 1 .6 %
P he(F ) 8 4.3%
Pro (P) 9 4.8%
S er(S ) 11 5.9%
T hr(T ) 10 5.3%
T rp(W ) 0 0 .0 %
T yr(Y ) 2 1 . 1 %
V al(V ) 9 4.8%
A sx(B ) 0 0 .0 %
G lx(Z ) 0 0 .0 %
X aa(X ) 0 0 .0 %
Total number of negatively charged residues (Asp + Glu): 29
Total number of positively charged residues (Arg + Lys): 30
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Atomic composition:
Carbon C 939
Hydrogen H 1546
Nitrogen N 246
Oxygen O 282
Sulfur s 4
Form ula : C939H i546N2460282S4 
T otal n u m b er o f atom s: 3017 
Extinction coefficients:
Conditions: 6.0 M guanidium hydrochloride, 0.02 M  phosphate buffer, pH  6.5
Extinction coefficients are in units o f  M -1 cm ' 1 .
The first table lists values computed assuming ALL Cys 
residues appear as half cystines, whereas the second table 
assumes that NONE do.
276
nm
Ext. coefficient 2900
Abs 0.1% (=1 g/1) 0.139
278 279 280 282
nm nm nm nm
2800 2690 2560 2400
0.134 0.129 0.122 0.115
276
nm
Ext. coefficient 2900
Abs 0.1% (=1 g/1) 0.139
278 279 280 282
nm nm nm nm
2800 2690 2560 2400
0.134 0.129 0.122 0.115
E stim ated  half-life:
The N-terminal o f  the sequence considered is M  (Met).
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
> 2 0  hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Instab ility  index:
The instability index (II) is computed to be 33.38 
This classifies the protein as stable.
Aliphatic index: 95.59
Grand average of hydropathicity (GRAVY): -0.331
